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The molecular signals specifying neuronal, glial or multipotent precursors in the 
developing and adult central nervous system (CNS) are largely unknown. Radial glial 
cells have recently been discovered as major precursor population generating neurons or 
glial cells in separate lineages in the developing CNS. Towards this aim to identify the 
key molecular determinants for neurogenic versus gliogenic fate in radial glial cells I 
used a novel method to selectively enrich neurogenic or non-neurogenic radial glia and 
compared their gene expression to adult subependymal zone (SEZ) precursors in vitro 
and in vivo. The expression profile of the transcription factors Olig2 and Pax6 were 
particularly intriguing. Olig2 was 67 fold higher in multipotent compared to neuronal or 
glial precursors, while Pax6 showed strongest expression in neuronal precursors. I 
therefore focused further on the functional analysis of Pax6 and Olig2 in neural stem cell 
in vitro and in vivo. Interference with Olig2 in neural stem cells in vitro revealed its role 
in self-renewal. In adult neural stem cells of the SEZ overexpression of Olig2 promoted 
oligodendrocyte formation. Pax6, in contrast, proved to be a very potent neurogenic 
determinant since neurogenesis is not only Pax6-dependent in neural stem cells in vitro, 
but also in adult neural stem cell in vivo.  
Taken together, these results demonstrate a pathway combining transcription factors of 
dorsal and ventral regions that is activated in a specific lineage progression of adult 
neural stem cells in vitro and in vivo. Most importantly also in regard to therapeutic 
approaches, this work revealed the molecular mechanisms to direct adult neural stem 




Sowohl während der Entwicklung, als auch im adulten Gehirn in jenen Regionen, in 
denen Neurogenese zeitlebens fortgesetzt wird, erfolgt eine hierarchische Spezifizierung 
von Vorläuferzellen. Multipotente Stammzellen generieren schnell proliferierende bi- 
oder multipotente Vorläuferzellen, die dann neurogene und gliogene Vorläuferzellen 
bilden. Die molekularen Mechanismen dieser Zellschicksalsspezifizierung zu ergründen, 
war Ziel dieser Arbeit. Es gelang mir mittels Fluoreszens-aktivierter Zellsortierung 
radiale Gliazellen, die auf die Bildung von Neuronen festgelegt sind, selektiv 
anzureichern. Deren spezifische Genexpression wurde mit jener von nicht neurogenen 
radialen Gliazellen verglichen. In dieser vergleichenden Expressionsanalyse war das 
Expressionsprofil der Transkriptionsfaktoren Olig2 und Pax6 besonders bemerkenswert. 
Olig2 ist in multipotenten Vorläuferzellen 67-fach höher exprimiert als in neuronalen 
oder glialen Vorläufern, während Pax6 43-fach in neuronalen Vorläufern angereichert 
war. Ich konnte Pax6 immunhistochemisch in neuronalen Vorläuferzellen der 
Subepenymalzone (SEZ) des lateralen Ventrikels und des rostralen migratorischen 
Stromes (RMS) lokalisieren. Im Gegensatz dazu  war Olig2 ausschliesslich in bi- oder 
multipotenten Vorläuferzellen in vivo und in vitro nachweissbar. Deshalb konzentrierte 
ich mich in meiner weiteren Arbeit auf die funktionelle Analyse von Pax6 und Olig2 in 
neuralen Stammzellen in vitro und in vivo. Experimente in denen die der Expression von 
Olig2 in neuralen Stammzellen in vitro behindert wurde, demonstrierten seine Rolle in 
Selbsterneuerung undifferenzierter Stammzellen und deren Fähigkeit, Neurone und 
Oligodendrozyten zu bilden. Pax6, hingegen, offenbarte sich als starker neurogener 
Faktor, da Pax6 notwendig und hinreichend für die Neurogenese nicht nur aus 
Stammzellen in Zellkultur, sondern auch aus adulten Stammzellen in vivo ist In diesen 
Versuchen zeigte sich zudem eine völlig neue Rolle des Transkriptionsfaktors Pax6 auf 
die Differenzierung von dopaminergen Neuronen in der adulten Neurogenese. Meine 
Arbeit konnte daher die Schlüsselrolle von zwei Transkriptionsgfaktoren bei der 
Zellschicksalsbestimmung neuraler Stammzellen aufzeigen.  
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INTRODUCTION 
3.1 Cell fate in the developing CNS 
A central question in neural development is how different precursor populations differ on 
a molecular level. The adult central nervous system is composed of different neuronal 
and glial cell types that are generated during development. Different lines of evidence 
show a hierarchical fate restriction as depicted in Fig. 1.  
In most CNS regions multipotent precursors are sequentially more and more 
restricted during development to generate a specific cell type (Fig. 1). Early 
neuroepithelial precursors throughout the CNS are multipotent and can generate 
undifferentiated precursors, astrocytes, oligodendrocytes and neurons (McCarthy et al., 
2000). However, during development, they do not generate these diverse cell types 
directly, but rather via precursors that are more restricted in their potential, i.e. generate 
exclusively a single cell type. This restriction occurs around the onset of neurogenesis 
when most progenitor cells in the cerebral cortex and striatum generate a single cell type, 
even though some precursors give rise to large and wide-spread clones containing 
multiple cell types (Grove et al., 1993; Luskin et al., 1993; Luskin et al., 1988; Price and 
Thurlow, 1988; Reid and Walsh, 2002; Walsh and Cepko, 1993).  
This fate restriction might occur step-wise with intermediate precursors that are 
not anymore multipotent, but only oligo- or bi-potent (see e.g. Williams et al., 1991; 
Mizuguchi et al., 2001; Novitch et al., 2001; Gregori et al., 2002). Neuronal progenitors 
are hence restricted to the generation of neurons but still proliferate and generate further 
neuron-restricted progenitors. It is conceivable that this amplification phase is also 
accompanied by further differentiation of the precursors so they can then generate the 
finally differentiating cells (Fig. 1). In contrast, the progeny of a single precursor in the 
retina frequently generates neurons and glia (Turner and Cepko, 1987), suggesting that 
fate specification occurs differently in these regions of the CNS.  
The intrinsic lineage bias of telencephalic precursors was confirmed when single 
cells were isolated in vitro and most of them also generated exclusively a single cell type 
(Qian et al., 1997), with approximately 15% of these being multipotent stem cells that 
generate both neurons and glia, while the remainder being restricted neuroblasts that 
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generate only neurons (Qian et al., 1997). Likewise, the addition of growth factors 
favoring either the neuronal lineage, such as the platelet derived growth factor (PDGF), 
or the glial lineage, such as ciliary neutrophic factor (CNTF) can no longer affect the 
progeny of precursors isolated during neurogenesis from the cerebral cortex. 
Nevertheless these factors still can influence fate decisions of neuroepithelial cells 
isolated at earlier stages (Götz et al., 2002; Williams and Price, 1995; Williams et al., 
1991). Similarly fate-restricted precursors have been isolated from the developing spinal 
cord (Kalyani et al., 1998; Mayer-Proschel et al., 1997). In these studies so-called 
neuronal-restricted precursor (NRP) cells have been found that express E-NCAM (high 
polysialic-acid NCAM) and are morphologically distinct from neuroepithelial cells 
(Kalyani et al., 1997) and spinal cord glial progenitors (Rao and Mayer-Proschel, 1997). 
Taken together, these experiments suggest a progressive fate restriction of precursors in 
some CNS regions during development by intrinsic fate determinants (Edlund and Jessell, 
1999) whose molecular nature, however, is still largely unknown (Fig. 1).  
 
3.2 Lineage restriction in the adult CNS 
For a long time, it had been the dogma that most neurons are generated during the 
development and there is no neurogenesis in the adult mammalian brain (Rakic, 1985). 
However, in the non-mammalian vertebrate adult brains, such as fish, amphibians, 
reptiles, and birds, widespread neurogenesis had reported (for review, see Doetsch et al., 
2002). For example, in the telencephalon of song birds there are hot spots of adult 
neurogenesis (Alvarez-Buylla and Nottebohm, 1988; Belluzzi et al., 2003). Newly 
generated neurons are important to learn songs for birds and actually those cells are 
generated from radial glia that persist throughout life in the hot spot.  
In contrast to these lower vertebrate classes, there are only two neurogenic sites in 
the adult mammalian brain including. One is the subepenymal zone (SEZ) in the lateral 
wall of the lateral ventricle of the brain and another is the subgranular layer (SGL) of the 
dentate gyrus of the hippocampus (Doetsch et al., 1999; Seri et al., 2004; Seri et al., 
2001). The SEZ and SGL are responsible for the adult neurogenesis of olfactory bulb 
interneurons and hippocampus granule neurons respectively (Fig. 2a).  
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The adult olfactory bulb (OB) is supplied lifelong distinct types of interneurons 
are continuously generated throughout adulthood (Altman, 1969; Lois and Alvarez-
Buylla, 1994; Luskin, 1993), the GABAergic interneurons located in the granule cell 
layer (GCL) and glomerular layer (GL) as well as the dopaminergic interneurons in the 
GL (Carleton et al., 2003; Kosaka et al., 1998; Kosaka et al., 1985). The newborn 
neurons originate from astroglia-like stem cells immunoreactive for the glia-fibrillary 
acidic protein GFAP (type B cells) lining the lateral wall of the lateral ventricle (SEZ; 
Fig. 2a,b; Doetsch et al., 1999). The adult neural stem cells divide slowly, while their 
progeny, the transit-amplifying precursors (type C cells; Capela and Temple, 2002; 
Doetsch et al., 1999; Doetsch et al., 2002), divide fast and generate neuroblasts (type A 
cells) that already express neuronal traits (PSA-NCAM or doublecortin) and migrate via 
the rostral migratory stream (RMS) towards the OB (Lois and Alvarez-Buylla, 1994; 
Luskin, 1993; Fig. 2a,b).  
This proposed lineage progression seems to resemble the progressive fate 
restriction as present during development observed (described above). Indirect evidence 
suggests that the type C cells are not yet irreversibly restricted to a certain lineage since 
they can still give rise to several cell types upon isolation in the neurosphere culture 
conditions (Capela and Temple, 2002; Doetsch et al., 2002; Imura et al., 2003; Morshead 
et al., 2003) and they can alter their progeny in response to certain lesion paradigms in 
vivo (Arvidsson et al., 2002; Decker et al., 2002). In contrast, the progeny of type C cells, 
the type A cells, express neuronal characteristics and seem to be specified to the neuronal 
fate (Doetsch et al., 1999; Menezes et al., 1995).  
Important progress has been made in the identification of factors regulating stem 
or transit-amplifying cell fate as well as asymmetric cell division (Doetsch et al., 2002; 
Molofsky et al., 2003; Shi et al., 2004). Dlx2 expression has been detected in transit-
amplifying cells (Doetsch et al., 2002), reminiscent of transcription factors specific for 
the ventral telencephalon during development, but its role for fate specification has so far 
only been examined in the developing telencephalon (Anderson et al., 1997a; Anderson 
et al., 1997b). Molofsky et al. showed that Bmi-1, a polycomb family transcriptional 
repressor, is required for adult neural stem cells to maintain their self renewal ability 
mainly by repressing the expression of p16Ink4a encoding a cyclin-dependent kinase 
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inhibitor (Molofsky et al., 2003). Polycomb family proteins are supposed to silence their 
target gene by binding DNA and modifying chromatin structure (Peterson et al., 1997). In 
addition, the transcriptional repressor, Tlx, was also shown to be crucial for adult neural 
stem cells (Shi et al., 2004) Tlx belongs to the nuclear orphan receptor and function as a 
transcription repressor (Yu et al., 2000). Shi et al. showed that in the adult Tlx deficient 
mice, neurosphere forming cells were greatly reduced and they differentiated into 
astrocyte spontaneously in vitro. Indeed, and also in vivo in the SEZ and SGL the 
absence of Tlx resulted in a reduction of the number of proliferating cells (Shi et al., 
2004). However, little is known about the molecular determinants of this sequential fate 
restriction and about the mechanisms directing cell progenitors towards specific neuronal 
or glial subtypes in the adult brain.  
 
3.3 Isolation of multipotent precursors in the neurosphere 
culture system 
The identification of such intrinsic fate determinants might be important to direct 
precursors of the adult telencephalon towards desired phenotypes. Notably, because of 
their role in neurogenesis in vivo, the isolation of multipotent cells from the adult CNS 
(Kilpatrick and Bartlett, 1995; Reynolds and Weiss, 1996) has prompted great hopes for 
reconstitution of degenerating neurons or oligodendrocytes in neuropathological 
conditions. The neurosphere culture system serves as a technique to expand precursors 
with a bi- or multipotent fate (Reynolds et al., 1992). The neurosphere model was 
previously used to characterize gene expression of multipotent and self-renewing 
precursors in comparison to stem cells of other organs (Ivanova et al., 2002; Ramalho-
Santos et al., 2002). Interestingly, a surprising similarity in gene expression was detected 
between cells cultured as neurospheres and undifferentiated embryonic stem cells 
(Ramalho-Santos et al., 2002).  
This might be due to alterations of the precursors induced by the neurosphere 
culture system. Are the same region-specific fate determinants acting normally in the 
ventral telencephalon important in neurospheres from the ventral, but not the dorsal 
telencephalon? Is patterning information in these precursors maintained? Indeed, region-
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specific differences between neurosphere cultures originating from different regions have 
been reported (Hitoshi et al., 2002b; Ostenfeld et al., 2002; Parmar et al., 2002), but 
others found significant changes in region-specific features after expansion in 
neurosphere cultures (Gabay et al., 2003; Santa-Olalla et al., 2003). Moreover, little is 
known about the differences or similarities of neurospheres derived from the adult 
subependymal zone to those from different embryonic regions.  
However, precursors isolated from the adult telencephalon and propagated as 
neurospheres generate disappointingly few neurons, both in transplantation paradigms as 
well as in differentiating conditions in vitro (Fricker et al., 1999; Herrera et al., 1999; 
Song et al., 2002; Winkler et al., 1998). Thus, the identification of fate determinants that 
direct the progeny of adult precursors towards the generation of neurons or 
oligodendrocytes will be very valuable for reconstitutive approaches. 
 
3.4 Isolation of functionally distinct precursor populations by 
FACS 
To identify intrinsic fate determinants directing distinct subsets of precursors towards a 
specific fate, I aimed to separate functionally distinct precursor populations from the 
developing telencephalon. Mayer-Pröschel and colleagues (1997) succeeded to isolate a 
neuron-restricted precursor cell from the developing spinal cord by immunopanning with 
an antibody directed against the embryonic form of the neural cell adhesion molecule (E-
NCAM). However, isolation of precursors by the same antigen from the developing 
telencephalon resulted in a mixed population of precursors with only 50-60% neuronal 
precursors (Blass-Kampmann et al., 1994), similar to the proportion of neurogenic cells 
in un-sorted cells at this stage (Götz, 1995; Heins et al., 2002; Williams et al., 1991). 
Another approach to isolate neuronal precursors was the use of the Talpha1-promoter 
active in neurons and their immediate precursors (Bamji and Miller, 1996; Wang et al., 
1998b). However, most of the cells isolated by this promoter are already postmitotic and 
double labeling with a nestin-enhancer driven transgene reveals co-localization only in 
1% of all cortical cells (Sawamoto et al., 2001). At this stage, about 40% of all cells in 
the developing cortex are neurogenic precursors (Hartfuss et al., 2001; Malatesta et al., 
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2000), suggesting that only a small subpopulation of these can be isolated by this dual-
promoter strategy. Finally, quintuple fluorescent activated cell sorting (FACS) analysis 
proved to be more efficient in selecting of neurogenic, gliogenic or immature precursors 
(Maric et al., 2000; Maric et al., 2003). Maric et al. used surface immunolabeling against 
the fibroblast growth factor receptor 1 (FGFR-1) and the epidermal growth factor 
receptor (EGFR) together with membrane potential and Ca2+ indicator dyes to 
characterize physiological properties emerging among precursors, neuroglial progenitors 
and differentiating neurons during neurogenesis of embryonic rat neocortex (Maric et al., 
2000; Maric et al., 2003). 
Here I focused on radial glial cells since they have been shown to constitute the 
majority of precursors in the ventricular zone (Hartfuss et al., 2003; Hartfuss et al., 2001; 
Noctor et al., 2002). Therefore these lineage data described above directly apply to radial 
glia, and suggest that they consist of different sublineages, some of which are specialized 
to generate neurons, and others to generate glial cells. Therefore, I choose the selection of 
radial glial cells by the green fluorescent protein (GFP) under control of the human glial-
fibrillary acidic protein (hGFAP) promoter (Nolte et al., 2001; Zhuo et al., 1997) because 
I suspected that their fate regulation might be similar to the hGFAP-GFP-positive adult 
neural stem cells that also exhibit astroglial features (Doetsch et al., 1999; Seri et al., 
2001). Specifically, hGFAP-GFP-positive radial glial cells isolated from the cortex at 
mid-neurogenesis contain three major lineages: precursors that generate only neurons, 
precursors that generate exclusively non-neuronal progeny (nestin- and GFAP-positive 
cells) and a small subset of precursors that generate neurons and glial cells (Götz et al., 
2002; Heins et al., 2002; Malatesta et al., 2003; Malatesta et al., 2000). Here, I attempted 
to separate these functionally distinct precursors by selecting for precursors expressing 
different levels of the transgene.  
Notably, however, radial glial cells do not only differ within a brain region, such 
as described above for the cerebral cortex, but also between regions of the developing 
CNS. This regional heterogeneity of radial glial cells is apparent at the molecular level, 
and translates into pronounced differences in cell fate. For example, radial glial cells of 
the lateral ganglionic eminence (LGE), the anlage of the striatum (Olsson et al., 1998), 
contain the retinol-binding protein 1 (RBP-1), which is not detectable in the medial 
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ganglionic eminence (MGE) or cortex (Toresson et al., 1999). Indeed, retinoid signaling 
seems important for the development of neurons in the striatum, but not in adjacent 
regions (Toresson et al., 1999). To determine whether the neurogenic lineage of radial 
glia observed in the cerebral cortex is an exception or the rule in the developing CNS I 
isolated in a second approach radial glia from different regions of the developing CNS, 
namely the ganglionic eminence (GE) and the spinal cord. To address this issue the 
progeny of radial glial cells was analyzed in vivo by Cre recombinase based fate-
mapping (Malatesta et al., 2003) and in vitro by FACS. Also in this second approach I 
took advantage of the transgenic mouse line expressing eGFP under the control of the 
hGFAP promoter since I found the transgene expressed in all three regions in radial glial 
cells.  
These different approaches allowed us to separate distinct precursor populations, 
the multipotent neurosphere cells and radial glial cells that are enriched for precursors 
that are firmly restricted to the neurogenic or the gliogenic lineage respectively (Fig. 3). 
 
3.5 Candidate genes 
In the developing CNS, some intrinsic fate determinants have been already identified. For 
example, our lab has recently characterized the transcription factor Pax6 as a potent 
neurogenic determinant in precursors of the dorsal telencephalon, the anlage of the 
cerebral cortex (Götz et al., 1998; Heins et al., 2002). The loss of Pax6 reduces the 
number of neurogenic radial glia cells in the cerebral cortex, resulting in a prominent 
reduction of neurons in a region-specific manner (Heins et al., 2002).  
Similarly, members of the basic helix loop helix (bHLH) transcription factor 
family also play important roles in the specification of neurons and oligodendrocytes, but 
they also act in a tight region-specific and cell-type specific context (Bertrand et al., 
2002). Yang and colleagues have recently suggested that the local influence of sonic 
hedgehog (Shh) induces the expression of the transcription factor Olig2 and thereby 
instructs precursors to generate GABAergic neurons and oligodendrocytes (Yung et al., 
2002). These data are therefore further in line with the suggestion that the Olig2-positive 
cells in the MGE generate GABAergic neurons and oligodendrocytes. Notably, however, 
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Mash1 seems to be additionally required for the lineage of GABAergic neurons (Yung et 
al., 2002), but only very few radial glial cells in the GE contain Mash1 (Hartfuss et al., 
2001; Malatesta et al., 2003). Taken together, these data would support a view that most 
radial glial cells of the MGE generate oligodendrocytes. Indeed, the loss of Olig2 in 
radial glial cells of the ventral telencephalon results in a lack of oligodendrocytes in the 
forebrain (Lu et al., 2002; Zhou and Anderson, 2002), the loss of Gsh2 in radial glia of 
the LGE leads to defects in olfactory bulb and striatal neurogenesis (Corbin et al., 2000; 
Toresson and Campbell, 2001; Yun et al., 2001) and the loss of Pax6 in cortical radial 
glia results in a reduction of cortical neurons (Heins et al., 2002). These results highlight 
the importance of patterning in CNS development and the close link between patterning 
and fate determination (Bertrand et al., 2002; Campbell and Götz, 2002; Götz et al., 
1998) and raise the question about these mechanisms in neurosphere cultures.  
To gain some insights into the molecular mechanisms of fate specification I first 
examined the expression of candidate fate determinants in neurospheres derived from 
different regions of the developing CNS and the adult SEZ before and after 
differentiation, and of the lineage restricted FACS sorted precursor populations (Fig. 3). 
These results showed a pan-regional downregulation of most transcription factors in the 
expansion phase of neurospheres with the exception of the Olig genes. Interestingly, a 
similar downregulation of most region-specific transcription factors except the Olig genes 
was also observed when adherent cells were exposed to the epidermal growth factor 
(EGF) or the fibroblast growth factor (FGF2). When neurosphere cells were exposed to 
differentiation conditions and in the FACS sorted neurogenic precursors, only Pax6 was 
upregulated.  
 
3.6 Tools for manipulating gene expression 
Therefore, I mainly concentrated on Olig2 and Pax6 and evaluated their role in loss-of-
function and gain-of-function experiments in neurosphere cultures and in vivo in adult 
neurogenesis. The gain of function experiments were performed with retroviral vectors 
containing the wildtype form of the Pax6 or Olig2 resulting in a strongly enhanced 
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expression of the respective gene (Fig. 4). However, gain-of-function approaches alone 
are not useful to fully determine the function of a gene of interest.  
To block the function of these endogenous transcription factors I used different 
approaches to validate the results observed with one approach. First, I used the knock 
down approach with small interfering RNA (siRNA) to block the transcription. These 
siRNA molecules are recruited by a protein complex, RNA-induced silencing complex 
(RISC) that recognizes and destroys complementary mRNAs, thereby preventing 
generation of the gene product. However, the knock down approach does only interfere 
with the production of new protein, but can not hinder the function of already expressed 
proteins. 
Therefore I used second approach, and exchanged the transactivating or repressor 
domain of the respective transcription factor. For example, the transactivating domain of 
Pax6 was replaced by a repressor domain of Engrailed (Pax6-engrailed; Yamasaki et al., 
2001) whereas the repressor domain of Olig2 was removed or replaced with the 
transactivator VP16 (Mizuguchi et al., 2001; Fig. 4). These recombinant proteins then 
interfere directly with the endogenous wildtype protein and compete with them for DNA-
binding. However, the replacement of a repressing domain by an activating domain, 
might not result in the same phenotype as it would be observed with a true loss of 
function. 
For that reason and to confirm the specificity of the observed results I took, lastly, 
advantage of the Cre-lox system (Dymecki and Tomasiewicz, 1998; Zinyk et al., 1998). 
By using mice in which an exon of the gene to be analyzed was replaced by a modified 
exon flanked by two lox sequences, the endogenous transcription factors could then be 
eliminated from cells by recombination performed by the Cre recombinase. By 
transducing few cells retroviral vectors the consequences of the inactivation of the target 
gene could be observed. Importantly, the combination of these distinct approaches makes 
me confident about the results obtained. 
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bFGF Basic fibroblast growth factor 
bHLH Basic helix-loop-helix 
BLBP Brain lipid binding protein 
BMP Bone morphogentic protein 
bp Base pairs 
BLBP Brain lipid-binding protein 
BrdU 5-bromo-2’deoxy-uridine 
cDNA Complementary DNA 
CDS Coding sequence 
CNS Central nervous system 
CNTF Ciliary neutrophic factor 




dd1 Differentiated for 1 day 
dd3 Differentiated for 3 days 
DIV Days in vitro 
DNA Desoxyribonucleic acid  
DNAse Desoxyribonuclease 
dNTP Deoxynucleotides 
dsRNA Double-stranded RNA 
E Embryonic day 
ECM Extracellular matrix 
EGF Epidermal growth factor 
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EGFR Epidermal growth factor receptor 
eGFP Enhanced green fluorescent protein 
eng Engrailed repressor domain 
ES cells Embryonic stem cells 
EtOH Ethanol 
FACS Fluorescent activated cell sorting 
FCS Fetal calf serum 
FGF Fibroblast growth factor 
FGFR Fibroblast growth factor receptor 
Fig Figure 
GABA Gamma-aminobutyric acid 
GAPDH Glyceraldehyde-3-phosphate dehydrogenase 
GCL Granule cell layer 
GE Ganglionic eminence 
GFAP Glial fibrillary acidic protein 
GFP Green fluorescent protein 
GL Glomerular layer 
GLAST Glutamate astrocyte-specific transporter 
GN Granule neuron 
GRP Glial restricted precursor 
GS Glutamin synthase 
HC Hippocampus 
hGFAP Human Glial fibrillary acidic protein  
HPRT Hypoxanthine guanine phosphoribosyl transferase 
HRP Horse radish peroxidase 
Ig Immunoglobulin 
IRES Internal ribosome entry site 
IZ Intermediate zone 
LGE Lateral ganglionic eminence 
LI  Labelling index 
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LTR Long terminal repeat 
LV Lateral ventricle 
mAB Monoclonal antibody 
MGE Medial ganglioniceminence 
MI Maximum intensity 
M-phase Mitosis phase of the cell cycle 
mRNA Messenger ribonucleid acid 
n Sample number 
Ngn Neurogenin 
NGS Normal goat serum 
NOP Neuron-oligodendrocyte precursor 
NRP Neuron restricted precursor 
NS neurospheres 
OB Olfactory bulb 
P Postnatal day 
pAB Polyclonal antibody 
Pax6eng Pax6 full legth cDNA fused to the repressor domain of 
engrailed 
PBS Phosphate buffered saline 
PCR Polymerase chain reaction 
PDL Poly-D-lysine 
PDGF Platelet derived growth factor 
PDGFR Platelet derived growth factor receptor 
PFA Paraformaldehyde 
PGN Periglomerular neuron 
PSANCAM Polysialylated neural cell adhesion molecule 
RA Retinoic Acid 
RBP-1 Retinol-binding protein 1 
RC2 Radial cell 2 
RMS Rostral migratory stream 
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RNA Ribonucleic acid 
RNAse Ribonuclease 
RNAi Inhibitory RNA 
rpm Rounds per minute 
RT Room temperature 
RT-PCR Realtime- polymerase chain reaction  
SEM Standard error of the mean 
Sey Small eye mutant 
SEZ Subependymal zone 
Shh Sonic Hedghog 
siRNA Short inhibitory RNA 
STDEV Standard deviation 
SVZ Subventricular zone 
TH Tyrosine hydroxylase 
TSA Tyramid signal amplification 
U Uridine 
ud undifferentiated 
UTR Untranslated region 




5 MATERIALS AND METHODS 
 
5.1 Animals 
The experiments of this work were performed with time-mated Wistar rats, C57/Bl6 and 
FVB/N mice, the Pax6-mutant allele Small-eye (Sey/Sey; Heins et al., 2002; Hill et al., 
1991) and the hGFAP-eGFP transgenic mouse line (background FVB/N; Malatesta et al., 
2003; Nolte et al., 2001). Embryos were collected from time-mated mice or rats (mice: 
day of plug=E0; rats: day of sperm detection=E1). 
The Pax6 mutant mouse carries the Sey allele on a C56BL6/6J x DBA/2J background. 
This naturally occurring point mutation leads to non-functional truncated proteins 
(Haubst et al., 2004; Hill et al., 1991). Heterozygous Sey mice were recognized by their 
eye-phenotype and were crossed to obtain homozygous and WT mice in a litter. WT and 
Sey/Sey mice were mainly used in the experiments. Sey/Sey embryos were recognized by 
the lack of eyes. Heterozygous (Sey/+) mice were recognized by their reduced eye size 
(Hill et al., 1991). The hGFAPeGFP mouse embryos were identified by visualization of 
green fluorescence at the fluorescent stereo microscope. The Pax6flox/flox mouse line 
contained two loxP sites in the region encoding the amino terminus of Pax6, including 
the initiator methionine and most of the paired domain(Ashery-Padan et al., 2000). These 
mice were kept in a homozygous colony. 
 
5.2 Genotyping 
For maintenance of the colony hGFAPeGFP mice were genotyped by PCR on tail DNA. 
DNA was obtained following the protocol from Laired at al. (Laird et al., 1991): Tail 
biopsies of less than 5mm length were transferred in 0.5ml lysis buffer and incubated 
rotating for several hours or overnight at 55°C in a modified hybridization oven. 
Following complete lysis, hairs and tissue residues were removed by centrifugation in an 
Eppendorf centrifuge at maximal speed (13.1 x 103g~ 16.000 rpm) for 10-20 minutes. 
The supernatant was poured into 0.5ml isopropanol and mixed well. DNA-precipitates 
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were transferred in 300-500µl TE-buffer. To solve the DNA, tubes were again rotated at 
55°C for several hours. 
The PCR protocol for genotyping of the hGFAP-GFP(94-4) and the hGFAP-eGFP mouse 
line was adapted from previous publications (Nolte et al., 2001; Zhuo et al., 1997). PCR 
was carried out using about 40ng of genomic DNA (~1µl) and 0.4µM of the primers 
GFAP-LZ: 5’-ACTCCTTCATAAAgCCCTCg-3’ and GFP-2 5’-
AAgTCgATgCCCTTCAgCTC-3’. in a 30µl reaction volume containing 0.2mM dNTPs, 
1.5 U of Taq-DNA-polymerase, 3µl 10xPCR-buffer and 3µl 5xQ-solution. Cycling 
conditions were: 4 minutes at 94°C, followed by 30 cycles at 94°C for 30 seconds, at 
61.5°C for 30 seconds and at 72°C for 1 minute. Finally, amplicons were extended at 
72°C for 5 minutes. 15µl of each PCR-product was analyzed on a 1 % agarose-TBE-gel. 
The amplicon obtained from transgenic animals is 498bp long. 
 
5.3 In vivo injections 
5.3.1 Anesthesia 
For the in utero injections mice were anesthetized by intraperitoneal injection of 
Medetomidine (Domitor, 0.5 mg per kg body weight), Midazolam (Dormicum, 5 mg per 
kg body weight), and Fentanyl (Fentanyl Hexal, 0.05 mg per kg body weight). The 
anesthesia was antagonized by intraperitoneal injection of Atipamezol (Antisedan, 5 mg 
per kg body weight), Flumacenil (Anexate, 0.5 mg per kg body weight) and Naloxon 
(Narcanti-vet, 1.2 mg per kg body weight) were used. 
For the adult injections animals were anesthetized by intraperitoneal injection of ketamin 
(Ketaminhydrochlorid, 100mg per kg of body weight) and rompun (Xylazinhydrochlorid, 
0.6mg per kg of body weight). 
 
5.3.2 Stereotaxic injections in adult mice. 
Injections of retroviral particles were done stereotactically on 9-10 weeks old male mice 
(C57BL/6J) as described (Carleton et al., 2003). Briefly, the adult mice were fixed in a 
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stereotactic apparatus (Kopf). The head was shaved and a 1 cm midline cut was 
performed. The skull was opened at the anterior-posterior and medio–lateral coordinates 
(see below) using a drill (Multipro395PR, Dremel). About 500 nl of virus were injected 
at both sites of each hemisphere by means of a glass micropipette prepared as described 
above. An oil microinjector (Narashige) was used to inject the solution with viral 
particles very slowly (100 nl/ min). I used the following coordinates for virus injections 
(relative to bregma): for the subependymal zone (SEZ), anterior–posterior = 0.75; medio–
lateral = 1.2; dorso–ventral = 1.7 and anterior–posterior = 1.0; medio–lateral = 1.0; 
dorso–ventral = 1.9 and for the rostral migratory stream (RMS), anterior–posterior = 3.3; 
medio–lateral = 0.82; dorso–ventral = 2.9.  
5.3.3 Stereotaxic injections in pups 
For injections into the cortex of 8-11 day old male mice (CD-1) I used the following 
coordinates: anterior–posterior = 1; medio–lateral = 1; dorso–ventral = 0.7. The injections 
were performed as described above (Stereotaxic injections in adult mice.). After 
injection, animals were returned to their mother and monitored every 10 min until they 
resumed nursing. 
 
5.3.4 In utero injections in E14 embryos 
Timed pregnant CD1 mice (Charles River) with embryos at a gestational age of 
embryonic day 14 (E14) were used for these experiments. Injection needles were made 
from glass micropipettes pulled to produce a long taper and broken under a dissection 
microscope at an inner diameter of 10–20 µm. The glass microcapillaries were sharpened 
with sharpener (Model EG44, Narishige) to produce a bevel angle between 25° and 35° 
as described previously (Olsson et al., 1995). The abdomen was wet shaved and a 2 cm 
midline laparotomy was performed. Each uterine horn was carefully taken out 
individually and kept wet with sterile saline. Embryos located on both sides were injected 
by positioning the uterine horns on a swan neck lamp to illuminate the uterus and to 
visualize the embryo. After positive identification of the forebrain the glass 
microcapillary was inserted in the uterine wall, and 500 nl–1 µl of virus solution was 
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injected into each site. The successful injection of the virus solution in the ventricles 
could be verified by the darkening of the ventricles by Fast Green (0.1%, Sigma) which 
was added to the virus suspension. Between four and ten embryos were injected in every 
pregnant mouse, and surgery was limited to half an hour for each to optimize survival. 
After injections, the uterine horn was washed again with sterile saline, placed back into 
the abdomen and the skin was sutured. The injected pups were sacrificed 2 or 21 days 
after birth. 
 
5.4 Tissue culture 
5.4.1 Cultures of primary dissociated neural precursors 
Embryos (E12– E14) were removed by caesarean section from time-pregnant mice 
anesthetized by an overdose of diethylether (Sigma). The meninges were removed, the 
telencephalic hemispheres separated, the hippocampi and the olfactoric bulbi removed. 
The cortex and the ganglionic eminence (GE) were dissected and collected in separate 
tubes under sterile conditions in HBSS (GIBCO) containing 10 mM HEPES (GIBCO) on 
ice (Götz et al., 1998). The tissue was then allowed to settle, and the balanced salt 
solution was removed and replaced by trypsin-EDTA (0.05 % [w/v] in HBSS (without 
Ca2+, Mg2+ with 0.02 [w/v] EDTA (GIBCO)) and incubated for 15 min at 37°C. The 
enzyme activity was stopped by the addition of twice the volume of Dulbecco’s modified 
eagle medium (DMEM; GIBCO) supplemented with 10 % fetal calf serum (FCS; Sigma) 
and penicillin/streptomycin (100 units/ml penicillin, 100 units/ml streptomycin (GIBCO). 
The tissues were mechanically dissociated with a fire-polished Pasteur pipette coated 
with serum, twice pelleted for 5 min at 172 x g and resuspended in FCS containing 
medium. Cells were plated at 106 cells/ml in DMEM/FCS (0.5ml/well) in a 24-well plate 
on poly-D-lysine (PDL) coated coverslips and incubated at 37°C and 5 % CO2. Acutely 
dissociated cells were fixed after 2 hours with 4% PFA for 15 minutes. Long-term cell 
cultures were maintained in SATO-medium (DMEM, 1g/l Glucose, 2mM Glutamine, 
10µg/ml Insulin (bovine), 100µg/ml Transferrin (human), 0.0286% BSA-pathocyte, 
0.2µM Progesterone, 0.1mM Putrescine, 0.45µM Thyroxine, 0.224µM Selenite, 0.5µM 
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Tri-iodo-thyronine), which was changed every second day and then fixed after 5-7 days 
in vitro (DIV) with 4% PFA for 15 minutes. After three washes with PBS at room 
temperature (RT), cells were processed for immunocytochemistry. In some experiments 
cells from E14 mouse cortex were plated without sorting and cultured for 2 days with or 
without 20 ng/ml fibroblast growth factor-2 (FGF2, human recombinant; Sigma) and/or 
20ng/ml epidermal growth factor (EGF, human recombinant; Sigma). 
For some experiments I established a method to separate ventricular from subventricular 
zone cells. Slices were cut at 300 µm thickness using a McIlwain tissue chopper from 
mouse E14 telencephalon, and the respective regions were then dissected in each slice as 
depicted in Figure 8b. 
 
5.4.2 Neurosphere cultures 
5.4.2.1 Embryonic neurospheres 
Embryonic neurosphere cultures were prepared from the cortex or ganglionic eminence 
(GE) of C57/Bl6 mice or Sey/Sey and wildtype littermates at E14 as described above 
with the exception that these cells were dissociated mechanically without enzymatic 
digestion, then pelleted and cultured after dissociation at clonal density (10 cells/µl) in a 
T75 flask in 15 ml serum-free DMEM/Nut.Mix.F-12 medium (GIBCO) containing B-27 
supplement (concentration 1:50 in F-12 medium; GIBCO), additional 3.5mM glucose, 
20ng/ml EGF and FGF2. Cells were passaged once a week by centrifugation at 172g for 
10 min, followed by mechanical redissociation and replating in 50% neurosphere-
conditioned medium and 50% fresh medium. Cells were frozen for RNA extraction and 
fixed for immunostaining 7 days after passage 4. This ensures that contaminating 
aggregates of cells that are not neurospheres are removed efficiently from the culture 
 
5.4.2.2 Adult neurospheres 
Adult neurospheres were obtained from the lateral wall of the lateral ventricle of adult 
(about 10 week old) mice. The SEZ was prepared after sagittal sectioning of the brain. 
The SEZ was cut in pieces and these pieces were incubated in a dissociation solution 
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containing 0.7 mg/ml hyaluronic acid, 0.2 mg/ml kynurenic acid, and 1.33 mg/ml trypsin 
in HBSS with 2 mM glucose at 37°C for 30 min and gently triturated. The cells were 
centrifuged at 200 g for 5 min, resuspended in 0.9 M sucrose in 0.5× HBSS, and 
centrifuged for 10 min at 750 g. The cell pellet was resuspended in 2 ml of culture 
medium, placed on top of 10 ml 4% BSA in EBSS solution, and centrifuged at 200 g for 
7 min, followed by washing in DMEM/F12. The culture conditions were identical to 
those described above for neurospheres from embryonic brains. 
 
5.4.2.3 Differentiation of neurosphere cultures 
For differentiation of cells from adult and embryonic neurospheres, spheres were spun 
down 7 days after the fourth passage, trypsinized at 37°C for 3 min and dissociated. 
Dissociated cells were plated on PDL-coated glass coverslips at a density of 2x105 
cells/ml and cultured for 1 day in the medium described above followed by 7 days  in the 
same medium without growth factors.  
 
5.4.2.4 Transduction of cultured cells 
Cultured cells were infected with retroviral vectors 2h after plating or transfected 24h 
after plating using 50nM of RNAi constructs and the Effectene Transfection Reagent 
(Qiagen). Then the cells were cultured as described above for 2-7 days.  
 
5.5 Tracing 
For the labelling of precursors with radial morphology from the pial surface, the 
meninges were removed from telencephali (Voigt 1998, Goetz 1998) and placed into a 
solution of green fluorescent beads (Lumafluor 50 nm; ventral side down for GE labeling, 
see Figure 8a and (Malatesta et al., 2000)). Briefly, the green fluorescent beads were 
diluted 1.1 in Hanks-balanced salt solution (HBSS, Gibco) and 5µl of this solution were 
used per brain. Brains were incubated for 10 minutes, transferred to fresh HBSS and 
incubated for further 15 min before dissection to allow sufficient time for transport of the 
fluorescent beads, as demonstrated previously (Malatesta et al., 2000).  
 29
 
5.6 Fluorescence-activated cell sorting (FACS) analysis and 
cell lineage analysis 
Cortex (Ctx), ganglionic eminence (GE) and spinal cord (SC) were dissected from 
hGFAP-EGFP mice (Nolte et al., 2001) at embryonic day (E) 12 (SC) and 14 (Ctx, GE). 
Fluorescent cells were isolated using a FACSort or FACSVantage (Becton Dickinson). 
By reanalysis a purity of 95% was confirmed. A negative control of non-fluorescent cells 
was used to determine the background fluorescence such that less than 1% of non-
fluorescent cells were included in the sort gate. Sorted cells were plated on PDL coated 
coverslips, in presence of a feeder layer derived either from the same or from different 
CNS region of rat embryos at the same developmental stage.(Malatesta et al., 2003; 
Malatesta et al., 2000).To analyze the composition of the cells, they were fixed as soon as 
they were adherent (2h).  
For cell lineage analysis, not more than 50 sorted cells were plated per coverslip to 
minimize the likelihood of clonal superimposition (see Williams et al., 1991) and 
cultured for 6-7 days in chemically defined medium (SATO) as described above (see also 
Götz et al., 1998; Williams and Price, 1995). To detect dividing cells, 5-bromo-2-
deoxyuridine (BrdU; Sigma) was added to the culture medium at a final concentration of 
10µM.  
 
5.7 BrdU administration and Histology 
For some experiments two to three months old FVB/N, C57/Bl6 or hGFAPeGFP mice 
were injected intraperitoneally with a DNA synthesis marker, 5-bromo-2’-deoxyuridine 
(BrdU; 50 mg/kg of body weight, dissolved in 0.9% NaCl with 0.4 N NaOH). After 
different survival times following a single BrdU pulse, the mice were anesthetized with 
3% chloralhydrat and perfused with 4% paraformaldehyde (PFA) in 0.1M phosphate-
buffered saline, pH 7.5, (PBS). After overnight post-fixation at 4°C in the same fixative, 
the tissue was incubated for 24hr in 30% sucrose in PBS and embedded in Tissue Tek 
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and stored at -20°C. Cryosections (15-20 µm thick) were cut sagittaly and collected on 




As primary antibodies I used anti-BrdU (Bio-Science, mouse IgG1), 1:10; anti-CC1 
(Oncogene, IgG2b), 1:200; anti-DCX (Chemicon, guinea pig), 1:2000; anti-Dlx (Hevner 
et al., 2003; rabbit) 1:75; anti-Emx1 (Briata et al., 1996; rabbit) 1:1000; anti- β-
galactosidase (IgG2b), 1:500; anti-GFAP (Sigma, mouse IgG1), 1:200; anti-GFP 
(Clontech, rabbit), 1:1000; anti glutamine synthase (Becton Dickinson, IgG2a), 1:500; 
anti-Gsh2 (Toresson et al., 2000; rabbit) 1:1000; anti-LewisX (Becton Dickinson, mouse 
IgM), 1:10; M2 and M6 (rat),1:200; anti-Mash1 (provided by D. Anderson; Lo et al., 
1998; IgG1) 1:2; anti-NeuN (Chemicon, IgG1), 1:50; anti-NG2 (Chemicon, rabbit), 
1:300; anti-nestin (Dev. Hybridoma Bank, mouse IgG1) 1:4; O4 (J. Price, mouse IgM), 
1:100; anti-Olig2 (Takebayashi et al., 2000; rabbit) 1:400; anti-Pax6 (BABCO, rabbit) 
1:500; anti-PSA-NCAM (kindly provided by P. Durbec, IgM) 1:500; RC2 (P. Leprince, 
mouse IgM) 1:500; anti-S100β (Sigma, IgG1), 1.1000; anti-Sox10 (kindly provided be 
M. Wegener, guinea pig), 1:1000; anti-β-III-tubulin (Sigma, mouse IgG2b), 1:100; anti-
TH (Pel-Freez, rabbit), 1:500. Usually the antibody mix was applied and incubated 
overnight at 4°C in a humid chamber, but for some antibodies special pretreatments were 
necessary. 
For BrdU immunostaining the sections and cell cultures were pretreated with 0.2 % 
Triton X–100 for 2 hrs, and DNA was denatured with 2N HCl for 30 min at 37°C 
followed by two washing steps of 15 min with 0.1M Sodium-tetra-borat (pH 8.5). 
Overnight incubation with the anti-BrdU antibody at 4°C was followed by 2 hrs of 
incubation at room temperature with the secondary antibody.  
Intermediate filament stainings like anti-nestin-, anti-β-tubulin-III- and anti-GFAP-
staining required a special pre-treatment for better visualization of intermediate filaments 
before application of the primary antibodies. Therefore, cells were incubated in EtOH-
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glacial acetic acid for 15 minutes at -20°C followed by three washes in PBS for 10 
minutes at. Acutely dissociated cells and long term cell cultures were incubated in the 
primary antibody at the appropriate dilution. After several washes in PBS cells were 
incubated in the secondary antibody for 45 minutes at room temperature. 
The primary antibodies were then detected by subclass specific secondary antibodies 
coupled to FITC- or TRITC at a dilution of 1:50, or Cy2- or Cy3-coupled antisera at 
1:100. For triple-stainings, I used biotinylated secondary antibodies (dilution 1:50) 
followed by incubation in Streptavidin-AMCA at a 1:50 dilution. After three further 
washes, the glass coverslips were mounted in Aqua Poly/Mount, a glycerol-based 
mounting medium. To rule out any unspecific binding of the secondary antisera, control 
experiments were performed by either leaving out the primary antibody or by using a 
primary antibody against an antigen that is not present in the respective tissue or at the 
respective developmental stage. The following secondary antibodies were used: anti-
rabbit Ig FITC / TRIC / biotinylated, anti-rabbit Ig Cy2 / Cy3, Streptavidin AMCA 
(Boehringer Ingelheim, Vector Laboratories), anti-mouse IgG+M Cy3, anti-mouse IgG1 
FITC / TRIC / biotinylated, anti-mouse IgG2b FITC / TRIC / biotinylated, anti-mouse 
IgM FITC / TRIC / biotinylated (EuroPath Ltd., Southern Biotechnology Associates), 
anti-guinea pig Ig Cy2 / Cy3, anti-rat FITC / TRIC Dianova Immundiagnostics, Jackson 
ImmunoResearch). 
 
5.8.2 X-Gal cytochemistry 
For X-Gal cytochemistry dissociated cell cultures were fixed for 15 min at RT or 30 min 
at 4°C. The fixative contained 0.5 % Glutaraldehyde, 2 mM MgCl2 and 1.25 mM EGTA. 
The cells were washed twice in PBS and incubated for 1 hour at 37°C in X-Gal staining 
solution, containing 4 mM K3Fe(CN)6, 4 mM K4 Fe(CN)6, 1 mM MgCl2, 0.01 % sodium 
desoxycholate and 0.02 % NP-40. The X-Gal (5-Bromo-4-chloro-3-indolyl-ß-D-




Cryostat sections were incubated free floating in primary antibody always containing 
0.5% Triton X-100 and 10% normal goat serum (NGS) overnight at 4°C. Special pre-
treatment as for anti-nestin, anti-β-tubulin-III or anti-GFAP was omitted for better 
preservation of the slices. Some stainings were enhanced using the tyramide 
amplification kit (Perkin Elmer) as described in the tyramide signal amplification (TSA) 
handbook (Perkin Elmer). Briefly, the TSA system uses horse radish peroxidase coupled 
to a secondary antibody to catalyze the deposition of fluorescein labeled tyramide 
amplification reagent onto tissue sections that have been previously blocked with proteins 
(e.g. NGS). This reaction results in the deposition of numerous fluorescin labels 
immediately adjacent to the immobilized HRP enzyme. Since this techniques result in a 
significant enhancement of the signal, it was used for antibodies with low affinity. 
Sections were then counter-stained with 4'-6-Diamidino-2-phenylindole (DAPI) and 
stainings were analyzed at a confocal microscope with 10x or 40x objectives (Leica).  
 
5.8.4 Tunel staining 
Tunel staining was carried out using the cell death kit (Roche) following manufacturer’s 
instructions. Briefly, sections were incubated for two min in 0.1% Triton X-100, 0.1% 
sodium citrate on ice. The slides were incubated with the Tunel reaction mixture (Roche) 
containing the fluorescein labeled nucleotides binding to double stranded low molecular 
weight DNA fragments occurring during apoptosis for 60 min at 37°C. The samples were 
directly analyzed by fluorescence microscopy. Apoptotic TUNEL-positive cells were 
detected in the green (515-565nm) wavelength spectrum. 
 
5.9 Retroviruses 
5.9.1 Retroviral vectors (Fig. 4) 
A 1873-bp fragment containing the entire coding sequence of Pax6 was inserted in the 
sense orientation into the BglII unique restriction site of the retroviral vector 1704 (gift of 
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J.E. Majors), between the upstream LTR and the IRES sequence followed by the lacZ 
gene (Ghattas et al., 1991; Heins et al., 2002). For co-expression with eGFP a 2050 bp 
fragment containing the entire coding region of Pax6 and parts of 5’UTR and 3’UTR was 
inserted in the sense orientation into the EcoRI unique restriction site of the retroviral 
vector pMXIG (Nosaka et al., 1999) between the upstream LTR and the IRES sequence. 
Similarly, the Pax6-EnR fusion construct described in (Yamasaki et al., 2001) was 
subcloned from pMES (consists of the chimeric CMV enhancer/β-actin promoter and the 
Pax6-enR construct, followed by an internal ribosome entry site (IRES) and the EGFP 
coding sequences) and inserted in sense orientation into the EcoRI unique restriction site 
of the retroviral vector pMXIG (Nosaka et al., 1999) between the upstream LTR and the 
IRES sequence. The entire coding sequence of Olig2 and a fusion construct of the entire 
coding sequence of Olig2 with a 675-bp fragment encoding for VP16 were inserted into 
the same site (Olig2-virus, Olig2VP16 virus). BAG (Price, 1987) or the CMMP (the 
transgene in the plasmid described by Klein et al (Klein et al., 2000) was replaced by 
eGFP to generate a control virus to express GFP under control of LTR) virus were used 
as controls.  
 
5.9.2 Retrovirus production with the 293gpg retrovirus producing cell line 
Gpg cells (Ory et al., 1996) were cultured in DMEM (Gibco) containing 10% (v/v) FCS 
(heat inactivated 30 min. at 56°C; Gibco), 1% (v/v) Penicillin-Streptomycin in DMEM 
(Gibco), 1 µg/ml tetracycline (Sigma), 2 µg/ml puromycin (Sigma) and 0.3 mg/ml G418 
(Gibco). Cells were passaged 1/week with PBS and trypsin containing 1ug/ml 
tetracycline. These cells allow for the production of high titer amphotropic retrovirus. 
Many retrovirus packaging cell lines lose packaging efficiency as they are cultured due to 
the gradual loss of expression of the packaging genes. The packaging plasmids 
introduced into this cell line were introduced using different selection markers 
(gentamycin (G418), puromycin). Therefore, expression of packaging proteins can be 
fairly well maintained by culturing the cells continuously in media containing the 
corresponding antibiotics. In addition, the vesicular stomatitis virus G (VSV-G) protein is 
toxic to gpg293 cells so expression of this gene is controlled by tetracycline. Therefore, 
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these cells are maintained in tetracycline, puromycin, and G418 containing medium 
(described above). Retroviral vectors pseudotyped with VSV-G differ from standard 
murine retroviruses by their very broad tropism and the capacity to be concentrated by 
ultracentrifugation without loss of activity (Galipeau et al., 1999). 
Gpg helper-free packaging cells were used for viral production (Pear et al., 1993; Yee et 
al., 1994). For retrovirus production 90-95% confluent gpg cells were transfected using 
Lipofectamine 2000 (Invitrogen) and Opti-MEM I reduced-Serum Medium (Invitrogen) 
as described in the Lipofectamin 2000 transfection protocol for adherent cells 
(Invitrogen). Transfection medium was replaced after 8-10 hours, and gpg cells were 
further cultured in DMEM containing 10% (v/v) FCS (heat inactivated 30 min. at 56°C; 
Gibco), 1% (v/v) Penicillin-Streptomycin in DMEM (Gibco). After 48h the virus-
containing-medium was combined and filtered through a 0.4 um filter (Becton 
Dickinson) and centrifuged at 50000 x g for 90 minutes at 4°C. The virus pellet was 
resuspended in TNE (50mM Tris-HCl (pH7.8), 130MM NaCl, 1mM EDTA) and 
aliquoted. Virus aliquots were stored at -80°C. Virus titres (viral particals/ml) were 
measured by transduction of primary cell cultures in a serial dilution. Cells were cultured 
for 2 days to allow expression of the transgene and then number of infected clones was 
counted (see below). The number of infected clones corresponds to the viral particals 
used for transduction of the primary cells. Viral titers typically were about 107 viral 
particals/ml. Reliable coexpression of GFP and Olig2 or Pax6 was observed 3, 7 and 21 
days after viral transduction with exception of neurons in the OB that had downregulated 
Olig2 14 days after transduction. 
 
5.10 RNA extraction and LightCycler RT–PCR analysis 
Total RNA was extracted using RNeasy kits (Qiagen), treated with DNAse I and 
quantified by optical density. 1µg of total RNA was used to synthesize cDNA with 
oligo(dT)12-18 primers and MoMLV reverse transcriptase (Superscript II; Roche). As 
negative controls, the reverse transcriptase was omitted at the cDNA synthesis step. RT–
PCR was performed with a LightCycler instrument (Roche) with 2µl of cDNA (40ng) 
and the primers listed in Table 1. The protocol consists of two programs: amplification of 
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cDNA and melting curve analysis for product identification and the LightCycler analysis 
software was used for quantitative analysis consisting of the specificity control of the 
amplification reaction using the melting curve program, followed by use of the 
quantification program. The SYBR Green I signal (included in the PCR reaction) of each 
sample is plotted versus the number of cycles and the background fluorescence is 
removed by setting a noise band. This fluorescence threshold is used to determine cycle 
numbers that correlate inversely with the log of the initial template concentration. The 
crossing points (CP) are the intersections between the best fit lines of the log-linear 
region and the noise band and correlate inversely with the log of the initial template 
concentration (LightCycler Operator’s Manual, Version 3.3, April 2000, Roche). The CP 
determined for the candidate mRNA were normalized to those of GAPDH to compensate 
for variability in RNA amount and for exclusion of general transcriptional effects. I 
calculated fold reduction (FR): FR = 2(CP1–CP2) with CP1 as the CP of GAPDH; CP2 
as the CP of the gene of interest. The mRNA levels of GAPDH in each tissue sample 
were set to 1. To test whether the expression of GAPDH remains constant, I quantified 
the expression levels of hypoxanthine phosphoribosyltransferase (HPRT). The 
differences in gene expression between these two genes remained similar in all of the 
examined mRNA samples from different cell types at different developmental stages. 
 
5.11 RNAi 
5.11.1 Construction of the RNAi 
The Olig2RNAi constructs including the scrambled controls were designed as described 
on Ambion webpage (see also Fig. 5a,b). Briefly, 29-mer-DNA-oligonucleotides (siRNA 
oligonucleotide templates) with 21 nucleotides encoding the siRNA and 8 nucleotides 
complementary to the T7 promotor sequence were designed and ordered at TibMolBiol 
(Berlin). The siRNA templates were hybridized to a T7 Promotor primer and the 3’ ends 
of the hybridized oligonucleotides were extended by the Klenow fragment (Ambion). The 
sense and the antisense siRNA templates were then transcribed by T7 RNA polymerase 
(Ambion) and the resulting RNA transcripts are hybridized to create dsRNA. The dsRNA 
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consists of 5’terminal single-stranded leader sequences, a 19 nucleotide target specific 
dsRNA and 3’terminal UUs. The leader sequence is removed by digesting the dsRNA 
with a single-strand specific ribonuclease. Overhanging UU dinucleotide will remain 
because the RNAse does not cleave U residues. The DNA template is removed at the 
same time by a deoxyribonuclease. The resulting siRNA is purified by glass fiber binding 
and elution which removes excess nucleotides, short oligomers, proteins, and salts in the 
reaction. The following primers were used for Olig2RNAi synthesis: Olig2RNAi#19: 5’-
AATGCGGCTGCCGACGGTGACCCTGTCTC-3’, scrambled Olig2RNAi: 5’-
AAGATAACGACGAAGTACGAACCTGTCTC -3’. The 21-nucleotide-long target 
sequence for Olig2 was chosen because it had no significant homology with other known 
genes, including the other members of the Olig family (Takebayashi et al., 2000).  
 
5.11.2 Labeling of the RNAi 
The Olig2RNAi constructs including the scrambled controls were fluorescently labeled as 
described on the Ambion webpage (see also Fig. 5b). Briefly, Cy3 was covalently 
attached to the synthesized RNAi molecules in a one step labeling reaction. The labeled 
RNAi molecules are then precipitated and resuspended in nuclease-free water (Ambion) 
and ready to be transfected. The labeled strands retain complete functionality and can 
therefore be used to reduce the expression of the corresponding target gene (Byrom et al., 
2002), own observations. 
 
5.12 Microarray analysis 
Total RNA was extracted using RNeasy kits (Qiagen), treated with DNAse I and 
quantified by optical density as descrbed above. Total RNA was processed and 
hybridized to the murine expression array 430A (Affymetrix) according to the 
manufacturer’s protocols. After hybridization, the gene chips were automatically washed 
and stained with streptavidin-phycoerythrin by using a fluidics station. Microarrays were 
scanned and analyzed using Affymetrix Microarray Suite v5.0 software (MAS 5.0). 
Output from the microarray analysis was annotated to the RefSeq or GenBank descriptor, 
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exported as an Excel data spreadsheet and stored as CEL files. Cells from 7 independent 
FACS experiments were pooled to obtain 10µg of total RNA for one microarray 
hybridization. Undifferentiated neurospheres and neurospheres differentiated for 1 day 
were pooled from 3 independent experiments to obtain 10µg of total RNA for the 
microarray hybridization. 
The probe sets were filtered with mean expression levels ≥ 1 and then selected all probe 
sets with a ratio smaller than 0.25 or larger 4 
 
5.13 Data analysis 
5.13.1 Quantification of fluorescent cells at the confocal 
Sections were optically sliced in the Z plane by using a 0.7 to 1 µm interval, and cells 
were rotated in orthogonal planes to verify double labeling. 
 
5.13.2 Clonal analysis 
For cell fate analysis in FACS- or retrovirus-experiments, clones were analyzed for their 
composition of neurons, astrocytes, oligodendrocytes and precursor cells. Clones are 
discrete clusters of cells, derived from a single progenitor. The percentage of pure 
neuronal, pure non-neuronal and mixed clones was calculated per coverslip. Clones from 
sorted cells were detected by labeling with the antibodies M2 (mouse precursors and glial 
cells) and M6 (mouse neurons), detecting all mouse cells on the rat feeder layer 
(Malatesta et al., 2000). Control-infected clones were detected by anti-β-gal and anti-GFP 
immunohistochemistry (see above). M2M6 or anti-β-gal respectively were combined 
with cell type specific markers like anti-β-tubulin-III for neurons, anti-GFAP for 
astrocytes or anti-nestin for precursor cells. Clones were analyzed at 40x magnification 
(Zeiss Fluorescent Microscope). The probability of clonal superimposition was calculated 
as described in (Williams et al., 1991), e.g. for coverslips containing a maximum of 65 
clones the probability was calculated to be 0.07, for those with 25 clones 0.02. The mean 






























 and the standard error of the mean n
sSEM =
 were 
computed. Error bars depict the SEM. The unpaired Student’s t-test was used to examine 
whether data sets differed significantly. Data were considered as significant with p<0.05 
and as highly significant with p<0.01. Calculations of the arithmetic average, the standard 
deviation, the standard error of the mean were performed with Microsoft Excel. The 
significance of the obtained data was tested using unpaired student’s T-test. 
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6 RESULTS 
6.1 Selective enrichment of functionally distinct precursor 
(stem cells, neurogenic and gliogenic precursors) 
6.1.1 Selective enrichment of functionally distinct precursor subsets 
from different regions of the embryonic CNS by means of GFP 
intensity in the hGFAPeGFP transgenic mouse model. 
 
As a first approach I examined whether radial glia isolated from different CNS regions, 
might differ in their intrinsic lineage restrictions. I concentrated on the developing 
telencephalon which is divided in two dorso ventral domains, namely the ventral domain 
(pallidum, ganglionic eminence, GE) and the dorsal domain (pallium, cortex) and the 
developing spinal cord (SC). In these regions it is known that radial glial cells act as 
precursors (Hartfuss et al., 2001; Haubst et al., 2004; Malatesta et al., 2000; McMahon 
and McDermott, 2001). To test the lineage restriction of radial glial cells from different 
CNS regions, I examined the progeny of individual radial glial cells, a clone, in vitro. 
Green fluorescent cells were isolated from three regions of the CNS (GE, cortex, SC) by 
FACS from a transgenic mouse line expressing eGFP (enhanced GFP) under the hGFAP-
promoter (Nolte et al., 2001). I first established whether the hGFAP promoter directs 
eGFP to radial glial cells also in this mouse line, as shown previously in a different 
hGFAP-GFP mouse line (Malatesta et al., 2000) and for the hGFAP-Cre line (Malatesta 
et al., 2003) Indeed, the hGFAP-promoter directs eGFP to radial glial cells in all CNS 
regions analyzed (Fig. 6a-e). GFP labelling was observed in the somata of the radial glial 
cells in the ventricular zone (VZ) and in the typical radial processes. After isolation of 
green fluorescent cells by FACS the majority of sorted cells express the radial glial 
markers GLAST and RC2 (Fig. 6e, Malatesta et al., 2000). Almost all of these cells were 
RC2 and GLAST positive (68±3% RC2-positive cells, n=288; 60±4% GLAST-positive 
cells, n=236). Taken together these data indicate that the sorting of eGFP-positive cells 
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from the cortex of hGFAP-eGFP transgenic mice therefore selectively enriches for radial 
glial cells and more specifically for precursor cells expressing GLAST. 
I then cultured the sorted cells on a feeder layer from either the same brain region 
of rat embryos at corresponding ages. The use of the mouse neural-specific antibodies 
M2M6 allows visualization of the sorted cells from mouse CNS and their progeny on the 
immunonegative rat feeder layer (Fig. 7a’,b,’,c’, see also Malatesta et al., 2000). Since 
fate changes require in most cases cell cycle progression (McConnell and Kaznowski, 
1991). I examined exclusively the progeny generated from sorted cells undergoing at 
least one cell cycle in vitro, detected by 5-bromo-2’deoxy-uridine (BrdU) incorporation 
(see Materials and Methods). BrdU is a DNA-base analogue that is incorporated into the 
DNA of dividing cells (Nowakowski et al., 1989), and can be therefore used to 
distinguish between cells that had divided in culture and cells that are already postmitotic. 
In vitro radial glia isolated from the GE and cultured in their normal environment did not 
generate neurons, in contrast to radial glia from the cortex or the spinal cord (Fig. 7a-d). 
Notably, radial glial cells from the cortex or the spinal cord generated significantly more 
neuronal progeny (p<0.005, Fig.7b-d). 
These profound lineage differences observed between cortical and GE radial glia 
might be instructed by the local environment or rely on intrinsic lineage differences. To 
allow manipulation of the in vitro environment, I cultured the sorted cells on a feeder 
layer not only from the same, but also from a different brain region of rat embryos at 
corresponding ages. Importantly, GE radial glia did not change their fate when plated on 
a cortex layer and still generated almost exclusively non-neuronal cell (nestin and/or 
GFAP positive precursors and astrocytes, Fig. 7a’,d) In contrast cortical radial glia still 
generated neurons on a feeder layer from the GE (Fig. 7d). Thus, the lineage differences 
of radial glial cells from different CNS regions persist in radial glia undergoing cell 
division in a different environment in vitro and hence seem to be cell-autonomous. 
Therefore, by isolating radial glial populations from different CNS regions I could 
separate intrinsically different precursor populations that are firmly restricted in the 




So far, my analysis in vivo (Malatesta et al., 2003) and in vitro (see above) relied on the 
hGFAP promoter-mediated targeting of the glutamate astrocyte-specific transporter 
(GLAST)-positive cells located in the ventricular zone (VZ). To confirm the result 
obtained in the FACS analysis, that the radial glial cells from the GE are mostly gliogenic 
precursors, I decided to employ two more independent techniques to isolate the radial 
glial cells and to isolate them from the potential neurogenic precursors located in the 
subventricular zone (SVZ) of the GE. I used first a previously established method to 
back-label precursors with long radial processes by application of fluorescent beads on 
the pial surface (see Malatesta et al., 2000). Since the radial processes of cells in the GE 
are curved ventrally, the fluorescent beads were applied by placing the brain on the 
beads-containing solution (Fig. 8a) with our previous data obtained in the cortex, this 
incubation labels only a few percent of all cells in this region (4.5%, Fig. 8a) that are 
mostly neurons (86% ± 1%) but that also comprise a small number of RC2-positive cells 
(14% ± 2%, n ± 179) as detected shortly after the sort. Therefore, in accordance to our 
previous data, the radial cells isolated by their morphology comprise not only GLAST-
positive but also a small population of RC2-only-positive precursors [(p<0.005, see also 
(Malatesta et al., 2003; Malatesta et al., 2000)]. The progeny of proliferating precursors 
was then examined by the selective analysis of clones that had incorporated BrdU during 
the 5–7 days in vitro, thereby excluding the postmitotic neurons that were included 
among the sorted cells. Notably, hardly any neurons were generated from precursors of 
the GE that had been labeled from the pial surface (4%, Fig. 8c) in pronounced contrast 
to precursors labeled by the same procedure in the cortex (42%, Malatesta et al., 2000). 
These experiments therefore support the region-specific difference of radial gial cells 
from the cortex and the GE in their neurogenic potential.  
To further confirm this region-specific difference, I took a second approach to 
separate VZ and SVZ precursors by surgical dissection, since the radial glial cells are 
exclusively located in the ventricular zone of the GE. Telencephalic slices were cut at 
300µm thickness, and in each slice, a small stripe of the GE adjacent to the ventricle as 
well as a larger piece comprising the SVZ was isolated as depicted in Figure 8b. Indeed, 
I succeeded to largely deplete the SVZ fraction from VZ precursors, since only 11% of 
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the SVZ fraction were RC2 immunoreactive (n =121), an antigen not present on SVZ 
precursors (Hartfuss et al., 2001). These mechanically separated fractions of GE 
precursors were then cultured at clonal density in BrdU on a rat feeder layer identical to 
the conditions of cells isolated by FACS. After 1 week in vitro, VZ cells enriched by 
dissection also generated hardly any neuronal clones, while many more were generated 
by the SVZ fraction (Fig. 8c). There was no difference in the size of the clones generated 
by VZ (3.1% ± 0.2%) or SVZ (3.6% ± 0.8%) precursors, nor in the proportion of neurons 
contained in mixed clones (VZ, 24% neurons; SVZ, 22%). Thus, three independent 
means of labeling VZ cells in the GE show consistently these precursors generate very 
few neurons and suggest that cortical and GE radial glia cell differ profoundly in their 
neurogenic potential. GE radial glia generate very few neurons and therefore these data 
suggest that the majority of neurons in the GE arise from the SVZ precursor pool (Miyata 
et al., 2004; Noctor et al., 2004).  
 
6.1.3 Selective enrichment of functionally distinct precursor subsets 
from the cortex by means of GFP intensity in the hGFAPeGFP 
transgenic mouse model. 
With the aim to separate neurogenic from gliogenic radial glial cells for a comparative 
gene expression analysis of neurogenic versus gliogenic radial glial cells, I examined 
whether these populations may differ in their GFP intensity in the same brain region. The 
rational of this approach is that the GFAP promoter is turned of in neurons and hence 
may be already down-regulated in neuronal precursors, while it should still be active in 
glial precursors. I therefore divided the GFP-positive cells from the cortex of hGFAP-
eGFP mice at embryonic day 14 (E14; Fig. 6a,b) in half to selectively enrich strongly 
and weakly GFP-positive precursors. The sorting gate was set such that about half of the 
GFP-positive cells with lower GFP intensity (=GFP+; but above negative control, see red 
in Fig. 9a,b) were separated by a small gap from the sorting gate selecting the strongest 
GFP-positive cells (=GFP++; Fig. 9a,b). Both gates sorted about 30% of all cells. To 
identify the nature of the sorted cells, they were immunostained shortly after plating (see 
Materials and Methods for details). Notably, both populations contained a similar number 
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of precursors immunopositive for RC2 (65% (GFP+), n = 110, 64% (GFP++), n = 102) 
and the remaining cells (33% ± 3% (GFP+)/ 33% ± 2% (GFP++); (n = 216 (GFP+)/ n = 
181 (GFP++)) were β-III-tubulin-positive postmitotic neurons (Malatesta et al., 2000) 
with no overlap between these antigens. This high percentage of neurons in the GFP+ -
sorted cell population can be explained by neurons that had shortly before sorting 
differentiated form GFP+ precursors, and therefore still contain endogenous GFP levels 
that can be detected by the detectors of FACS sorter. 
Despite this relative high degree of contaminating neurons in the sort, the progeny 
of the weakly and the strongly GFP-positive cells isolated from E14 cortex differed 
markedly after 1 week in vitro. Most of the clones, i.e. the cells generated by a single 
sorted precursor detected by M2M6 and cell type specific antibodies (see Materials and 
Methods), derived from weakly GFP-positive cells contained only neurons (77%), while 
only 43% neuronal clones were observed in cultures of strongly GFP-positive radial glia. 
However, as described above for the analysis 2 hours after sorting, about 30% of all cells 
are already postmitotic neurons in both fractions. Therefore, the number of newly formed 
neuronal clones is 44% in the weakly GFP-positive fraction, but only 10% in the strongly 
GFP-positive fraction. This proportion of neurogenic precursors was directly assessed by 
addition of BrdU to the culture medium. While 54% ± 9% (n = 31) of BrdU-containing 
clones were purely neuronal in the GFP+ fraction, the precursors isolated by their strong 
GFP signal generated hardly any neurons (9% ± 10, n = 34). Taken together, these results 
show that the GFP intensity driven by hGFAP allows enriching populations of 
neurogenic and non-neurogenic precursors, respectively, about 2-fold. Under these 
culture conditions, most of the sorted precursors generated only a single cell type (GFP+: 
92.4%, GFP++: 92% of all clones). To determine whether these cells are truly restricted 
in their fate, I challenged the potential of these cells in the neurosphere culture 
conditions. Notably, the GFP+ precursors generated only 53% of the number of 
neurospheres formed by the GFP++ fraction (6000 GFP+ cells: 100 ±8 neurospheres; 
6000GFP++ cells: 170+18 neurospheres). Thus, only a small fraction of the sorted 
precursors (1.6%/3%) can be expanded in neurosphere culture conditions, consistent with 
the predominant fate restriction in these precursors.  
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6.1.4 Neurosphere cultures to enrich a population of multipotent 
precursors 
To complement these models of different fate-restricted precursors, I used the 
neurosphere assay as an in vitro model for bi- or multipotent precursors. In this assay 
cells are cultured in non-adherent conditions at clonal density in the presence of mitogens 
such as epidermal growth factor (EGF) and fibroblast growth factor-2 (FGF2; Reynolds 
and Weiss, 1992). Under these conditions the neural stem cells generate clonal aggregates 
called neurospheres. The multipotency of the neural stem cell can then assessed by 
allowing cells derived from a single sphere to differentiate. If progeny of all three neural 
cell types, i.e. astrocytes, oligodendrocytes and neurons, is produced, this is taken as 
direct evidence for multipotency of the founder stem cell. Likewise, when a neurosphere 
can give rise to secondary neurospheres upon dissociation, this is taken as proof of self-
renewal capacity of the cell of origin of the primary neurosphere. Consistent with this, 
cells from the adult subependymal zone (SEZ), E14 cortex and GE were cultured at 
clonal density (10cell/µl; Morshead et al., 2003) for 4 passages as neurospheres (NS, Fig. 
10, see Materials and Methods) and then plated in differentiating conditions (see 
Materials and Methods for details). Consistent with previous data the progeny of 
neurospheres included few neurons (adult NS: 12% ± 5%, n = 75; E14 ctx: 9% ± 5%, n = 
199; E14 GE: 9% ± 4%, n = 140) and oligodendrocytes (adult NS: 3% ± 1%, n = 45; E14 
ctx: 5% ± 1%, n = 257; E14 GE: 5% ± 2%, n = 201), but many astrocytes (adult NS: 50% 
± 13%, n = 112; E14 ctx: 47% ± 15%, n = 232; E14 GE: 40% ± 10%, n = 214) 7 days 
after exposure to differentiation conditions. Thus, these techniques provide model 
systems for populations of enriched in neurogenic, non-neurogenic and less fate restricted 
precursors (Fig. 10). 
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6.2 Gene expression analysis of functionally distinct 
precursors (stem cell, neurogenic and gliogenic precursors) 
6.2.1 Candidate transcription factor analysis of functionally distinct 
precursor subsets as a test for microarray analysis 
Next, I examined the expression of candidate genes to evaluate whether differential 
expression can be detected. I chose transcription factors expressed in subsets of 
telencephalic precursors, such as Pax6, Emx1, Emx2, Ngn2 and Olig1/2, Dlx1, Dlx2, 
Gsh2, and Mash1. During midneurogenesis (E14) Pax6, Emx1, Emx2 and Ngn2 are 
expressed in the dorsal telencephalon (cortex), while Dlx1, Dlx2, Mash1, Gsh2 and 
Olig1/2 are expressed in the GE (Götz et al., 1998; Rubenstein and Puelles, 1994; 
Stoykova et al., 1997; Toresson et al., 2000). I used this region-specific difference in 
expression levels during development to evaluate the accuracy of the real time RT-PCR 
method. Indeed, all of the dorsally expressed genes showed 7-36 fold higher expression 
(all normalized to GAPDH, see Materials and Methods) in tissue from dorsal compared 
to ventral telencephalon (Fig. 11a), consistent with their well known region specific 
expression. Conversely, Olig1/2, Dlx1/2, Mash1 and Gsh2 were enriched 9-40 fold in the 
tissue from the ventral compared to the dorsal telencephalon (Fig. 11a, Table 2). These 
data show that differential expression levels of 7 fold reflect prominent differences in 
gene expression. For example Emx1 is expressed 7 fold higher in the dorsal than ventral 
telencephalon and is in fact not detectable by in situ or antibody staining in the latter 
region (Briata et al., 1996; Stoykova et al., 2000). This method therefore allows assessing 
reliably the expression levels of one gene in different conditions (tissues or cell culture). 
However, the comparison of absolute mRNA levels of different genes in the same 
condition is not possible, since the measured expression levels of Olig2 in the GE are 
similar to the ones of Pax6 in the GE. Nevertheless Olig2 can be detected on protein level 
in the GE (Tekki-Kessaris et al., 2001), but not Pax6 (Gulisano et al., 1996; Stoykova et 
al., 2000), Fig. 11a). Only the high expression levels of Pax6 such as present in the 
cortex are functionally relevant and detectable on protein level. These difficulties to 
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compare absolute mRNA levels may be due to differences in the rate of reverse 
transcription of different mRNAs or the binding site of different primer sets.  
When I isolated RNA from the cortical precursors sorted on the basis of their GFP 
content from the cortex of E14 hGFAP-eGFP mice, I observed that the population 
enriched two fold in neurogenic precursors (GFP+) expressed 4.6x higher levels of Pax6 
compared to the more non-neurogenic population (GFP++; Fig. 11b), consistent with its 
previously described neurogenic role in cortical progenitors (Heins et al., 2002). Olig2 
(4,5x) and Emx2 (6,4x), however, are enriched in the less neurogenic population 
(GFP++) that was also enriched in neurosphere-forming cells (Fig. 11b). No significant 
differences were detected in the expression of the other genes examined (Emx1, Ngn2, 
Mash1, and Dlx1/2). Gsh2 is expressed at higher levels in the neurogenic precursors, but 
the expression levels are below the level detectable by antibody staining (data not 
shown). Thus, the precursors isolated by FACS from the dorsal telencephalon maintained 
their region specific expression and Pax6 was specifically enriched in neurogenic, 
whereas Olig2 and Emx2 were enriched in non-neurogenic precursors. Thus, this 
enrichment is sufficient to detect differences in genes expression and hence these 
populations were further processed for microarray analysis. 
As mentioned above, cells cultured as neurospheres were used as model for 
multipotent precursors in comparison to the fate restricted precursor populations isolated 
by FACS. I therefore examined the expression levels of candidate genes listed above also 
in this model. Strikingly, cells isolated from the dorsal or ventral telencephalon that had 
cultured as neurospheres for 4 passages exhibited hardly region-specific differences in 
the expression level of Pax6, Ngn2, Emx1, Emx2, Dlx1/2, Mash1, Gsh2 and Olig1/2 
anymore (Fig. 11c). Cortical neurospheres reduced the normally high levels of Emx1, 2, 
Pax6 and Ngn2 even below the low expression levels of these genes in the E14 GE. 
Similarly, neurospheres derived from the E14 GE reduced gene expression of Dlx1, 2, 
Gsh2, Vax1, Islet1 and Nkx2.2 to or below the low level of expression of these genes in 
the dorsal telencephalon (Fig. 11a and Table 2). However, independent of their region of 
origin, the expression levels of Olig1 and Olig2 were very high, even exceeding the 
levels seen in the E14 GE in situ (Fig. 11a,c and Table 2). Mash1 and Prox1, were 
detected at levels intermediate between cortex and GE in neurospheres, i.e. they were up-
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regulated in neurospheres derived from the E14 cortex and down-regulated in 
neurospheres from the GE (Fig. 11a,c and Table 2). Thus, quantitative mRNA analysis 
of 14 transcription factors with distinct expression in dorsal and ventral regions in vivo 
revealed a prominent reduction in region-specific differences under neurosphere culture 
conditions. Notably, even neurospheres from adult SEZ contained the same expression 
levels of these transcription factors as seen in neurospheres from the embryonic dorsal or 
ventral telencephalon (Fig. 11c and Table 2). Only the expression of Emx2 and Islet1 
was slightly higher in adult neurospheres compared to those from embryonic stages. 
Thus, neurospheres from adult and embryonic telencephalon exhibit similar patterns of 
gene expression with particularly high levels of Olig1 and Olig2.  
To confirm these data obtained on mRNA level I performed 
immunocytochemistry on single neurospheres after the fourth passage (Fig. 13). 
Consistent with the real-time PCR data, 97% (n = 316) of all cells in a single neurosphere 
were Olig2 immunopositive, while Mash1 was detected in about 30% of neurosphere 
cells (n = 187; Fig. 13). Pax6 and Ngn2 were undetectable at the protein level in 
neurospheres, in agreement with their low amount of mRNA.  
Taken together, this candidate gene approach revealed the highest expression 
levels of Olig2 in a culture system enriched in bi- or multipotent precursors, while Pax6 
expression was strongly enriched in neuronal precursors (Fig. 12). Moreover it 
demonstrated a deregulation of region specific gene expression in neurosphere cells. Is 
this part of the dedifferentiation process? To identify the mechanisms for this I examined 
the influence of the growth factors EGF and FGF2 on the expression of these candidates 
 
6.2.2 Regulation of transcription factors upon growth factor exposure 
Since neurosphere cultures are maintained in high concentrations of FGF2 and EGF, I 
examined the influence of these potent growth factors after short-term exposure (48 
hours) in adherent dissociated cell cultures by immunostaining for the dorsal transcription 
factors Pax6 and Emx1, and the ventral transcription factors Olig2, Mash1, pan-Dlx and 
Gsh2. Importantly, the regionalization of the precursors is maintained in this cell culture 
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model (e.g. Pax6: cortex 21±3%; GE 2±1%; Fig. 14, Fig. 15). However, upon exposition 
of cortical cultures to EGF and FGF2 the number of Pax6- and Emx1-immunopositive 
cells was down-regulated in cultures, while the number of Mash1- and Olig2-
immunopositive cells increased in either of the growth factor treated compared to control 
cultures (Fig. 14). In cultures from E14 GE the number of Olig2-positive cells was 
doubled after 2 days and increased to 88% ± 7% of cells (n = 64) after 7 days exposure to 
FGF2 or EGF (90% ± 7%, n = 52). No further increase, however, was observed in the 
number of Mash1-, Dlx- or Gsh2-positive cells upon growth factor exposure (Fig. 15). 
Taken together, these data suggest that FGF2 and EGF are responsible for the loss of 
dorsal identity in neurosphere cultures, since Pax6 and Emx1 were reduced, but do not 
account for the partial loss of ventral identity since the number of Dlx- or Gsh2-
immunopositive cells were not influenced by exposure to these growth factors. 
Thus, this cell culture system allowed me to isolate multipotent precursor cells, 
and hence these neurosphere cultures were further processed for microarray analysis. 
However, one has to keep in mind that these cells are deregulated by EGF and FGF2. 
 
6.2.3 Transcription factor analysis in neurosphere cultures in 
differentiation conditions 
To analyze the consequences of this observed deregulation of genes in the neurosphere 
cultures and the loss of regional specificity I exposed the neurospheres to differentiation 
condition. Under these conditions the neurosphere cells are forced to differentiate due to 
the withdrawal of the growth factors. Since Pax6 expression was strongly enriched in 
neuronal precursors of the E14 cortex, one would predict its upregulation at least during 
differentiation of the cortical neurosphere cultures. Indeed, when I exposed neurosphere 
cells to differentiation conditions (see Materials and Methods), the number of Pax6-
immunopositive cells increased to 7% ± 3% (Ctx NS, n = 30). Surprisingly this was also 
observed in the GE, where 8% ± 3% (GE NS, n = 26) were observed 3 days after plating. 
In contrast, Olig2-immunoreactivity decreased to 74% ± 7% (Ctx NS, n = 51) or 73% ± 
6% (GE NS, n = 45) immunoreactive cells 3 days after plating. Notably, the upregulation 
of Pax6 and downregulation of Olig2 was also observed at mRNA level (Fig. 16a,b). The 
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expression levels of Emx1, Emx2, Ngn2 and Mash1 were all increased in differentiation 
conditions, while Olig2 and Dlx1 decreased. However, the increase or decrease in 
expression levels was very similar for neurospheres derived from E14 cortex and GE 
(Fig. 16a,b). One exception was Dlx2 mRNA that increased only in differentiating 
neurospheres derived from the GE, suggesting some remnants of regional specification. It 
is important to realize, however, that the Dlx2-expression levels after differentiation of 
neurospheres from the GE were still 3 orders of magnitude (1000x) below the levels seen 
in the GE during development. Taken together, this candidate gene approach revealed 
that the regionalization is still lost after differentiation. Moreover, it demonstrated that the 
highest expression levels of Olig2 in expansion conditions of neurosphere cells, while 
Pax6 was most prominently up-regulated in differentiation conditions (Fig. 16a,b). 
 
6.3 Microarray analysis of differential gene expression in 
functionally distinct precursor subtypes 
 
The gene expression data obtained in the candidate gene approach with the different 
precursor populations (the neurogenic precursors (GFP+) and the more non-neurogenic 
population (GFP++) from E14 hGFAP-eGFP mice or the neurosphere cells isolated from 
different regions and or differentiated for 1 and 3 days showed that these cell types are 
not only functionally different, but that some differences can also be detected on the gene 
expression level. These results encouraged me to evaluate global differences in gene 
expression of these functionally distinct precursor populations by oligonucleotide 
microarrays (Affymetrix). More specifically I selected for the microarray study the 
neurogenic precursors (GFP+) and the more non-neurogenic precursor population 
(GFP++) from E14 hGFAP-eGFP mice as model for neuronal and glial fate restricted 
precursors and the neurosphere cells isolated from the E14 cortex undifferentiated as 
model for multipotent precursors. Neurospheres that had been differentiated for 1 day 
represent again the progression to more fate-restricted precursors.  
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10µg total RNA were collected from these cells and purified as described in the 
Materials and Methods. The probe sets were filtered with mean expression levels ≥ 1 and 
then all probe sets with a ratio smaller than 0.25 or larger 4 were selected. For 
neurosphere cells isolated from the E14 cortex undifferentiated and differentiated for 1 
days (dd1) this resulted in a set of 1354 probe sets (down in dd1: 617, up in dd1: 737; see 
Table 3). Interestingly, for the neurogenic precursors (GFP+) and the more non-
neurogenic population (GFP++) from E14 hGFAP-eGFP mice this resulted in a set of 
4398 probe sets with a majority of probe sets upregulated in the GFP++ , i.e. the more 
gliogenic precursors (down in GFP++: 189, up in dd1: 4109; see Table 4) 
To verify the data obtained by microarray analysis, I performed RT-PCR with 
RNA from either the microarray experiments or from independent RNA preparations. 
The genes of interest (Fig. 17) were chosen because of their expression profile apparently 
correlated with cell fate according to the following categories: 
1) Genes expressed in multipotent stem cells: high expression in undifferentiated 
neurosphere cells, medium expression in differentiated neurospheres and GFP++ 
gliogenic precursors, lowest expression in the GFP+ neurogenic precursors (Fig. 
17a, tweety (Suzuki and Mizuno, 2004), yellow bars; sirtuin2 (Fulco et al., 
2003), dark orange bars and FABP7 (Veerkamp and Zimmerman, 2001), light 
orange bars). 
2) Genes expressed in neurogenic precursors: lowest expression levels in 
undifferentiated neurosphere cells, low expression in differentiated neurospheres 
and GFP++ gliogenic precursors, highest expression in the GFP+ neurogenic 
precursors (Fig. 17c, LMO1 (Hinks et al., 1997), dark blue bars and Sox4 
(Cheung et al., 2000), light blue bars). 
3) Genes expressed in gliogenic precursors: medium expression in undifferentiated 
neurosphere cells, highest expression in differentiated neurospheres and GFP++ 
precursors, low expression in the GFP+ neurogenic precursors (Fig. 17b, Sox9 
(Stolt et al., 2003), brown bars and Klf9 (Zhang et al., 2003), red bars). 
Not surprisingly the expression profiles of  Pax6 and Olig2 in these 4 functionally distinct 
populations (Fig. 12, 16), strikingly fit into the expression profiles of group 2 (for Pax6) 
and group 1 (for Olig2), respectively. Seven of nine (78%) of the selected genes from the 
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MAS5.0 probe summary reproduced the data collected by the microarrays over a broad 
spectrum (Fig. 17a,b,c). I thus concluded that the microarray data are relatively 
reproducible and reliably reflect both cellular RNA content as well as the difference of 
gene expression in distinct precursor subsets. 
 
6.4 Functional analysis of Pax6 and Olig2 for fate specification 
6.4.1 Functional analysis of Pax6 and Olig2 in vitro 
6.4.1.1 Functional analysis of Pax6 in neurosphere cells 
Since I observed upregulation of Pax6 in a subset of neurosphere cells exposed to 
differentiating conditions and enhanced expression in neurogenic precursors from the 
E14 cortex (Fig. 16a,b, Fig. 11c and Fig. 12), I tested whether I could boost 
neurogenesis by forcing Pax6 expression in cells differentiating from neurosphere 
cultures of the adult telencephalon. Towards this end I used different replication-
incompetent retroviral vectors containing full-length Pax6 cDNA and either the marker 
gene lacZ or GFP (Heins et al., 2002; Fig. 4a,f). Neurosphere cells dissociated after 4 
passages were infected shortly after plating and analyzed the fate of infected cells by 
double immunocytochemistry for cell type specific antigens 5-7 days after infection and 
culturing under differentiating conditions. Amongst the control infected cells (n = 122) 
25% ± 8% turned into β-III-tubulin-positive neurons, whereas significantly more β-III-
tubulin-positive neurons (87% ± 6%) were detected amongst the Pax6-infected cells (n = 
143; Fig. 18a,b,c). Thus, Pax6 is sufficient to direct almost all precursors from adult 
neurospheres towards neurogenesis. This is to my knowledge the highest amount of 
neuronal differentiation achieved in cultures of adult neurospheres and is highly relevant 
for attempts to regenerate dying neurons by transplantation of neurosphere cells [see for 
example (Li et al., 2003)].  
In order to assess whether adult neurospheres are particularly amenable to Pax6, I also 
examined its effect in neurosphere cultures from E14 cortex or GE. In neurospheres from 
the cortex I observed 72% ± 7% of the cells infected with Pax6-encoding virus (n = 234) 
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had generated neurons compared to 11% ± 5% of the control infected cells (n = 496; Fig. 
19a). Surprisingly, also neurospheres from the embryonic GE could be induced to 
differentiate into neurons by Pax6 overexpression (Pax6: 79% ± 10%, n = 353; control: 
10% ± 7%, n = 366; Fig. 19a). This is in pronounced contrast to primary cells from the 
GE cultured without growth factors that are resistant to effects mediated by Pax6 (Fig. 
19c,d; Heins et al., 2002). Interestingly, even neurosphere cultures from the E14 
midbrain that were infected with Pax6-encoding retrovirus generated significantly more 
β-III-tubulin-positive neurons compared to control infected cultures (Pax6: 64% ± 8%, n 
= 205, control: 19% ± 2%, n = 103). Thus, culturing cells from different brain regions as 
neurospheres not only abolishes their region-specific expression profile, but also renders 
them susceptible to Pax6 overexpression.  
To evaluate whether neurogenesis in neurosphere cells also becomes Pax6 
dependent, I examined the cell fate of neurosphere cells generated from the Pax6 mutant 
(Sey/Sey) cortex (Heins et al., 2002; Hill et al., 1991) after 4 passages. Interestingly, cells 
from Pax6 deficient neurospheres were not able to generate neurons, while neurospheres 
from widtype (WT) littermates generated the normal low percentage of neurons in the 
same culture batch (Fig. 19b). Thus, the alterations in regionalisation of neurosphere 
cells seemingly activate a Pax6 dependent mode of neurogenesis. 
Taken together these results confirm at a functional level the role of Pax6 in 
directing stem cells towards a neurogenic lineage (Fig. 3) 
 
6.4.1.2 Functional analysis of Olig2 in neurosphere cells 
Since the above analysis showed Olig2 expression in fast proliferating, not lineage 
restricted precursors, I next examined its role in self-renewal and fate specification in the 
neurosphere cultures by RNA interference with Olig2 expression levels. I first tested 
several 21 nucleotide double stranded siRNAs in their effectiveness to reduce the Olig2 
protein. Neurospheres were plated after 4 passages, transfected with different siRNA and 
control constructs and immunostained for Olig2 2 days later. Different target sequences 
proved to be more (reduction by 41%, Olig2 RNAi#19) or less (reduction by 14%, Olig2 
RNAi#1) effective in their reduction of Olig2 protein. Consistently, there was no 
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significant reduction in the number of Olig2-immunoreactive cells when cells were 
treated with each of these constructs containing the same sequence in a scrambled 
manner (Fig. 20a). For all constructs the percentage of transfected cells was similarly 
high (80% of cells) as detected by labeling the siRNA constructs with Cy3 (see Materials 
and Methods).  
Then, I examined the effect of Olig2 reduction on self-renewal of neurosphere 
cells by transfection of Olig2RNAi#19 and its scrambled RNAi control 1 day after 
dissociation of the spheres into single cell suspension and quantification of the newly 
formed neurospheres 6 days later. Notably, only about half the number of neurospheres 
was generated by cells transfected with Olig2 RNAi compared to the control transfected 
cultures (Fig. 20b). I also noted that Olig2 RNAi treated neurospheres were smaller than 
neurospheres observed under control conditions. Since the remaining 40% neurospheres 
may still be Olig2-positive as they correspond in number to the cells not affected by the 
Olig2-knock down, I conclude that Olig2 is required for the generation of neurosphere 
cells and may act as an essential mediator of EGF and FGF2 signaling in this system.  
Next, I studied the influence of Olig2 on cell fate by transfecting the neurosphere 
cells 1 day after plating in differentiating conditions. In cultures examined 7 days after 
transfection, the number of neurons and oligodendrocytes generated from Olig2RNAi 
transfected cells was reduced to a third of the control treated cells (Fig. 20c). To further 
ensure the specificity of the observed effects I used a replication-incompetent retroviral 
vector containing full-length Olig2 cDNA fused to the herpes simplex virion protein 
VP16 in front of an IRES sequence and GFP (Olig2VP16; Fig. 4d). As reported 
previously, Olig2 acts normally as a repressor (Novitch et al., 2001; Zhou et al., 2001), 
but is converted into an activator by fusion to VP16 (Sadowski et al., 1988). This 
construct therefore interferes with the normal function of Olig2 (Novitch et al., 2001). 
When cultures were examined 7 days after viral infection a similar reduction in the 
number of neurons and oligodendrocytes as detected by RNAi was observed (Fig. 21a,b). 
Notably, cells infected with Olig2VP16 differentiated almost exclusively into GFAP-
positive astrocytes (CTX NS: 88 ± 5%, n = 969; GE NS: 88% ± 2%, n = 874). Consistent 
with the high expression of Olig2 right after plating of the dissociated neurosphere 
cultures the effect of Olig2 overexpression was very mild showing a slight increase in the 
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number of neurons (β-III-tubulin, 11% ± 1%; n = 595 compared to 9% ± 1% in the WT; n 
= 813) and oligodendrocytes (O4, 13% ± 1%; n = 595 compared to 8% ± 1% in the WT; 
n = 813). However, the number of GFAP-positive astrocytes was fully suppressed after 
Olig2 transduction (0%, n=355, consistent with Gabay et al., 2003). Taken together the 
high levels of Olig2 in neurosphere cells play a role in self-renewal as well as 
neurogenesis and oligodendrogenesis from neural stem cells. Thus, Olig2 favors a stem 
cell fate with self renewal and bi-/multipotency. 
Since Olig2 seems to promote neural stem cell fate, I examined whether it may be 
sufficient to convert fate-restricted into multipotent precursors. Towards this end I 
overexpressed Olig2 for 7 days in cell prepared from the cortex at E14 and cultured as 
high density adhesive cultures without or with factors. Also in this experimental system I 
found an increase in the number of oligodendrocytes (O4, 10% ± 1%; n = 204 compared 
to 3% ± 1% in the control; n = 317) and a decrease in the number of mature neurons 
(NeuN, 52% ± 5%; n = 204 compared to 44% ± 2% in the WT; n = 317). Thus, Olig2 
seems to act in a context dependant way by promoting bi-/multipotency in neurosphere 
cells and by promoting oligodendrogenesis in more restricted precursors. 
 
6.4.2 Functional analysis of Pax6 and Olig2 in vivo 
6.4.2.1 Functional analysis of Olig2 in vivo during embryonic 
development 
So far I could show that Olig2 acts in a strong context dependant manner and therefore I 
decided to compare this observed effect in precursors in vitro to precursors in vivo during 
embryonic development. By injecting an Olig2 containing retroviral expression vector 
into mouse forebrain ventricles at midneurogenesis (E14), I achieved focal misexpression 
of Olig2 in cortical progenitor cells that do not normally express Olig2. Injected embryos 
developed to term and were harvested at two different postnatal time points, namely at 
postnatal day 2 (P2) and postnatal day 21 (P21). Infected cells were identified by staining 
for GFP encoded by the pMXIG retroviral vector or CMMP (see Materials and Methods 
for details, Fig. 4). Cell types of the retroviral-infected cells were assigned on the basis of 
 55
immunostaining with cell type specific markers (Fig. 22c-f) and morphology of the GFP 
positive cells (Fig. 22b). When examined at P21, cells infected with the control retrovirus 
CMMP were mainly neurons; only few astrocytes and few oligodendrocytes were noted. 
In contrast, cells infected with the Olig2 retrovirus were exclusively glia. A high 
percentage of these glia were astrocytes (S100β-immunoreactive, Fig. 22d) and 
oligodendrocytes (data not shown), which were found in all brain regions analyzed 
(cortex, corpus callosum, Fig. 22b–d). However the astrocytes were GFAP negative 
consistent with previous results that had shown the Olig2 potently suppresses GFAP 
expression (Fig. 22c; Gabay et al., 2003). To determine whether Olig2 misexpression 
affects formation or survival of neurons, I examined the brains of Olig2 infected animals 
at an earlier postnatal time point, P2. Cortical cells that were infected with the control 
virus had a constant ratio of neurons to glia from P2 to P21 (33%, n=613). In contrast, 
cortical cells that were infected with the Olig2 retrovirus had a much reduced ratio (Fig. 
22e,f). These data indicate that Olig2 has similar effects on cortical development as other 
bHLH genes tested to date. Previous misexpression studies have identified a wide range 
of positive regulatory bHLH genes (including Olig1, Mash 1, Math 2, Math 3, Ngn 1, 
Ngn 2, NeuroD and NeuroD2) that are deleterious to the survival of neurons in the 
developing mouse cortex (Gangemi et al., 2001). These same bHLH proteins permit, and 
perhaps even promote, the formation and survival of astrocytes (Cai et al., 2000; 
Gangemi et al., 2001). 
Consistent with my observation that high levels of Olig2 are deleterious for 
neuronal differentiation and survival, endogenous Olig2 protein in the adult (P22) mouse 
cortex is exclusively detectable in CC1-positive oligodendrocytes (Fig. 23b) and a subset 
of glutamine synthase (GS)-positive (Fig. 23c) or S100β-positive astrocytes (Fig. 23d). 
Notably, Olig2-immunoreactivity was never detectable in neurons labeled with antibodies 
directed against β-III-tubulin or NeuN. 
Taken together, these data indicate that overexpression of Olig2 induces 
oligodendrocyte and neuronal differentiation in both, the neurosphere cultures and 
precursors of the dorsal telencephalon in vivo and in vitro. However, these data further 
suggest, that Olig2, such as other bHLH transcription factors, induces apoptosis in 
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neurons when high expression levels persist during terminal differentiation of postmitotic 
neurons.  
 
6.4.2.2 Functional analysis of Olig2 and Pax6 in vivo in adult neural 
stem cells 
6.4.2.2.1 Expression analysis of the transcription factors Pax6 and Olig2 in 
adult neural stem cells and their progeny in vivo 
In order to further evaluate the correlation of Pax6 to neurogenesis, and Olig2 to fast 
proliferating precursors, neurogenesis and oligodendrogenesis, I examined Pax6 and 
Olig2 in the adult SEZ in vivo, where multipotent and fate-restricted precursors can 
nicely be discriminated as described in the introduction (Fig. 24a; Doetsch et al., 1999; 
Doetsch et al., 2002).  
 
6.4.2.2.2 Expression pattern of Pax6 in adult neurogenesis 
Notably, however, a prominent gradient of Pax6-immunopositive cells was observed 
along the rostro-caudal extension of the SEZ/RMS system that had previously not been 
noticed. The number of Pax6-immunostained cells was lowest in the region lining the 
ventricle, where only 7±3% of DAPI-labeled cells were Pax6-positive (n = 223, 3 
animals; Fig. 25b). Already in the caudal RMS immediately adjacent to the SEZ the 
proportion of Pax6-immunopositive cells increased to 42±6% (n= 126, 1 animal; Fig. 
25c) with a further increase to 61±5% (n = 221, 3 animals; Fig. 25d), where the 
descending limb of the RMS intersects with the horizontal limb. 
Interestingly, the number of Pax6-positive cells then decreases when cells reach 
the OB (26±4% of DAPI-labeled nuclei are Pax6-positive in the RMS in the OB; n = 131, 
1 animal; Fig. 25e) and only few Pax6-immunopositive cells were scattered throughout 
the OB (Fig. 26d). Most of these were migrating neuroblasts as detected by PSA-NCAM- 
or doublecortin (DCX)-immunoreactivity (76±6%, n = 131, 1 animal, Fig. 25g) as 
observed throughout the SEZ/RMS (SEZ: 74±4% of Pax6-positive cells were DCX-
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positive, n = 235, 2 animals; RMS: 67±5%, n = 563, 2 animals), and virtually no 
colocalization of Pax6 and GFAP could be detected (<1%, n = 112, 1 animal). 
Interestingly, Pax6 immunoreactive cells with weak levels of GFP were observed in the 
RMS (Fig. 25f) consistent with the idea that the Pax6-positive neuroblasts derive from 
hGFAPeGFP-positive astrocytes (Doetsch et al., 1999; Fig. 24b). Thus, about two thirds 
of Pax6-positive cells are neuroblasts, and one third is precursors at a less committed 
stage throughout the SEZ/RMS system.  
A notable accumulation of Pax6-positive cells was then again apparent in the 
glomerular layer (GL; Fig. 26d), where most Pax6-immunoreactive cells had 
differentiated into postmitotic NeuN-positive neurons (81±3% of Pax6-positive cells 
were NeuN-positive, n = 126, 1 animal). In contrast, hardly any of the few Pax6-positive 
cells in the GCL were NeuN-positive (9±1%, n = 186, 1 animal), suggesting that Pax6 is 
downregulated in granule cells, but not periglomerular cells during neuronal 
differentiation.  
Next, I identified the subtype of neurons in the glomerular layer. I observed that 
Pax6 was contained mostly in tyrosine hydroxylase (TH)-positive neurons of the GL 
(78% of Pax6-positive cells in GL were TH-positive and 95% of TH-positive neurons 
were Pax6-positive, n=683, 3 animals, Fig. 26e). Almost no Pax6/calretinin double 
positive cells was observed (1,5±0.4%; n = 361 cells, 1 animal), while 9,8±0,9% (n = 437 
cells, 2 animals) were co-labeled for Pax6 and calbindin. Taken together, these data 
suggest that Pax6-expression is mostly maintained in the dopaminergic subset of 
periglomerular neurons [(Gall et al., 1987; Kosaka et al., 1998; Kosaka et al., 1985), see 
also (Dellovade et al., 1998; Vitalis et al., 2000)]. These data demonstrate an intriguingly 
dynamic regulation of Pax6 in adult neurogenesis: first, Pax6 is up-regulated in almost all 
neuroblasts along the RMS, but down-regulated during neuronal differentiation in most 
neurons except those of the GL.  
 
6.4.2.2.3 Expression pattern of Olig2 in adult neurogenesis 
In contrast to Pax6, Olig2 did not double-stain for PSA-NCAM or DCX (SEZ: 0%, n = 
123; RMS: 2%, n = 111, Fig. 27d) or for GFAP (0% in SEZ, n = 120, or RMS, n = 100, 
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Fig. 27e). To further elucidate the identity of Olig2-immunopositive precursors, I 
employed different BrdU-labeling paradigms. When BrdU was continuously supplied in 
the drinking water for 14 days all proliferating cells are labeled, and according to their 
higher incidence the majority of BrdU-positive cells are fast proliferating cells, type C or 
type A. In this paradigm many BrdU-positive cells also contained Olig2 (Fig. 27f). Next, 
I used a single BrdU-pulse and examined colocalization 45 minutes after this pulse, a 
paradigm that should exclusively label fast proliferating cells in S-phase. Fig. 27g depicts 
an example of an Olig2- and BrdU-double-labeled cell, demonstrating that Olig2 is 
contained in fast proliferating precursors in the adult SEZ.  
Indeed, the localization of Olig2 in fast proliferating precursors, is further 
confirmed by the 6-fold higher labeling index (LI) as determined with a short BrdU-pulse 
(1 hour) of Olig2-positive precursors (LI (%BrdU-positive cells amongst all Olig2-
positive cells) = 0.3) compared to Pax6-positive precursors (LI = 0.05).This suggests that 
it is mostly contained in the transient-amplifying precursors which are negative for 
GFAP, as well as GFAP. Consistent with this I detected some co-localization within 
Lewis X antigen, a proposed maker for type C cells (Capela and Temple, 2002; arrows in 
Fig. 27c). Note however, that not all Olig2-positve cells co-localize Lewis X (arrowheads 
in Fig. 27c), nor all Lewis X-positive cells contain Olig2 (arrowhead with asterisk in Fig. 
27c). Since Lewis X was shown to contain type C and supposedly also some type B cells 
(Capela and Temple, 2002), this cell type analysis would suggest that Olig2 is contained 
in some or most typeC cells.  
Interestingly, the transcription factor Olig2 exhibited the opposite gradient with 
18±4% Olig2-immunopositive amongst all DAPI-positive cells in the SEZ (n = 341, 2 
animals), while only 2±1% (n = 412, 2 animals; Fig. 27b,b’) Olig2-positive cells were 
detectable within the RMS. In contrast to Pax6, the number of Olig2-positive cells did not 
increase again and no Olig2-immunopositive neurons could be detected within the OB (n 
= 196, 1 animal). 
Thus, Olig2-positive adult neural precursors are fast-proliferating type C cells 
with their highest density in the SEZ and decreasing numbers within the RMS. Notably, 
no co-localization of Pax6- and Olig2-immunoreactivity could be detected (n = 186) 
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suggesting that these transcription factors are contained in truly separate sets of 
progenitor cells.  
Taken together, the examination of the endogenous localization of Pax6 and Olig2 
in adult neural precursors revealed a striking difference along the rostro-caudal extension 
of the SEZ/RMS system that had previously not been noticed (Fig. 25b-e; Fig. 27b,b’). 
This analysis of the adult SEZ confirmed the correlation of Pax6 to PSA-NCAM-positive 
neurogenic precursors and Olig2 to PSA-NCAM-negative fast proliferating precursors, 
most likely type C cells. Moreover in contrast to Olig2 expression, Pax6 remains to be 
expressed in matured neurons in the OB and more specifically in the TH-positive 
dopaminergic neurons of the GL. 
 
6.4.2.2.4 The role of Pax6 and Olig2 in adult neural precursors 
Next, I examined the cell autonomous function of Pax6 and Olig2 by the use the 
replication-incompetent retroviral vectors. Given the pronounced gradient of Pax6 and 
Olig2 in the SEZ/RMS system I decided to compare the manipulation of these 
transcription factors at both positions. When, viral infections were stereotactically 
targeted to the SEZ (Belluzzi et al., 2003; Carleton et al., 2003; Petreanu and Alvarez-
Buylla, 2002), 95±2% of all GFP-positive cells were still located close to the SEZ three 
days after injection and only 5±2% were detected at some distance within the RMS (n = 
45, 1 animal; Fig. 28a,b,c). When the injection coordinates were modified to target the 
central RMS (see Materials and Methods), I reliably observed the vast majority of GFP-
positive cells 3 days after injection migrating forward in the RMS (72±1% in the RMS 
outside the OB, 21±5% in the RMS inside the OB) with only 6±1% of cells apparently 
migrating backwards to the SEZ (n = 66, 1 animal; Fig. 28d). Thus, the targeted injection 
of viral vectors allows manipulating gene expression locally at two distinct places of the 
SEZ/RMS system. 
To manipulate the expression patterns of Pax6 and Olig2 in the SEZ and the 
RMS, I used vectors containing the wildtype forms of Pax6 or Olig2 coexpressing the 
green fluorescent protein (GFP) mediated by the IRES sequence(Hack et al., 2004), see 
above, Fig. 3). As dominant-negative construct I used Pax6-engrailed (Yamasaki et al., 
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2001) that contained the Engrailed repressor domain instead of the normal transactivating 
domain of Pax6, whereas the repressor domain of Olig2 was removed (see Materials and 
Methods) or replaced with Olig2-VP16 (as described above, Mizuguchi et al., 2001) 
replacing its normal repressor domain (Fig. 3). Previous in vivo and in vitro studies 
showed that these constructs produce the opposite effect as the wildtype transcription 
factor, suggesting that they indeed antagonize the function of Olig2 and Pax6 
respectively(Hack et al., 2004; Mizuguchi et al., 2001; Novitch et al., 2001; Yamasaki et 
al., 2001).  
I have performed further control experiments by comparison to loss of function 
conditions (Fig. 30). I used a dissociated cell culture system of embryonic E14 cortex or 
striatum (GE) for analysis of precursors infected at the day of plating and the progeny 
analyzed 7 days later(Heins et al., 2002). This is a well-established in vitro system for the 
analysis of telencephalic precursor fate, where the effect of Pax6 is particularly well 
characterized(Haubst et al., 2004; Heins et al., 2002). Previous work had shown that Pax6 
overexpression promotes neurogenesis and reduces clone size, i.e. the number of 
descendants generated by a single precursor cell, while the loss of functional Pax6 in 
Small Eye mutant mice (Sey/Sey; Heins et al., 2002) results in decreased neurogenesis 
and an increase in clone size(Haubst et al., 2004; Heins et al., 2002). As expected, 
infection with the Pax6-engrailed containing virus resulted also in a decrease of 
neurogenesis that was almost identical to the effect in Sey/Sey mutant cells deficient of 
functional Pax6 protein compared to wildtype cells. Thus, the Pax6-engrailed is as 
sufficient as the loss of functional Pax6 protein. Next, I also examined the specificity of 
both, the Pax6-engrailed and the Olig2VP16 constructs by expression in cells that do not 
contain Pax6 or Olig2 respectively. For example, cells from the embryonic cortex do not 
express Olig2 and should therefore not be affected by Olig2-VP16 transduction, as is 
indeed the case. Thus, Olig2-VP16 does not superactivate target genes in cells where 
Olig2 plays no endogenous role. Similarly, Pax6-engrailed transduction of precursors 
from the ventral telencephalon that do not contain endogenous Pax6 protein exerted no 
effect, despite its pronounced effect in the cortical progenitor cells. Taken together these 
experiments showed that dominant-negative constructs are specific and exert no effects in 
cells that do not endogenously express the respective transcription factor. 
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When Pax6-containing was injected into the adult SEZ (Fig. 29a,c), a larger 
number of Pax6-transduced precursors had progressed to the neuronal lineage (DCX-
immunopostive; n = 281, 3 hemispheres, 3 animals) compared to those infected with the 
control virus containing GFP only (n = 183, 4 hemispheres, 3 animals; p < 0,05) one 
week after injection (Fig. 29c). Conversely, a prominent reduction in the proportion of 
neuroblasts (to 42% of the control, n = 100, 3 hemispheres, 2 animals; p < 0,05) and a 
respective increase in other precursors was observed in the SEZ and initial RMS one 
week following transduction with Pax6-engrailed containing vectors (Fig. 29b,c). As 
depicted in Figure 31a, a comparable reduction of infected precursors assuming a 
neuronal precursor fate (DCX-positive, to 39±11%, n = 83, 3 hemispheres, 2 animals) of 
the control virus injections (control: n = 70, 2 hemispheres, 2 animals; p = 0,013) was 
observed by deleting Pax6 using Cre-virus injection into mice in which the N-terminal 
part including the paired domain of the Pax6 gene was flanked by loxP sites(Ashery-
Padan et al., 2000). These effects are not due to selective death of precursor subtypes, 
since analysis of DAPI-labeled nuclei or tunel-staining performed 3 or 7 days after viral 
injection showed no differences in death of infected cells. These results rather imply Pax6 
in the regulation of adult neurogenesis, supposedly via its coordinated effects on cell 
proliferation and cell fate as observed in cerebral cortex development(Haubst et al., 2004; 
Heins et al., 2002). 
Intriguingly, Olig2 exerted the opposite effects to Pax6 on precursor cells in the 
adult SEZ. Olig2-overexpression resulted in a decrease of neuronal precursors 
immunoreactive for DCX (Fig. 29f; to 35±3% of control; n = 181, 3 hemispheres, 3 
animals, p < 0,0001) to comparable levels as achieved by Pax6-engrailed expression 
(compare Fig. 29c and f). Notably, however, the decrease of neuronal precursors resulted 
mostly from an increase in precursors negative for both GFAP and DCX, supposedly the 
transit-amplifying type C cells. Indeed, consistent with the expression of endogenous 
Olig2 exclusively in this precursor type, expression of the dominant-negative form, 
Olig2-VP16, virtually abolished this precursor cell type. Similar effects were obtained 
with a loss of function construct containing the Olig2 bHLH (Fig. 3), but no repressor 
domain (Fig. 31b). Thus, Olig2 is necessary and sufficient to specify transit-amplifying 
precursors in the SEZ. Taken together, these data support the functional role as deduced 
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from the protein localization: Olig2 is crucial to specify transit-amplifying and Pax6 
neuronal precursors.  
 
6.4.2.2.5 Olig2 promotes adult oligodendrogenesis 
With Olig2 overexpression I also noted a prominent emigration from the SEZ/RMS 
system already apparent 3 days after viral injection (Fig. 29e), while no cells infected 
with the control virus were located outside the SEZ/RMS system, at this stage (<1%, n = 
45, 1 animal, see also above). However, 7 days postinjection also in control virus 
injections some descendants of the infected cells had left the RMS and migrated to the 
corpus callosum (CC, Fig. 32e, 1±1%, n = 201, 4 hemispheres, 3 animals). These cells 
were identified as oligodendrocytes, or their precursors, by CC1 or Sox10-
immunoreactivity, respectively. Since no infected cells could be detected within the CC 
shortly after injection, precursors of the adult SEZ also generate oligodendrocytes one 
week after Olig2-virus injection into the SEZ, however, 50±9% of all infected cells (n = 
207, 3 hemispheres, 3 animals, p < 0,001 compared to GFP-control injections) were 
detected within the CC (Fig. 32b) 1 week post-injection and had acquired 
oligodendrocyte identity (Fig. 29e). Notably, the increase in oligodendrogliogenesis was 
accompanied by a decrease in neuronal precursors as well as the proportion of neurons 
reaching the OB (Fig. 29f, Fig. 32b), suggesting that neurons and oligodendrocytes 
originate from the same progenitors in the SEZ rather than from direct transfection of 
oligodendrocyte precursors in the CC. Indeed, the maintenance of Olig2 expression 
interferes with neuronal differentiation as previously shown (Lee et al., 2005; Lu et al., 
2002). Consistent with an endogenous role of Olig2 in the endogenous low degree of 
oligodendrogliogenesis, this was completely blocked after injection of Olig2-VP16 in the 
SEZ (Fig. 32c).  
 
6.4.2.2.6 RMS precursors are further restricted towards the neuronal fate 
Given the gradient of these transcription factors along the RMS, I next performed the 
same functional analysis by injection into the RMS (Fig. 28c,d). These experiments 
revealed intriguing differences in the cell type specification at this position. When the 
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Pax6-engrailed containing virus was injected into the RMS, the effect on neurogenesis 
was notably weaker (control 94±1% DCX-positive cells amongst GFP-positive cells, n = 
80, 2 hemispheres, 1 animal, Pax6engrailed: 78±4%, n = 80, 2 hemispheres, 1 animal, see 
also Fig. 32e). Thus, precursors are further committed to the neuronal lineage within the 
RMS and this commitment is hardly reversible by Pax6-engrailed transduction. Similarly, 
overexpression of Olig2 in the RMS could not elicit oligodendrocyte generation (Fig. 
32b). Taken together, these data indicate that precursors in the RMS are further fate-
restricted and instead of promoting the generation of non-neuronal cells, both Pax6-
engrailed and Olig2 transduction still resulted in a large number of cells progressing 
towards the neuronal lineage.  
 
6.4.2.2.7 The role of Pax6 for the specification of dopaminergic 
periglomerular neurons 
Next, I examined neuronal subtypes generated by precursors manipulated within the SEZ 
or the RMS 2-3 weeks after injection. First, I compared the neuronal subtypes generated 
by cells infected with the GFP-control virus in the SEZ or the RMS. Consistent with 
previous data(Belluzzi et al., 2003; Carleton et al., 2003; Luskin, 1993; Petreanu and 
Alvarez-Buylla, 2002), most SEZ precursors gave rise to GFP-positive neurons (NeuN-
immunopositive) in the GCL (94±2%, n = 316, 4 hemispheres, 3 animals) and only few 
neurons were detected in the GL (2±1%, Fig. 33e). Remarkably, control virus injection 
into the RMS resulted in a significantly larger proportion of periglomerular neurons 
(PGN) amongst all GFP-positive cells in the OB (30±3%, n = 379, 3 hemispheres, 2 
animals, Fig. 33f, p < 0,001 compared to GFP injections into SEZ). These results suggest 
a new concept, namely that PGNs originate mostly at a rostral position of the SEZ/RMS 
system and few are derived from SEZ precursors. Notably, however, the majority of 
progenitor cells infected in the RMS (70%±2, n = 379, 3 hemispheres, 2 animals, Fig. 
33f) were still granule neuron (GN) precursors. Since most neuronal precursors in the 
RMS contain Pax6 (64%±2, n = 235, 2 animals), these data further support that Pax6 is 
also contained in GN precursors. 
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Given that Pax6 persisted in postmitotic PGNs while it was down-regulated in 
postmitotic GNs, I next examined whether the retrovirally mediated persistence of Pax6 
protein in OB neurons would be sufficient to instruct the differentiation towards the PGN 
fate. Indeed, Pax6 overexpression in RMS precursors is sufficient to convert the fate of 
70±2% GN neurons in the control injections towards a PGN fate with almost all of the 
neurons overexpressing Pax6 located then in the GL (85±5%, n = 90, 3 hemispheres, 3 
animals, p < 0,0001 compared to GFP-control injections into the RMS, Fig. 33f). These 
data imply Pax6 as a key determinant for PGN neuronal subtype specification. Indeed, 
injection of Pax6-engrailed virus into the RMS significantly reduces the proportion of 
PGN normally generated here to less than a third of the value obtained in control virus 
injections (6±2%, n = 141, 4 hemispheres, 3 animals, Fig. 33f, p < 0,001 compared to 
GFP injections into RMS), suggesting that the maintenance of endogenous Pax6 
expression in RMS precursor cells is required to progress towards a PGN subtype. Pax6-
virus injection into the SEZ was also sufficient to instruct PGN fate (30±5%, p < 0,001, 
compared to GFP control injection into SEZ, n = 80, 3 hemispheres, 3 animals, Fig. 33e), 
albeit to significantly lower levels as seen in the RMS injections (p < 0,001 comparison 
Pax6 injection into SEZ and RMS). These data may be explained by SEZ precursors 
being biased – either by intrinsic or extrinsic factors – towards a GN fate, suggesting a 
new concept of early subtype specification during adult neurogenesis. 
Given the close correlation of Pax6- and TH-immunoreactivity I next examined 
whether Pax6 overexpression is also sufficient to induce differentiation of PGNs towards 
a dopaminergic transmitter phenotype. Indeed, already 2-3 weeks after viral injection, the 
number of TH-positive PGNs was significantly increased after Pax6 transduction 
compared to the control virus injections in both SEZ (Fig. 34b). Since it is well 
established that the final acquisition of TH-immunoreactivity for newborn neurons takes 
several weeks (Winner et al., 2002) and requires synaptic contacts (Brunjes, 1994), I also 
examined TH-immunoreactivity 3 months after viral injection. Now 33.2±5.7% of all 
GFP-positive PGNs resulting from control virus injections in the RMS had acquired TH-
immunoreactivity (n = 123, 3 hemispheres, 2 animals; Fig. 34a). Strikingly, about half of 
all GFP-positive PGN had acquired TH-immunoreactivity 2-3 months after injection of 
Pax6-containing virus into the RMS (48.1±1.4%, n = 116 GFP-positive PGN from 4 
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hemispheres, 3 animals; p < 0.05 as compared to control vector injection to the RMS). 
These results strongly suggest that Pax6 overexpression significantly promotes the 
acquisition of a dopaminergic transmitter phenotype in adult neurogenesis.  
In the RMS injections, Olig2 was able to interfere with the differentiation of 
PGNs (Fig. 33f; n = 373, 4 hemispheres, 2 animal, p < 0,0001 compared to GFP-control 
virus injection into the RMS).  In contrast, Olig2-VP16 exerted no significant effects on 
neuronal subtype specification in the RMS (Fig. 33f), further supporting that it does not 
exert unspecific effects on precursors devoid of endogenous Olig2. Since Olig2 is not 
expressed in RMS precursors I wondered whether the ectopic expression by Olig2-
containing virus may exert its effects by downregulation of Pax6. Indeed, few Olig2-
infected precursor cells in the RMS expressed Pax6 7 days after infection 
(Olig2IRESGFP: 19±1%, n = 99, 1 hemisphere, 1 animal) compared to a majority of 
Pax6-positive cells (80±3%, n = 163, 1 hemisphere, 1 animal) after control virus 
injection. However, injections of Olig2 or Olig2-VP16 constructs into the SEZ were not 
able to elicit any change in neuronal subtype specification (Fig. 33e; Olig2: p < 0,05 
compared to GFP control in the SEZ, n = 176, 3 hemispheres, 3 animals; Olig2-VP16: p 
= 0,21 compared to GFP control in the SEZ, n = 406, 4 hemispheres, 3 animals) Taken 
together, these data suggest that olig2 exerts no direct effect on neuronal subtypes and 
endogenous Olig2 expression in the immature type C precursors is not required for 
granule cell specification. These data, taken together with the results for Pax6, would 
imply that neuronal subtypes are specified at later stages in the lineage progression. 
 
6.4.2.3 Overexpression of Pax6 in non neurogenic astrocytes in vivo 
The results presented above revealed a potent role of Pax6 as neurogenic fate determinant 
in endogenous adult neurogenesis originating from astrocytes. Therefore one could 
suggest that Pax6 may be sufficient to convert non-neurogenic astrocytes towards 
neurogenesis in endogenous adult neurogenesis  
However, most other astrocytes in the adult brain are not neurogenic under normal 
conditions. Indeed it was recently shown that astrocytes isolated from non neurogenic 
regions of the postnatal (P11) brain could still differentiate into neurons by 
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overexpression of the transcription factor Pax6 (Heins et al., 2002). However since these 
experiments were carried out in vitro it was not possible to distinguish if it was the 
intrinsic change of the astrocytes by Pax6 alone or if other alterations of the astrocytes or 
their environment helped these cells to differentiate into neurons. Towards this end, I 
decided to carry out these overexpression experiments in vivo at comparably early 
postnatal stages (P8) when many GFAP-positive cells in the cortex are still dividing. 
Retroviral vectors (control and Pax6) described above were injected into the cerebral 
cortex of p8 pups (see Materials and Methods) and the animals were sacrificed after two 
different survival times, namely after 7 and 14 days.  
After transduction with the control virus almost all GFP-positive cells were 
GFAP-positive astrocytes (91% ± 9%, = 119, 3 animals, Fig. 36f) 7 days after injection. 
No neurons or cells expressing early neuronal markers (PSANCAM or DCX) were 
observed amongst the GFP-positive cells after control virus injection. To study the 
amount of endogenous neurogenesis ongoing in the postnatal cortex, I examined the 
phenotype of the control infected cells also 14 days post injection. Again I found no 
neurons and no cells expressing early neuronal markers (PSANCAM or DCX) in these 
experiments. Notably, however, some cells seem to lose GFAP-expression, but the vast 
majority of all GFP-infected cells were still GFAP positive astrocytes (75% ± 19%, n = 
109, 4 animals, Fig. 36b,f). These data indicate that GFAP positive astrocytes were the 
main cell type affected by the injection of the retroviral particles and therefore validated 
the experimental system as useful for studying the effect of Pax6 on astrocytes in their in 
vivo environment. 
In contrast to these control injections, the number of GFAP-positive, GFP-positive cells 
was reduced (62% ± 11%, n = 25, 3 animals, Fig. 36d,f) compared to control injections 7 
days after transduction with the Pax6 containing virus. Furthermore, a larger number of 
Pax6 transduced cells expressed of early neuronal markers (DCX: 8% ± 1%, n = 33, 3 
animals; PSANCAM 6% ± 6%, n = 31, 3 animals, Fig. 36f). However no NeuN positive 
neurons could be detected (0%, n = 18, 3 animals, Fig. 36f), suggesting that the 
neuroblasts/ neurons induced by Pax6 are still immature. To determine whether the 
number of newly born neurons would increase and differentiate in the adult cortex, I 
examined the phenotype of the Pax6 transduced cells 14 days post injection. Indeed a 
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further increase in the number of cells with neuronal characteristics was observed (DCX: 
20% ± 6%, n = 29, 3 animals; PSANCAM 10% ± 9%, n = 32, 3 animals, Fig. 36c,e,f) 
and also the number of GFAP positive cells were further decreased (20% ± 6%, n = 23, 3 
animals, Fig. 36d,f). Taken together these results indicate that non neurogenic 
endogenous astrocytes of the cerebral cortex can be induced to differentiate into cells 





The molecular signals specifying neuronal, glial or multipotent precursors in the 
developing and adult CNS are largely unknown. Radial glial cells have recently been 
discovered as major precursor population generating neurons or glial cells in separate 
lineages in the developing CNS.  
Here I present a novel method to selectively enrich neurogenic or non-neurogenic 
radial glia. Towards the aim to identify fate determinants I compared their gene 
expression to multipotent precursors in vitro and in vivo Olig2 was expressed to higher 
levels in multipotent compared to neuronal or glial precursors, while Pax6 showed the 
converse expression profile.  
Therefore I focused further on the functional analysis of Pax6 and Olig2 in neural 
stem cell in vitro and in vivo. Pax6 expression is enriched in neurogenic radial glia and 
adult SEZ precursors, while Olig2 expression levels are higher in neural stem cells in 
vitro and transit-amplifying precursors of the SEZ. Interference with Olig2 in neural stem 
cells in vitro revealed its role in self-renewal.  
In adult neural stem cells of the SEZ overexpression of Olig2 promoted 
oligodendrocyte formation. Pax6, in contrast, proved to be a very potent neurogenic 
determinant since neurogenesis is not only Pax6-dependent in neural stem cells in vitro, 
but also in adult neural stem cell in vitro.  
Taken together, these results demonstrate a pathway combining transcription 
factors of dorsal and ventral regions that is activated in a specific lineage progression of 
adult neural stem cells in vitro and in vivo. Most importantly also in regard to therapeutic 
approaches, this work revealed the molecular mechanisms to direct adult neural stem 
cells towards a specific cell fate, neuronal or oligodendroglial. 
 
7.1 Regional heterogeneity of radial glial cells 
Radial glial cells have recently been discovered as an important CNS precursor 
population comprising neurogenic and non-neurogenic lineages in the cortex (Malatesta 
et al., 2003; Malatesta et al., 2000; Miyata et al., 2001; Noctor et al., 2001; Tamamaki et 
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al., 2001). My experiments show that the fate of radial glia progeny differs if radial glia 
are isolated from different brain regions. Cortical radial glia mostly generated neurons, 
whereas GE radial glia generated mostly glial cells (Fig.7). Importantly, this did not 
change, when these radial glia were cultured in the GE or the cortex environment, 
respectively. Cortical radial glia (cultured in a GE environment) still generated mostly 
neurons and GE radial glia still generated mostly glia in a cortex environment in vitro 
(Fig.7). Therefore, I conclude that these subpopulations of radial glia are intrinsically 
different. Since the transcription factor Pax6 is expressed only in cortical but not GE 
radial glia (Götz et al., 1998) and the neurogenic radial glia is severely reduced in the 
Pax6 mutant cortex (Ericson et al., 1997; Heins et al., 2002), Pax6 seems to act as cell-
autonomous determinant of neurogenic radial glial fate in the developing telencephalon. 
Interestingly, Pax6 is also expressed in a subset of radial glia in the spinal cord (Ericson 
et al., 1997) and might also contribute to the neuronal lineage of the radial glia in this 
region.  
Since radial glia in the ventral telencephalon contribute little to the generation of 
neurons in the basal ganglia, different precursors must be responsible for their generation. 
Indeed, the GE contains a particularly prominent subventricular zone (SVZ) during 
embryogenesis, a region populated by precursors that undergo mitosis at some distance 
from the ventricular surface (Smart, 1976). In contrast to the cortex where the SVZ is 
very small, almost half of the progenitor pool of the GE is located in the SVZ (Smart, 
1976). I confirmed this hypothesis, that SVZ cells generate the neurons in the GE by 
subdissection of the GE VZ and SVZ (Fig. 8). Selective enrichment of VZ or SVZ 
precursors confirms that few of the VZ precursors in the GE generate neurons, while 
precursors located above the VZ generate neurons more frequently. My in vitro data are 
further supported by previous genetic evidence implying the embryonic SVZ as the 
source of striatal neurons. The embryonic SVZ precursors express the transcription 
factors Dlx1, Dlx2, Mash1, and Ebf1 (Eisenstat et al., 1999; Garel et al., 1999; Porteus et 
al., 1994) that have been implicated with neurogenesis in the GE (Xu et al., 2003). 
Importantly, mouse mutants for these transcription factors expressed mostly in the 
embryonic SVZ of the GE have defects in neurons of the striatum (Anderson et al., 1999; 
Casarosa et al., 1999; Eisenstat et al., 1999), supporting the role of Mash1 and Dlx genes 
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in neurogenesis from SVZ precursors. Lineage tracing in the GE revealed clones 
containing neurons and radial glial cells (Reid and Walsh, 2002) that derive either from a 
radial glia cell generating a neuron and a radial glia (as observed in the cortex by Noctor 
et al., (Noctor et al., 2001) or from an earlier neuroepithelial precursor giving rise to a 
radial glia and neurogenic precursors, e.g., located in the SVZ (Haubensak et al., 2004; 
Miyata et al., 2001; Noctor et al., 2004). Indeed, neuroepithelial cells generating both 
SVZ cells and radial glia with mostly the former continuing to produce neurons is a 
scenario that would unify all presently available data. Surprisingly few clones containing 
neurons and radial glia have been described in the cortex, where radial glia are the main 
source of neurons. This is explained by the observations of Miyata et al. and Noctor et al. 
(Miyata et al., 2001; Noctor et al., 2001; Noctor et al., 2004; see also Fig. 1) that radial 
glial cells transform into postmitotic neurons (Malatesta et al., 2003). Thus, these data 
suggest that there are two different ways to generate neurons. One from radial glial cells 
that seems the predominant mode in the developing CNS, and a second way to generate 
neurons from SVZ precursors as observed in the developing basal ganglia. 
Interestingly, when GFP positive radial glial cells are isolated from transgenic 
mice expressing GFP driven by the brain lipid binding protein (BLBP) promoter and 
examined at E10 or mid-neurogenesis stages, only the former, but not the later generate 
neurons (Anthony et al., 2004) Thus, my analysis and Anthony et al. agree in the 
observation that radial glial cells in the ventral telencephalon are mostly not neurogenic 
except at very early stages. However, it should be noted, that in the developing mouse 
brain, VZ cells generate SVZ cells already around E11 (Hashimoto and Mikoshiba, 
2004). Thus, the early onset of GFP expression under the control of the BLBP promoter 
in the basal telencephalon can label not only early precursors/radial glia themselves but 
of course also their descendant SVZ precursors. Since SVZ cells are neurogenic, the 
neurons that are supposed to be generated from radial glia may be generated indirectly 
via SVZ cells 
Additionally, Anthony et al (Anthony et al., 2004) also showed that the majority 
of BLBP-positive cortical radial glia at E14 generated mixed clones while the majority of 
clones were composed only of neurons and were not committed to the neuronal fate. 
There are two important differences between my data and the ones from Anthony et al 
 71
(Anthony et al., 2004). First I isolated GLAST-positive radial glia (see also page 37, 
Malatesta et al., 2000), but Anthony et al. isolated BLBP-positive radial glia. It was 
shown that there are different subsets of radial glial and the composition of these subsets 
changes during development (Hartfuss et al., 2001). Most radial glia express GLAST 
throughout embryonic development, whereas BLBP is up-regulated in the radial glial 
during development becoming the major population of all radial glial cells at late 
developmental stages (E18). (Hartfuss et al., 2001) These facts suggest that BLBP-
positive radial glia are precursor restricted to the glial lineage, but can not be taken into 
account for the higher proportion of mixed clones observed by Anthony et al.  
However, the second important difference can be found the cell culture system 
used. Anthony et al. cultured isolated radial glia on feeder cells, but added high 
concentration of FGF2 to the medium. Even though it was shown by many labs that the 
culturing of primary cells in chemically defined medium can very well mimic the in vivo 
environment (Hack et al., 2004; Hajihosseini and Dickson, 1999; Lillien, 1997; Qian et 
al., 1998), I have found FGF2 or EGF elicit prominent changes in transcription factor 
expression in this cell culture system. For example, Olig2 was strongly upregulated also 
in neurosphere cultures, a culture system to specifically enrich multipotent neural stem 
cells. Therefore these changes could well impose such changes in cell fate and could 
therefore explain the high proportion of mixed clones generated by cortical radial glia at 
E14. Taken together, these different lines of evidences suggest that the mode of 
neurogenesis is different between dorsal and ventral telencephalon, the former generates 
neurons mostly from radial glial cells while in the latter region most neurons are 
generated from SVZ precursors. 
 
7.2 Radial glial cells from the cortex are heterogeneous 
Given that radial glial cells even within the cortex gave rise to distinct lineages 
(multipotent, glial-restricted, and neuronal-restricted), I aimed to separate these to 
determine their intrinsic fate differences. The isolation of the strongly green fluorescent 
fraction of cells from the cortex of hGFAP-eGFP mice lead to an enrichment in non-
neurogenic precursors while the neurogenic precursors were depleted to a fifth of the 
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content in the weakly green fluorescent fraction. This enrichment allowed me to detect 
significant differences in expression levels of several candidate genes (Fig. 11), for 
example a five-fold increase in the expression levels of Olig2 and Emx2 in the fraction 
enriched in non-neurogenic precursors. Notably, the non-neurogenic progeny is 
heterogeneous with only some precursors generating differentiated glial progeny (most 
GFAP-positive astrocytes and very few O4-positive oligodendrocytes), while many cells 
remain undifferentiated and contain only nestin (Malatesta et al., 2003; Malatesta et al., 
2000). Since these less differentiated cells do not generate neurons and hardly any 
oligodendrocytes in dissociated cell cultures, even after growth factor addition (Götz et 
al., 2002), I interpret these as immature astroglial cells and refer to this fraction of 
precursors as ‘gliogenic’ with a predominant astroglial fate (Fig. 2). However, at least 
some of these astroglial precursors can still react to the neurosphere culture conditions, 
since the strongly green fluorescent cells generated more neurospheres than the weakly 
green fluorescent fraction see Results page 41). Thus, the increased level of Olig2 
expression in this fraction also correlates to an increased neurosphere-forming capacity, 
consistent with the upregulation of Olig2 in neurosphere cultures and its role in 
undifferentiated multipotent precursors. Similarly, the increased level of Emx2-
expression might be linked to a more immature precursor state of this fraction, since our 
previous functional analysis implied Emx2 as a positive signal for immature and bi-
/multipotent precursors in dissociated cell cultures without growth factor addition (Heins 
et al., 2001).  
In the fraction of radial glia enriched in neurogenic cells, I detected a five-fold 
higher expression level of Pax6, consistent with the previous evidence for a role of Pax6 
in neurogenesis from cortical radial glia (Heins et al., 2002). Ngn2 is a direct target of 
Pax6 (Scardigli et al., 2003), and hence would be expected to be up-regulated as well in 
neurogenic precursors. However, the mRNA level of Ngn2 proved to be sensitive to the 
FACS procedure and was reduced in all the cells sorted from cortex even below the 
levels normally seen in the GE. No conclusions can therefore be drawn about Ngn2. 
Notably all the other transcription factors examined here were not affected in their 
expression level by the FACS procedure in comparison to un-dissociated cortical tissue 
from the same embryonic stage. The sorted cells also maintained region-specific 
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differences in expression levels (high levels of Emx1, 2 and Pax6 and low levels of Dlx1, 
2, Mash1, Gsh2 and Olig2). Taken together, the five-fold enrichment of neurogenic 
versus gliogenic/immature precursors by FACS is a useful procedure to identify relevant 
differences in gene expression levels. 
 
7.3 Changes of gene expression patterns upon EGF and FGF2 
in neurosphere cultures 
In comparison to the sorted precursors I examined gene expression patterns in the widely 
used culture model of neurospheres that takes advantage of the dedifferentiating function 
of EGF and FGF2. When I analyzed the influence of these growth factors on gene 
expression, I observed prominent changes even after short-term exposure to these growth 
factors in adherent dissociated cell cultures. While the regional specification is well 
conserved in these cultures without growth factor addition, the number of Olig2- and 
Mash1-immunoreactive precursors is increased already two days after EGF or FGF2 
addition until almost all precursors from the cortex or GE become Olig2-immunopositive 
after 1 week in FGF or EGF (Fig. 14,15). Conversely, Pax6 and Emx1 were down 
regulated, while Dlx-and Gsh2-immunoreactivity was not affected (Fig. 14,15). Thus, at 
least some of the gene expression changes observed in neurosphere cultures seem to be 
due to the growth factor exposure.  
Indeed, EGF infusion in vivo elicits similar changes in the adult subependymal 
zone (SEZ; Doetsch et al., 2002) with a decrease in PSA-NCAM-positive type A and a 
corresponding increase in the fast proliferating type C cells. These data are well 
consistent with my data on a downregulation of Pax6 upon EGF exposure in vitro and the 
localization of Pax6 in the PSA-NCAM-positive type A cells in vivo (Fig. 25). 
Furthermore, I observed an upregulation of Olig2 upon EGF in vitro and found Olig2 in 
the fast proliferating precursors labeled by a short BrdU-pulse in the adult SEZ in vivo.  
These data obtained with telencephalic cells are well consistent with recent data 
obtained with precursors from the spinal cord that also up-regulate Olig2 and down-
regulate the dorsal spinal cord transcription factors Pax3 and Pax7 upon FGF2 exposure 
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(Gabay et al., 2003). Interestingly, FGF4 was recently also identified as signal from 
presomitic mesoderm restraining neuronal differentiation by interfering with e.g. the 
onset of Pax6 expression (Bertrand et al., 2000; Diez del Corral et al., 2003; Novitch et 
al., 2003), suggesting a common dedifferentiating function of FGF2 and FGF4 signaling. 
Taken together, these data suggest that the ventralizing function of FGF2 is rather 
context- and stage-dependent, while the inhibitory effect on cell differentiation seems 
rather widespread during nervous system development.  
Indeed, the neurosphere culture model may be best viewed as an environment 
repressing regional or cell type specific differentiation accompanied by high rates of 
proliferation. Notably, telencephalic cells cultured for 4 passages as neurospheres 
seemingly had lost any patterning information, and undergone more severe changes in 
gene expression than observed after short-term exposure to growth factors when cells still 
maintained some region-specific patterns (Dlx and Gsh2 in GE cells). No or negligible 
differences were detectable in the expression levels of 14 transcription factors that 
normally differ between cortex or GE cells after exposure to neurosphere culture 
conditions for 5 weeks. Consistent with a general dedifferentiation, the expression levels 
of most transcription factors were reduced in the neurosphere cultures, regardless of their 
normal expression in the dorsal (Pax6, Ngn2, Emx1, 2) or ventral telencephalon (Dlx, 
Gsh2, Vax1, islet-1; Nkx2.2), with the exception of Olig1 and 2 that were up-regulated to 
even higher levels than normally in the GE. These gene expression changes therefore 
abolished almost all region-specific differences between the precursors from which the 
neurosphere cultures were originally started. This dedifferentiation to a pan-neurosphere 
expression level might explain the surprising similarity in the transcriptom analysis of 
neurosphere and embryonic stem cells (Ramalho-Santos et al., 2002). Thus, this profile of 
gene expression may reflect the undifferentiated state of an early, not yet regionally 
specified neural precursor, similar to the type of precursor that is maintained by FGF 
signaling during development in the neural tube in vivo until retinoid signaling initiates 
neurogenesis accompanied by dorso-ventral patterning (Diez del Corral et al., 2003; 
Novitch et al., 2001; Sockanathan et al., 2003). 
However, how can these data that suggest dedifferentiation and/or loss of 
regionalization of neural cells in neurosphere cultures (Gabay et al., 2003; Santa-Olalla et 
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al., 2003), be reconciled with previous work claiming a maintenance of region-specific 
differences in neurosphere cultures (Hitoshi et al., 2002b; Ostenfeld et al., 2002; Parmar 
et al., 2002). One interesting explanation could be the effect of cell density that would 
also explain some of the differences seen with adherent cell cultures and neurosphere 
cultures. As long as cells still interact with their normal neighbors they might still receive 
positional information that is only partially overridden by the potent growth factor 
signaling. This effect is known as ‘community effect’ and may account for the 
maintenance of some regional differences in the high density neurosphere cultures 
(Ostenfeld et al., 2002; Parmar et al., 2002) where cells were grown at 25-40x higher 
concentrations than in my clonal culture conditions (Morshead et al., 2003). Interestingly, 
loss of regionalization has been reported by Santa-Olalla et al. (Santa-Olalla et al., 2003) 
that also use relatively high density cultures, but also use 5-10x higher growth factor 
concentrations. There is, however, also a technical concern with studies that only rely on 
semi-quantitative RT-PCR data (Hitoshi et al., 2002b; Santa-Olalla et al., 2003). Here I 
have used real-time RT-PCR that is certainly a technical improvement in accuracy, since 
it allows data analysis in the phase of constant amplification efficiency and normalized 
relative quantification is not dependant anymore from estimating DNA band densities on 
agarose gels that is subject to contamination and lack of sensitivity. Moreover, I have 
confirmed my data at the protein level, especially for those genes where there are 
discrepancies to other studies (Emx1, Pax6, and Dlx). However, it is also important to 
realize that some region-specific differences between neurosphere cells might not be 
completely lost, since there are still small differences in the number of neuronal subtypes 
generated from neurosphere cells of different origin. For example, I also observed that 
Dlx2 (one of the 4 genes that were maintained in a region-specific manner in the analysis 
of Hitoshi et al., (Hitoshi et al., 2002b)) is up-regulated  during differentiation of 
neurosphere cells only in those originating from the GE, but not in those of the cortex 
(Fig. 16). Indeed, these subtle differences upon differentiation may also explain the 
distinct cell migration behavior after transplantation on slices (Hitoshi et al., 2002b). 
However, it is important to realize that even though some subtle regional differences may 
still exist they are minor compared to the in vivo situation. For example, the ‘region-
specific’ Dlx2-expression levels in GE neurospheres were 1000x lower than the normal 
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Dlx2 expression level in the ventral telencephalon. Indeed, the loss of regionalization is 
also obvious at the functional level, e.g. in regard to neuronal differentiation. Notably, 
neurosphere cells from different regions mostly generate GABAergic neurons (own 
observations; (Ciccolini et al., 2003; Hitoshi et al., 2002b; Parmar et al., 2002), a wide-
spread neuronal subtype, while those subtypes that occur only in specific regions, such as 
dopaminergic neurons, are notoriously difficult to produce from neurospheres even if 
they originate from the region that generates dopaminergic neurons in vivo (Yan et al., 
2001). Taken together, these results underline the concept that regionalisation and 
neurogenesis are inseparably linked during normal development (Bertrand et al., 2002; 
Götz et al., 1998) and the loss of regionalisation in neurosphere cultures impairs 
neurogenesis.  
 
7.4 Transcriptom analysis 
The characterization of the global gene expression profiles described in this Ph.D. work 
gives me and others a database to explore the basic biology of functionally distinct 
precursor populations. In the current study, I performed an oligonucleotide microarray 
analysis on the neurogenic precursors (GFP+) and the more non-neurogenic population 
(GFP++) from E14 hGFAP-eGFP mice and the neurosphere cells isolated from the E14 
cortex undifferentiated and differentiated for 1 days. The undifferentiated neurospheres 
are a population enriched for multipotent precursors. The neurosphere cultures 
differentiated for 1 day are a population of mostly gliogenic precursors, and would 
therefore be most similar to the non-neurogenic population (GFP++) from E14 hGFAP-
eGFP mice (Fig. 3). 
The comparison of gene expression in the model of multipotent cells, the 
neurosphere cultures, to previous analysis revealed several similarities (Geschwind et al., 
2001; Ivanova et al., 2002; Ramalho-Santos et al., 2002). Recent descriptions of gene 
expression patterns within stem-cell populations are starting to define their molecular 
profiles (Geschwind et al., 2001; Ivanova et al., 2002; Ramalho-Santos et al., 2002). 
Ivanova et al. generated neurospheres from the embryonic ganglionic eminence, while 
Ramolho-Santos derived their neurospheres from the adult mouse SEZ. As discussed 
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previously, there are at least for some important candidate genes no significant 
differences in gene expression between both regions. These authors then compared the 
gene expression in neurosphere cells to embryonic or hematopoietic stem cells to identify 
common genes determining “stemness” multipotent fate. 
Notably I also observed upregulation of a number of genes in the undifferentiated 
neurosphere cultures that were identified as stem-cell specific in common by those 
groups (Ivanova et al., 2002; Ramalho-Santos et al., 2002). These genes include Fyn, 
Slit2, tenascin C, and insulin-like growth factor binding protein 2 or cyclin D.  
Furthermore I looked for genes specifically associated with neural development. 
It is of interest that only few of the Wnt genes are expressed within the neurospheres 
(Wnt 5a, 7a, 7b). Wnt has recently been show to antagonize neural development in mouse 
ES cells (Aubert et al., 2002). In some cases, these findings may be very relevant to 
future studies looking at differentiation or proliferation of these cells. For example, the 
FGF receptors FGFR1 and FGFR3 were expressed but not FGFR2. The expression of 
FGF-2 and its receptor FGFR1 may imply paracrine or autocrine effects of this mitogen 
on the growth of these neurosphere cells. Similarly, platelet-derived growth factor 
receptor (PDGFR) alpha, but not beta, was expressed. However, a number of genes that I 
expected to be expressed at high levels were not expressed. For example, musashi1 has 
been associated with neural stem cell populations (Kaneko et al., 2000; Keyoung et al., 
2001), but was absent in the mRNA of undifferentiated neurospheres. As Keyoung et al. 
examined musashi1 in short-term cultures only, it is possible that this RNA-binding 
protein is down-regulated after the longer growth periods used in this study. 
Since I was able to isolate and to enrich three to four functionally distinct 
precursor populations (Fig. 3), I wanted to assess which genes might be linked to 
different fate decisions. Several known genes were expressed in only one or two related 
populations of the four different precursor populations. Some of these genes have not yet 
been implicated with neural development. Some genes are specifically highly expressed 
in undifferentiated neurosphere cultures and would therefore be expected to play a role in 
multipotent cell fate. One of these was tweety is a novel maxi-Cl(-) channel (Suzuki and 
Mizuno, 2004) and FABP7 is the brain specific fatty acid binding protein (Hartfuss et al., 
2003; Hartfuss et al., 2001; Veerkamp and Zimmerman, 2001). While the function of 
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tweety in multipotent precursors remains to be determined, FABP7 (BLBP) was shown to 
label a population of cells in the embryonic telencephalon enriched for multipotent 
precursors (Anthony et al., 2004). The expression levels of sirtuin2, a NAD-dependent 
deacetylase that regulates muscle gene expression and differentiation by possibly 
functioning as a redox sensor (Fulco et al., 2003), were also increased in undifferentiated 
neurosphere cultures.  
The expression of Sox9 peaked in the populations enriched for gliogenic 
precursors (GFP++, dd1) and indeed when Sox9 is ablated in neural stem cells the 
specification of astrocytes and oligodendrocytes is strongly affected (Stolt et al., 2003). 
Finally Sox4 and LMO-1 (Lim domain only-1) were strongest expressed in the 
neurogenic precursors. Both of them are known to be expressed in the developing and 
adult CNS in specific precursor populations, but their specific function in cell fate 
specification still remains to be determined (Cheung et al., 2000; Hinks et al., 1997).  
Clearly, the limitations of detection of the microarray system preclude the 
complete description of gene expression in neural stem cells and restricted precursors. 
However, given this caveat, this database displays highly reliable gene expression data 
and may be considered as at least a representative part of distinct telencephalic 
precursors. 
Taken together this gene expression analysis revealed the differential gene 
expression of several interesting candidates that could be grouped to functionally distinct 
precursor subsets. Most importantly, the expression of Pax6 could be linked to neuronal-
restricted precursors, whereas the expression of Olig2 could be restricted to multipotent 
neural stem cells. A further analysis of the microarray data may allow us to understand 
the transcriptional context in which these two fate determinants act. 
 
7.5 The role of Pax6 in neurogenic precursors  
7.5.1 Role of Pax6 in vitro in neurosphere cultures 
Since I detected this strong upregulation of Pax6 in neurogenic precursors of the 
developing cortex in the gene expression analysis, I decided to analyze Pax6 functionally 
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in vitro. Previously, Pax6 transduction has been shown to have a potent neurogenic effect 
in precursors from the embryonic cortex (Heins et al., 2002), but no effect could be 
detected upon transduction of cells from the GE. In contrast, neurosphere cultures, 
however, all cells, independent of their region of origin reacted strongly to Pax6 
expression and turned to more than 80% into neurons. Importantly, this was not only true 
for neurospheres generated of the embryonic brain, but also for neurospheres generated 
from the adult SEZ.  
Moreover, neurogenesis from all neurosphere cells even became dependent on 
Pax6, indicated by the almost complete loss of neurogenesis from neurospheres 
independent from their region of origin of homozygous Pax6 mutant mice. In contrast, in 
vivo, neurogenesis in the cortex depends only partially on Pax6 (neurons are reduced by 
half) and Pax6 plays no role in neurogenesis in the GE (Heins et al., 2002; Schmahl et al., 
1993). Notably, the Pax6-dependent neurogenic pathway was activated not only along the 
dorso-ventral axes, but also along the anterior-posterior axes since even cells from 
midbrain became Pax6-dependent for neurogenesis after neurosphere expansion. Thus, 
Pax6-mediated neurogenesis is the neurogenesis pathway activated in neurosphere 
cultures.  
It will be important to determine the signaling mechanisms inducing this pathway 
in vitro as a lead into the mechanisms instructing this mode of fate specification in vivo. 
One explanation for the activation of this pathway, however, might be our previous 
suggestion that neurosphere cells assume a radial glia like phenotype (Hartfuss et al., 
2001) and that Pax6 is the major neurogenic determinant for radial glial cells (Heins et 
al., 2002). Moreover, when mouse embryonic stem (ES) cells are treated with retinoic 
acid they generate an essentially pure population of glutamatergic projection neurons 
(Bibel et al., 2004; Plachta et al., 2004). Surprisingly this neuronal differentiation 
happens via a Pax6-positive radial glial-like cell like it is present in the dorsal 
telencephalon, but also in the spinal cord (Bibel et al., 2004), highlighting again Pax6 as a 
strong neurogenic fate determinant in different precursor cells.  
By itself, however, the potent neurogenic role of Pax6 in neurosphere cultures is 
highly relevant for the attempts to reconstitute neurons in the adult mammalian brain that 
have so far suffered from the low degree of neuronal differentiation from neurosphere 
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cells in vitro (Song et al., 2002) and upon transplantation in vivo (Fricker et al., 1999; 
Herrera et al., 1999; Lim et al., 2000; Winkler et al., 1998). Indeed, I know that the 
neurons generated by Pax6-overexpression are functionally, even receiving synaptic 
inputs (Berninger, Hack, Grothe and Götz, unpublished observations). These data provide 
a promising avenue to improve functional reconstitution in vivo.  
 
7.5.2 Role of Pax6 in vivo  
7.5.2.1 Pax6 in adult neurogenesis 
In fact, adult neural stem cells might depend on the same fate determinants as radial glial 
cells since I also detected Pax6 in neuroblasts migrating along the RMS. Indeed, adult 
neural stem cells have been identified as astrocytes and share not only many cell 
biological characteristics with radial glia but even have a common lineage origin (Merkle 
et al., 2004). This is in line with the observation that similar molecular pathways are 
involved in their specification.  
Therefore the neurogenesis supplying the adult olfactory bulb (OB) is an excellent 
system to address the role of Pax6 in vivo. During adult neurogenesis distinct types of 
interneurons are continuously generated throughout adulthood (Altman, 1969; Lois and 
Alvarez-Buylla, 1994; Luskin, 1993). These are the GABAergic interneurons located in 
the granule cell layer (GCL) and glomerular layer (GL) as well as dopaminergic 
interneurons in the GL (Carleton et al., 2003; Kosaka et al., 1998; Kosaka et al., 1985). 
Important progress has been made in the identification of factors regulating stem or 
transit-amplifying cell fate as well as asymmetric cell division (Doetsch et al., 2002; 
Molofsky et al., 2003; Shi et al., 2004), but still nothing is known about the mechanisms 
directing cell progenitors towards specific neuronal or glial subtypes in the adult brain. 
Since Pax6 is contained only in adult neuroblasts (Fig. 25), I suggested that it may play 
an important role in this fate decision. 
However, in the absence of functional Pax6 protein in the Small Eye mice, the OB 
fails to form altogether (Dellovade et al., 1998; Stoykova et al., 2003). Remnants of the 
OB lie as ectopic vesicles in the ventral telencephalon, and consist mostly of reelin-
positive cells, potentially remnants of the mitral cells (Jimenez et al., 2000). Therefore, it 
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is impossible to conclude whether other neuronal subtypes fail to be generated, are 
misspecified or alternatively fail to migrate to this mislocalized vesicle.  
My results imply Pax6 acts in the adult neurogenesis as a key factor in regulating 
this progression towards the neuronal lineage. Pax6 overexpression increases the 
proportion of neuroblasts amongst the infected cells, while interference with its normal 
function of transactivating specific target genes reduces the proportion of neuroblasts 
amongst the infected cells. This reduction seems not to be due to selective cell death upon 
viral infection, but rather to the effect of Pax6 to direct precursors towards a neurogenic 
fate. Notably, neurogenesis eventually leads to the generation of postmitotic daughter 
cells, a function combined by the target genes regulated via the paired domain of Pax6 
that acts neurogenic and anti-proliferative in cortical precursors (Haubst et al., 2004; 
Heins et al., 2002). Indeed, the endogenous gradient of Pax6-positive precursors 
increasing rostrally within the RMS correlates to a reduced cell proliferation with 
increasing distance from the SEZ (Smith and Luskin, 1998).  
These data prompt two important conclusions. First, Pax6 is involved in 
neurogenesis throughout the SEZ/RMS system, and second, SEZ and RMS precursors 
differ in their fate restriction mediated by Pax6. In regard to the first conclusion, it is 
important to bear in mind that GN precursors are the most frequent cell type throughout 
the SEZ/RMS (more than 90% in SEZ and still 70% in the center of the RMS). Thus, 
Pax6 is expressed in 50% of the GN precursors in the caudal RMS and all of them in the 
center of the RMS. Thus the effect of Pax6 deletion or dominant-negative constructs in 
the SEZ obviously blocks further Pax6 upregulation necessary for progression of the 
neuronal lineage. When Pax6 function is blocked in the SEZ, almost all infected 
precursors are deviated from the neuronal lineage – only 30% DCX-positive precursors 
are detectable 1 week after Pax6-engrailed virus infection, but none of these ever makes 
it to the OB and differentiates into a proper neuron. Since similar results were obtained 
by deletion of Pax6 in the SEZ, I conclude that neuronal specification is still reversible in 
almost all transduced SEZ precursors. This scenario fits well with the idea that 
upregulation of Pax6 mediates an irreversible commitment to the neuronal lineage. Most 
neuronal precursors in the SEZ have still very low levels of Pax6 not yet detectable by 
immunocytochemistry but soon become Pax6-immunoreactive within the RMS already 
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adjacent to the SEZ and most neuronal precursors migrating along the RMS express high 
levels of Pax6 and have obviously up-regulated its crucial target genes for neurogenesis. 
At this stage, the fate of most neuronal precursors (70% GN precursors in the RMS) can 
not be reversed anymore with the exception of the PGN precursors (30% GN precursors 
in the RMS) that seem to be specified much closer to the OB than the GN precursors.  
The neurogenic role of Pax6 in adult neurogenesis is of interest also with regard to 
the origin of adult OB precursors. There is evidence suggesting that some adult SEZ 
precursors are derived from the ventral telencephalon (Merkle et al., 2004; Tramontin et 
al., 2003) as well as for extensive mixing between precursors from the dorsal and ventral 
telencephalon at early postnatal stages in this region (Marshall et al., 2003). Notably, 
Pax6 plays no role for neurogenesis in the ventral telencephalon (Heins et al., 2002) 
where neurons are generated by a very different precursor population during most of 
neurogenesis (Anthony et al., 2004; Malatesta et al., 2003). However, the OB originates 
from a unique domain in the dorso-lateral telencephalic neuroepithelium characterized by 
the expression of several ventral telencephalic transcription factors, such as Gsh2 and 
Dlx, together with Er81 and Pax6 (Stenman et al., 2003). Thus, adult OB precursors may 
maintain these characteristics from an earlier developmental stage and henceforth exhibit 
the unique combination of these transcription factors into adulthood. However, further 
lineage analysis is required to clearly define the fate of dorsal telencephalic progenitors 
melting into this region at postnatal stages (Marshall et al., 2003). 
 
7.5.2.2 Neural subtype specification by Pax6 
During development the local environment specifies fate by regulating intrinsic 
determinants. My results imply Pax6 in such a role, since GNs down-regulate Pax6 
during neuronal differentiation within the OB, while Pax6 is maintained in the TH- and 
calbindin-positive subset of PGNs. The importance of the late expression of Pax6 in a 
specific neuronal sublineage was confirmed at the functional level, since retroviral 
transduction of Pax6 allows maintaining Pax6-expression and this resulted in the almost 
complete conversion of all precursors in the RMS towards a PGN fate. Thus, while GN 
precursors in the RMS are firmly restricted to the neuronal lineage and can no longer be 
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converted to a glial lineage – at least by the cues assessed here –their neuronal subtype is 
not yet fixed and maintenance of Pax6 is sufficient to direct them to a PGN fate. These 
data show that Pax6 is sufficient to instruct a PGN fate in adult neurogenesis, even 
though SEZ precursors seem to be less amenable to this fate conversion. My results also 
suggest that endogenous Pax6 levels are important for PGN specification while Pax6-
engrailed transduction was not conclusive in this regard, because neurogenesis of PGN 
precursors was abolished altogether. Olig2-containing virus injected into the RMS still 
allowed neuronal differentiation of most infected precursors (90%), but none acquired a 
PGN identity. These data suggest that the delayed downregulation of Pax6 in Olig2-
infected precursors still allowed neuronal differentiation but not anymore the acquisition 
of a PGN fate for which a late phase of Pax6 expression seems to be crucial. These data 
are particularly exciting since Pax6 imposed not only a lamina bias in the differentiation 
of OB neurons, but also promoted the acquisition of a dopaminergic transmitter 
phenotype. Thus, this study discovered the first fate determinant for the generation of 
dopaminergic neurons in the adult mammalian forebrain. This finding may have profound 
implications for human patients, where adult neurogenesis also continues in the OB 
(Bedard and Parent, 2004), despite a first failure to localize an RMS at more caudal 
positions (Sanai et al., 2004).  
Taken together, the identification of a key fate regulator of adult dopaminergic 
neurogenesis combined with methods to allow RMS precursors to spread into the 
adjacent striatum (Saghatelyan et al., 2004) may hence provide a powerful tool to 
improve the dopaminergic supply to diseased basal ganglia.  
 
7.5.2.3 Pax6 in non neurogenic astrocytes  
Besides rerouting the endogenous precursors present in the adult, an alternative approach 
may be to evoke neurogenic potential in astrocytes of other brain regions. Since my 
experiments showed that Pax6 has a potent neurogenic role in radial glia astrocytes could 
be an ideal system to utilize the neurogenic role of Pax6 for therapeutic purposes. This 
question was addressed in preparations of astrocytes from the postnatal cortex that 
generate functional neurons upon Pax6 transduction (Heins et al., 2002). Importantly this 
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is therapeutically very interesting since these experiments instruct the most frequent cell 
type in the adult brain, the astrocytes, towards the reconstitution of neurons. Moreover, 
astrocyte cultures in contrast to neurosphere cultures can be expanded in vitro without 
loosing their region-specific properties (as outlined above), and also instruct specific 
neuronal phenotypes depending on their region of origin (Barbin et al., 1988; Denis-
Donini et al., 1984; Wagner et al., 1999). These region-specific differences might be 
highly relevant for the attempts to reconstitute specific types of degenerating neurons.  
The astrocyte cultures might serve as source for cell transplantation into lesioned 
brains, but the even better approach is for sure to activate endogenous astrocytes towards 
neurogenesis in vivo. Towards this end I examined whether astroglial cells in the mouse 
postnatal cortex, a non-neurogenic brain region, can be instructed towards neurogenesis 
by Pax6 transduction. Indeed, almost 20% of all infected cells expressed immature 
neuronal markers 2 weeks after infection with the Pax6-containing virus while no such 
cells could be observed after control virus injection. These experiments need to be 
continued for longer survival times to examine the neuronal survival and subtype 
identity. However, retrovirally mediated sustained expression of Pax6 in neurons of the 
cortex, that normally lose Pax6 during the maturation process, might be detrimental for 
the survival of the newly generated neurons. Inducible retroviral constructs allowing the 
initiation but also the termination of transcription of retrovirally transduced Pax6 might 
help to circumvent this problem. 
The observation that there might be endogenous precursors with the ability to act 
as stem cells, but which are missing the right cues is also supported by other publications 
(Belachew et al., 2003; Chen et al., 2004; Magavi et al., 2000). In the specific lesion 
paradigm of phototoxic lesions in the cortex, neurogenesis was observed and it was 
reported that the new neurons differentiated from two different precursor populations, the 
SEZ precursors and precursors residing in the parenchyma (Chen et al., 2004; Magavi et 
al., 2000). Interestingly, in these photolytic injured brains, Leavitt et al. described that 
mature astrocytes dedifferentiated into RC2 + radial glia (Leavitt et al., 1999). As 
mentioned above, Pax6 is expressed in radial glial cells during neurogenesis (Götz et al., 
1998) and is then down-regulated at the end of neurogenesis when radial glial cells 
differentiate in astrocytes and lose RC2 expression. It was further shown that cells 
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expressing NG2, a marker used for oligodendrocyte precursors, are neurogenic and can 
form neurospheres in vitro (Belachew et al., 2003). Taken together, these data imply that 
subpopulations of glial cells reside in the parenchyma outside of the neurogenic niches 
can act as neurogenic precursors. Therefore it might be necessary that mature astrocytes 
dedifferentiate in an earlier radial glia like state that enables them again to divide and to 
give rise to new neurons. The dedifferentiation seemingly can be induced by lesion 
(Leavitt et al., 1999) or overexpression of Pax6.  
This leads us to the issue why some astrocytes in the adult CNS are neurogenic 
and others are not. These astrocytes could differ intrinsically or the local environment 
outside of the neurogenic niches may not be permissive. Shh and BMPs, which form 
opposing gradients of diffusible signaling molecules along the dorso-ventral axis (Tekki-
Kessaris et al., 2001), respectively promote oligodendrogliogenesis during 
embryogenesis at the ventral telencephalon in vivo (Tekki-Kessaris et al., 2001) and 
astrocytogenesis (Mabie et al., 1997; Mehler et al., 2000; Nakashima et al., 2001). In 
dorsal regions BMPs not only promote astrocyte fate, but also inhibit neurogenesis and 
oligodendrocytogenesis, both of which developments can be inhibited by the antagonist, 
Noggin. Many, if not all, of these molecules are expressed within the SEZ. For example, 
BMP4 is expressed in SVZ/SEZ cells from the embryonic period through adulthood, 
along with type I and II BMP receptors, suggestive of an autocrine loop (Gross et al., 
1996). In the adult telencephalon, BMPs are expressed by SEZ cells while the antagonist 
Noggin is expressed by ependymal cells adjacent to the SEZ (Lim et al., 2000). Indeed 
Lim et al. further showed that overexpression of BMPs in ependymal cells inhibits 
neuronal differentiation in vivo, and ectopic overexpression of noggin in the striatum 
creates a neurogenic environment for transplanted neurosphere cells (Lim et al., 2000). 
Therefore, the blocking of BMPs might be one way to convert a non-neurogenic into a 
neurogenic environment. Also Shh has also been localized only so far within the SEZ in 
the developing brain (Murray et al., 2002). 
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7.6 The role of Olig2 in multipotent precursors 
7.6.1 Olig2 in vitro in neurosphere cells 
Since Olig2 expression levels correlated to a multipotent fate, I examined this at the 
functional level first in neurosphere cells. The two main characteristics of a stem cells are 
the multipotency and the ability to self renew. Therefore, I performed experiments to 
assess if Olig2 has a role in one of these stem cell characteristics or even in both. Indeed. 
interference with Olig2 function in differentiating neurosphere cells impaired both the 
generation of neurons as well as oligodendrocytes, consistent with a role of Olig2 in 
neurogenesis and oligodendrocyte specification (Lu et al., 2002; Mizuguchi et al., 2001; 
Novitch et al., 2001; Park and Appel, 2003; Tekki-Kessaris et al., 2001; Zhou and 
Anderson, 2002). The competition of the repressor Olig2 and the activator Olig2VP16 in 
neurosphere cells exposed to differentiation conditions results in a 70% reduction in 
neuronal and oligodendrocyte differentiation. The remaining neurogenesis and 
oligodendrogenesis seen in Olig2VP16-expressing cells may be due to effects of Olig1 
that is also increased in neurosphere cultures, or to the high endogenous Olig2 expression 
levels. Indeed it was observed that Olig1 can compensate for functions of Olig2 in studies 
that compared Olig2(-/-) mutants to Olig1/2(-/-) in the spinal cord(Lu et al., 2002; Zhou 
and Anderson, 2002). Due to the high degree of protein conservation, Olig1 could 
partially compensate the loss of Olig2, so that several markers of the pMN domain were 
maintained (Lu et al., 2002). While Olig2 is required in most cells to generate neurons 
and/or oligodendrocytes, it is not sufficient to instruct neurons or oligodendrocytes in 
neurosphere cells, in contrast to Pax6. Notably, at the time of Olig2 infection most 
neurosphere cells still expressed Olig2 and higher levels do not further promote the 
generation of neurons or oligodendrocytes. Thus, other crucial fate determinants are 
lacking, such as Pax6 and Ngn2 for neurogenesis and Nkx2.2 for oligodendrogliogenesis 
(Mizuguchi et al., 2001; Novitch et al., 2001). Conversely, however, the downregulation 
of Olig2 in neurosphere cells exposed to differentiation conditions seems to be required 
for the differentiation into GFAP-positive astrocytes, since overexpression of Olig2 
potently repressed the acquisition of astroglial fate, consistent with previous data (Gabay 
et al., 2003; Zhou and Anderson, 2002; Zhou et al., 2001). Thus, Olig2 as a repressor 
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inhibits astroglial differentiation and this may be one reason why the few neuronal and 
oligodendrocyte precursors differentiating in this system require Olig2 function for their 
differentiation.  
However, under expansion conditions with high levels of EGF and FGF2, Olig2 
obviously does not promote the generation of neurons and oligodendrocytes, but rather is 
required for the proliferation and self-renewal of neurosphere cells, since interference 
with Olig2 under these growth conditions severely reduced the generation of new 
neurospheres.  
Similar to the effect of Bmi-1 deletion (Molofsky et al., 2003), interference with 
Olig2 under these growth conditions severely reduced the number and size of 
neurospheres, implying Olig2 also in self-renewal and proliferation of neurosphere stem 
cells. However, how similar is a neurosphere stem cell in vitro to a neural stem cell in 
vivo? The SEZ can be temporarily depleted of fast proliferating cells using the anti-
mitotic agent cytosine- β-D-arabinofuranoside (Ara-C) thereby deleting neurogenesis. 
These studies revealed that cells positive GFAP were the slow dividing neural stem cells 
since they were able to reconstitute all other types of precursors (Doetsch et al., 1999; 
Kirschenbaum et al., 1999). And indeed, neurosphere stem cells differ from neural stem 
cells in vivo by their fast proliferation. Indeed, Olig2 may also mediate proliferation upon 
exposure to EGF or FGF2, as its expression was also increased in adherent cells treated 
with these growth factors that may be less multipotent.  
 
7.6.2 Olig2 in vivo in adult neurogenesis 
Consistent with these in vitro data, I observed Olig2 in fast proliferating cells in 
the adult SEZ in vivo where Olig2 mostly co-localized with Lewis X, but not with PSA-
NCAM or GFAP, suggesting a role of Olig2 in transit-amplifying type C cells. 
Interestingly, in vivo infusion of EGF enhanced the proliferation of these transit 
amplifying that express high levels of the EGF receptor (Doetsch et al., 2002). These in 
vivo results together with my in vitro data indicate Olig2 is expressed in EGF-responsive 
typeC cells. My data were further confirmed by a study from Aguirre et al. (Aguirre et 
al., 2004), in which NG2 expressing fast proliferating precursors in the adult SEZ were 
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identified coexpressing Olig2 and Lewis X. Taken together, these data suggest that Olig2 
may act in transit-amplifying precursors in vivo and mediate their proliferation.  
Consistent with this scenario of progressive neuronal fate specification observed 
with Pax6 (discussed above), high levels of Olig2 were only able to convert neurogenesis 
to oligodendrogliogenesis in the SEZ, but not RMS. Olig2 is almost exclusively 
expressed by the transit-amplifying cells in the SEZ, but not in the RMS. While cells with 
the antigenic characteristics of transit-amplifying precursors are detectable in the RMS, 
they are not Olig2-immunopositive, suggesting that this lineage differs intrinsically from 
the lineage in the SEZ. One interpretation is that these cells are also not bi-potent as there 
is no oligodendrogliogenesis from RMS cells (Fig. 3), consistent with a role of Olig2 in 
bi- or tri-potent cells (Gabay et al., 2003; Hack et al., 2004; Lu et al., 2002; Zhou and 
Anderson, 2002). However, further analysis is required to characterize the nature of 
precursor subtypes within the RMS, since it is not yet clear to which extent the supposed 
type C cells in the RMS really have transit-amplifying identity (Doetsch et al., 2002; 
Garcia et al., 2004; Gritti et al., 2002). Importantly, however, precursors in the RMS 
(even the PGN precursors) can not be converted to the oligodendroglial lineage by 
transduction with Olig2, in contrast to half of the SEZ precursors diverted to the 
oligodendroglial fate by Olig2 overexpression. Notably, a small but significant lineage of 
oligodendrocytes was also apparent in control virus injections into the SEZ, and was 
completely blocked by the loss of function and dominant-negative construct of Olig2. 
Thus, my study demonstrates that adult SEZ cells commit to both neuronal and glial 
lineages that take respectively, a rostral migratory route toward the bulb, where they give 
rise to interneurons (Lois and Alvarez-Buylla, 1994; Luskin, 1993) or migrate radially to 
the white matter where they give rise to oligodendrocytes (Zerlin et al., 1995). The 
difference between these two lineages seems to be determined by factors regulating 
Olig2. If Olig2 is down-regulated progression to the neuronal lineage occurs (see also Lu 
et al., 2001; Zhou and Anderson, 2002), while its maintenance promotes an 
oligodendroglial fate (see also Results for downregulation of Olig2 in neurons derived 
from retrovirally infected precursors). Importantly, this regulation may change after 
certain brain lesions with an obvious increase in the recruitment of endogenous 
oligodendrocyte precursors from the SEZ (Picard-Riera et al., 2002). 
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As during embryogenesis, I observe a role of Olig2 in the specification of 
oligodendrocytes, revealing quite a strong increase in oligodendrocytes migrating to the 
CC upon overexpression. In the developing brain, some SVZ cells become specified as 
oligodendroblasts or astroblasts (Levison and Goldman, 1993; Parnavelas, 1999) while 
others remain uncommitted as glioblasts until they migrate into the overlying 
parenchyma, where they diverge into lineages of astrocytes or oligodendrocytes (Levison 
and Goldman, 1993). This study demonstrates that postnatal SVZ cells commit to both 
neuronal and glial lineages that take respectively, a rostral migratory route toward the 
bulb, where they give rise to interneurons (Lois and Alvarez-Buylla, 1994; Luskin, 1993) 
or radial migration to the white matter where they give rise to oligodendrocytes. It is 
important to realize, however, that the endogenous degree of oligodendrogliogenesis is 
very low, suggesting that most Olig2-positive precursors are in type C cells in the SEZ 
and are therefore involved in the generation of GABAergic GN, the majority of neurons 
generated from the adult SEZ (Ciccolini et al., 2003; Parmar et al., 2002). Notably, this 
specification occurs at an early stage within the lineage, since Olig2 was hardly detected 
in neuroblasts and neither in postmitotic neurons (see also Material and Methods), but is 
mostly contained in precursors at earlier stages in the lineage progression (Hack et al., 
2004).  
While Olig2 is downregulated in neurons, it is maintained, however, in 
oligodendrocyte precursors, and hence maintenance of high levels of Olig2 expression as 
mediated by retroviral vector transduction directs most progenitors towards an 
oligodendroglial fate (Fig. 32). During development of the spinal cord, Olig2 functions in 
context with other transcriptional fate determinants, Olig2 together with neurogenin 2 
(Ngn2) result in motoneuron generation while Olig2 and Nkx2.2 result in 
oligodendrogliogenesis (Novitch et al., 2001; Zhou et al., 2001). In the adult SEZ/RMS 
Ngn1 or 2 are not expressed at detectable levels, but Mash1 is contained also in a subset 
of PSA-NCAM-negative and GFAP-negative precursors, similar to its colocalization with 
Olig2 in the developing central telencephalon. However, since also Mash1 is involved in 
the specification of both, neurons and oligodendrocytes, during adult neurogenesis 
(Parras et al., 2004), probably other mechanisms must be involved in the choice between 
these two fates. The bHLH transcriptional code, described above, may not be sufficient to 
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account for the choice between neuronal and glial fates, since precursors for GABAergic 
interneurons and oligodendrocytes share the same protein profile.  
Therefore, I suggest that other signals could be implicated in this fate 
specification. As noted previously, Olig2 is expressed in immature precursors of the 
developing brain and spinal cord in regions that give rise both to oligodendrocytes and 
neurons (Lu et al., 2002; Zhou and Anderson, 2002). Olig2 is expressed in the VZ where 
Notch activity maintains a population of Olig2-positive cells in the proliferative state 
(Park and Appel, 2003). Notch signaling promotes neurosphere formation (Chojnacki et 
al., 2003; Grandbarbe et al., 2003; Hitoshi et al., 2002a; Nakamura et al., 2000) and 
promotes astrocytogenesis (Tanigaki et al., 2001), while inhibiting 
oligodendrocytogenesis (Wang et al., 1998a) and neurogenesis (Morrison et al., 2000), 
through binding their ligands Jagged and Delta and activating the signaling pathway 
towards their downstream effectors, the Hes genes (Furukawa et al., 2000; Hojo et al., 
2000). Therefore, I would suggest that high levels of Olig2 in the presence of active 
Notch signaling maintain a neural stem cell fate. Consistent with this scenario, the role of 
Olig2 in neuronal fate specification requires downregulation of Notch signaling 
(Mizuguchi et al., 2001; Zhou et al., 2001). Along these lines, radial glia, infected at E14, 
remain undifferentiated in the presence of high Notch levels and differentiate into 
neurons in the presence of low Notch levels. Nonetheless, sustained overexpression of 
Olig2 under control of a retroviral promoter causes postnatal cell death of neurons 
generated from cortical precursors in vivo and in vitro (Fig. 22). The undifferentiated 
radial glia infected with Olig2-containing retrovirus at E14 then differentiated into 
astrocytes at later developmental stages when neurogenesis has ceased. Interestingly, it 
was found that cortical radial glia expressed Olig2 robustly during the perinatal period 
(P0-P10; C. Marshall, personal communication). Therefore, Notch signaling can promote 
astroglial specification together with high levels of Olig2 such as in the differentiating 
conditions of neurosphere cells or cortical radial glia at late developmental stages. 
Interestingly, the expression of Notch1 and its ligands, as well as Hes5, was shown in the 
SEZ including the RMS of adult brains (Stump et al., 2002), indicating that similar 
mechanisms could act during development and adult neurogenesis.  
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The postnatal cell death of neurons upon Olig2 overexpression raised the idea of a 
relationship between Olig2 gene dose and Down syndrome comes up. A universal feature 
of the Down syndrome phenotype is mental retardation resulting, in part, from age-
related neuronal degeneration (Holtzman et al., 1996). Olig2 maps to a region of 
chromosome 21 associated with severe mental retardation in Down patients (Korenberg, 
1991). There are less than 50 known or predicted genes within this region, and Olig1 and 
2 are the only bHLH genes within this domain (Hattori et al., 2000). The present data 
suggest that sustained overexpression of Olig2 through trisomy 21 could contribute, at 
least in part, to the neuronal degeneration observed in Down syndrome patients. 
 
7.6.3 Are Olig2-positive precursors in the adult SEZ neuron-
oligodendrocyte precursors (NOPs) or glial restricted precursors 
(GRPs)? 
One of the striking features of studies on the development of oligodendrocytes is that 
different experimental approaches have led to strikingly different theoretical views 
regarding the ancestry of these cells. One hypothesis is that the steps leading to the 
generation of oligodendrocytes begin with the generation of a glial-restricted precursor 
(GRP) cell from neuroepithelial stem cells. GRP cells are thought to be capable of giving 
rise to all glial cells (including oligodendrocytes and multiple astrocyte populations, Rao 
and Mayer-Proschel, 1997), but not to neurons. The latter are generated by neuron-
restricted precursor (NRP) cells, and were shown to give rise to multiple different kinds 
of neurons, but not to glia (Mayer-Proschel et al., 1997). The other hypothesis is that 
oligodendrocytes are derived from a bipotent precursor cell that generates only motor 
neurons and oligodendrocytes (NOP), with astrocytes being generated through a separate 
lineage. This so called NOP hypothesis was based initially on data from the Jack Price 
lab (Williams et al., 1991) and on observations in the spinal cord that both motor neurons 
and oligodendrocytes arise in a similar (and possibly identical) discrete zone of the 
ventral spinal cord (Richardson et al., 1997; Richardson et al., 2000).  
The idea that motor neurons and oligodendrocytes might be developmentally 
related was given a further boost by the findings, from three separate laboratories, that 
 92
compromising the function of members of the Olig gene family can prevent the 
generation of both motor neurons and oligodendrocytes (Lu et al., 2002; Takebayashi et 
al., 2000; Zhou and Anderson, 2002). However, since these studies provide no evidence 
that has been presented of the derivation of both motor neurons and oligodendrocytes 
from a single lineage-restricted founder cell, the only conclusion that can be drawn from 
these experiments is that Olig1 and Olig2 genes are expressed in a population of ancestral 
cells of unknown heterogeneity and that this population may well consist of separate 
Olig1-positive/Olig2-positive precursors for neurons and for oligodendrocytes (Rowitch 
et al., 2002). 
Unfortunately, from my data it is also not possible to discriminate whether there 
are two subsets of Olig2-positive precursors in the adult SEZ, or whether indeed the same 
precursor generates mostly neurons and occasionally oligodendrocytes. Notably however, 
the decrease in neurogenesis accompanying the increase in oligodendrogliogenesis and 
the absence of astrogliogenesis seen upon Olig2 overexpression (Fig. 24) suggests a 
bipotent lineage. This would be the first proof of NOPs in the adult SEZ.  
One should keep in mind, however, that high endogenous Olig2-protein levels can 
be detected in vivo in both, astrocytes and oligodendrocytes of the white matter, the 
cortex and the striatum (Fig. 23). Indeed when Olig2 was injected into the embryonic 
cortex, it mostly lead to the generation of astrocytes (after a period of neuronal death 
discussed above) as has been recently demonstrated for Olig1 (Lu et al., 2001). This 
points to the fact that Olig2 permits, and perhaps even promotes, additionally the 
formation and survival of astrocytes (Cai et al., 2000; Gangemi et al., 2001). 
 
7.7 Patterning of the SEZ/RMS system 
From the in vivo results of Pax6 and Olig2 in adult neurogenesis discussed above, two 
observations pointed to a regionalization of lineage and fate along the SEZ/RMS system. 
First, transit-amplifying precursors in the SEZ and RMS differ by their expression of 
Olig2, suggesting that these lineages diverge at an early stage of commitment. Second, 
most PGN precursors become fate-restricted at a much more rostral position than GN 
precursors (see above). These data imply that the majority of GNs and PGNs, 
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respectively are specified at distinct locations along the SEZ/RMS system. Indeed, the 
spatially distinct specification and birth of PGN precursors was also apparent from two 
further independent sets of experiments (Hack et al., 2005). BrdU-birthdating analysis 
revealed that a significant proportion of PGNs arrives in the OB only few days after 
BrdU-injection, while this takes about 2 weeks for GNs (Hack et al., 2005). These data 
could either be explained by different speeds of cell migration in which case the PGNs 
should migrate with 5-10 higher speed of migration (about 170-340µm/hour). While this 
seems unlikely (Davenne et al., 2004; Wichterle et al., 1997), the BrdU-birthdating 
results would still be consistent with a single lineage of GN and PGNs, both originating 
in the SEZ, but the latter becoming postmitotic at latter stages of cell migration. When 
the control retrovirus was injected into the SEZ, the vast majority of labeled cells became 
GNs consistent with previous data (Belluzzi et al., 2003; Carleton et al., 2003). In 
contrast, when control virus was injected into the central RMS a higher proportion of 
labeled newborn neurons became PGNs. These results indicate that there are laminar 
differences between the fate of cells originating in the central RMS compared to those 
originating in the SEZ.  
Possibly, the RMS and SEZ precursors may differ already since early 
developmental stages and the spatial differences seen in the adult may result from early 
patterning along the rostro-caudal axis. This issue could be addressed by Cre-based fate-
mapping analysis (Merkle et al., 2004), at earlier developmental stages. Notably, during 
development the OB originates from the most rostral portion of the telencephalon, where 
Pax6 levels are highest and specific extrinsic factors, such as FGF8 act as important fate 
determinants (Meyers et al., 1998). Taken together, my data challenge the concept of a 
single lineage of adult precursors originating from the SEZ, and rather support a concept 
with diversity of progenitor cells along the rostro-caudal axis – despite the migration of 
one cell lineage, namely the GN precursors, from caudal to rostral positions.  
Interestingly, similar differences in fate of precursors have been suggested along 
the rostro-caudal axis of the lateral ventricle with precursors at more caudal positions 
biased more towards gliogenesis (Luskin, 1993). This does not exclude that neuronal 
precursors originate also in the most caudal areas of the wall of the lateral ventricle, as 
demonstrated beautifully in the whole-mounts of the lateral ventricle wall (Doetsch et al., 
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1999), but it rather implies that in addition to neurogenesis there may be a larger number 
of glial precursors at caudal positions respectively. While I did not examine this gradient 
specifically, I noted that the number of Pax6-positive precursors was much lower in the 
posterior parts of the SEZ, consistent with its developmental gradient rostral high and 
caudal low (Mallamaci et al., 2000; Muzio et al., 2002), while Olig2-immunoreactive 
cells were more frequent in posterior parts of the SEZ. Moreover, my results also suggest 
a greater degree of plasticity within the SEZ (i.e. more caudally), compared to further 
rostral levels of the RMS where precursors seem firmly restricted towards neurogenesis. 
Taken together, patterning cues seem to persist into adulthood and position may be as 
important for cell fate as it is during development.  
 
7.8 Cell therapy for human neurodegenerative disorders 
In this study I discovered important fate determinants for the generation of dopaminergic 
neurons and oligodendrocytes in the adult mammalian forebrain. Besides instructing the 
PGN fate, Pax6 further promotes the acquisition of a dopaminergic transmitter phenotype 
and is the first fate determinant for dopaminergic neurons in the adult mammalian brain. 
This finding may have profound implications for reconstitutive therapies that can be 
applied to human patients. Strikingly, patients with Pax6 mutations suffer from hypo- or 
anosmia (Martha et al., 1995) consistent with a similar role of Pax6 in the adult human 
OB, where adult neurogenesis continues also in humans (Bedard and Parent, 2004), 
despite a first failure to localize a RMS at more caudal positions as reported in (Sanai et 
al., 2004). Furthermore, an upregulation of TH-positive PGN has been detected in 
Parkinson's patients, reflecting the apparent attempt to increase this neuronal phenotype 
(Huisman et al., 2004). As mentioned above, Pax6 as a key fate regulator of adult 
dopaminergic neurogenesis combined with methods to allow RMS precursors to spread 
into the adjacent striatum (Saghatelyan et al., 2004) may hence provide a powerful tool to 
improve the dopaminergic supply to diseased basal ganglia. Similarly, the results with 
Olig2-overexpression promoting the generation of oligodendrocytes may be beneficial 








Figure 1. Schematic lineage diagram during embryonic neurogenesis. This lineage diagram depicts the 





Figure 2. Location of adult neurogenesis and lineage diagram. (a) Scheme of a sagittal section of an 
adult mouse brain, indicating the locations of adult neurogenesis (SEZ and DG) with GFAP-positive type B 
cells (red) and migrating neuroblasts (blue). (b) Schematic drawing illustrating the lineage and cell type 
markers of adult neural precursors. Multipotent precursors are located in the adult SEZ and consist of 
astrocytes, the type B cells (red), that give rise to the transit-amplifying type C cells (yellow) and the PSA-
NCAM (polysialylated form of the neural cell adhesion molecule)-positive neuronal precursors (blue). The 
type A cells then migrate along the RMS in the OB where they differentiate into different types of 
GABAergic interneurons (Glomerular neurons or granule neurons). CC: corpus callosum; SEZ: 





Figure 3. Revised lineage diagram. This lineage diagram depicts the progression from multipotent 
precursors to the differentiated progeny via lineage-restricted precursors (see text for details). I also 
incorporated the potential heterogeneity of precursors able to contribute to the formation of neurospheres 
(see text for details), as indicated by the grey shading. Note that the neurosphere culture system combined 
with the separation of strongly fluorescent hGFAPeGFP-positive radial glia (GFP++) and weakly green 
fluorescent radial glia (GFP+) covers three major precursor fates – a bi/multipotent fate (neurosphere 
model), mostly neuron-restricted precursors (GFP+ radial glia) and mostly astroglia-restricted precursors 





Figure 4. Schematic drawing of the retroviral constructs used 
Schemes depicting the retroviral vectors used in during my studies (see Materials and Methods). The Pax6-
containing vectors co-express either lacZ (f) or GFP (a) and Pax6 cDNA. Pax6eng mediated the co-
expression of GFP and Pax6 cDNA fused to the repressor domain of engrailed (Pax6eng, b). The control 
retroviral vector contained only GFP (g) and or lacZ (h) and the neomycin resistance gene (Neo). The 
Olig2-containing vectors co-express GFP and Olig2 cDNA (c). Olig2VP16 mediated the co-expression of 
GFP and Olig2 cDNA fused to the herpes simplex virion protein VP16 (Olig2VP16, d). Olig2 bHLH-only 
construct (see Materials and Methods for details) coexpressed the bHLH domain of Olig2 together with 
GFP. (i) pMES (Swartz et al., 2001a; Swartz et al., 2001b) (j) pMXIG (Nosaka et al., 1999. MCS: Multiple 





Figure 5. Silencer siRNA construction Kit procedure overview. (a) 29-mer-DNA-oligonucleotides 
(siRNA oligonucleotide templates) with 21 nucleotides encoding the siRNA and 8 nucleotides 
complementary to the T7 promotor sequence were designed and ordered at TibMolBiol (Berlin). The 
siRNA templates were hybridized to a T7 Promotor primer and the 3’ ends of the hybridized 
oligonucleotides are extended by the Klenow fragment. The sense and the antisense siRNA templates were 
then transcribed by T7 RNA polymerase and the resulting RNA transcripts are hybridized to create dsRNA. 
The dsRNA consists of 5’terminal single-stranded leader sequences, a 19 nucleotide target specific dsRNA, 
and 3’terminal UU. The leader sequence is removed by digesting the dsRNA with a single-strand specific 
ribonuclease. Overhanging UU dinucleotide will remain because the RNAse does not cleave U residues. 
The DNA template is removed at the same time by a deoxyribonuclease. The resulting siRNA is purified 
by glass fiber binding and elution which removes excess nucleotides, short oligomers, proteins, and salts in 
the reaction. (b) shows a cortical precursor (nuclei are labeled with DAPI in blue) transfected with Cy3-
labeled RNAi (red dots). This confirmed that primary embryonic precursor cells could be successfully 





Figure 6. Characterization of radial glial cells in the hGFAPeGFP transgenic mouse. Green 
fluorescent cells were analyzed in the transgenic mouse line hGFAPeGFP expressing eGFP under the 
control of the human GFAP promoter (Nolte et al., 2001). (a,b) depict micrographs of a maximum intensity 
projection confocal image of the different regions in a frontal section of the cortex from an E14 
hGFAPeGFP embryo, stained with GFP antibody (green): in the CP (b) and the VZ (a). (c-e) Confocal 
images (c, single optical section, d,e, maximum intensity projection) of frontal sections of the ganglionic 
eminence (c) or spinal cord (d,e) of an E14 hGFAP-eGFP mouse embryo, stained with GFP antibody 
(green) and RC2 (red, e). Scale Bars: (a): 40µm, (b): 80µm, (c): 40µm, (d,e): 80µm. VZ: ventricular zone, 
SVZ: subventricular zone, IZ: intermediate zone, CP: cortical plate,  
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Figure 7. Clonal analysis of radial glia progeny from the cortex, the GE and the SC in vitro. (a-c) 
depict examples of fluorescent-activated cell sort (FACS) profiles of cells from the respective region of 
hGFAP-EGFP mice at E14 (a,c) and E12 (b). The left columns show the dot plots of cells in forward 
scatter (FSC) and side scatter (SSC) with a polygon indicating the gate selecting healthy cells. The 
histograms in the middle columns show the number of cells (‘events’, y-axes) with a fluorescent intensity 
indicated on the x-axis of wild-type controls (red) and hGFAP-EGFP transgenic littermates (green). The 
percentage of fluorescent cells in the sort gate (grey shading: light green) is indicated.  
(a’-c’) depict examples of clones derived from single sorted radial glial cells of the respective brain region. 
Sorted cells are plated at clonal density on a rat feeder layer and their progeny is detected after 7 days in 
vitro as distinct cell clusters labeled by the mouse neural-specific monoclonal antibody mix M2M6 (in red), 
the neuron-specific β-tubulin-III (green in b’,c’) or the astrocyte-specific GFAP (green in a’). The 
incorporation of the DNA-base analog BrdU (blue) indicates that cells divided in vitro. a’ depicts a pure 
non-neuronal clone, b’ and b’ show each a pure neuronal clone composed of two neurons.  
(d) Histogram represents the composition of the progeny of radial glial cells isolated by FACS after 5-7 
days in vitro plated on different feeder layers. The progeny of a single sorted cell is a clone, classified as 
pure neuronal when all cells were β-tubulin-III immunoreactive, as pure non-neuronal when no cell of a 
clone was β-tubulin-III immunoreactive, and as mixed neuronal and non-neuronal when clones contained 





Figure 8. Clonal Analysis of Precursors from the Ventricular and Subventricular Zone In Vitro (a) 
and (b) depict two ways to isolate ventricular zone (VZ) precursors independent of the hGFAP promoter 
activity. (a) Precursors with long radial processes were back labeled by green fluorescent beads applied to 
the surface of the GE after removal of the meninges. Cells that incorporated the green fluorescent beads 
were then isolated by FACS (profiles in right panels of (a)), and their clonal progeny was analyzed in vitro 
as described in Figure 6. (b) Schematic drawing illustrating the surgical separation of the VZ and SVZ 
regions in the GE in slices cut frontally with a tissue chopper. Cells were then dissociated and plated at 
clonal density on a rat feeder layer from GE as described in Figure 6. (c) The histogram depicts the 
composition of BrdU-positive clones generated by the precursors isolated as depicted in (a) and (b). Note 
that VZ precursors from the E14 GE enriched either by dissection or tracing from the pial surface generate 
few neurons, while precursors residing above the VZ mostly in the SVZ are more neurogenic. Number of 





Figure 9. Characterization of subsets of hGFAPeGFP sorted cortical radial glia and their progeny 
isolated from the cortex of hGFAPeGFP transgenic mice and their progeny. (a,b) depict examples of 
sort profiles of cells from E14 cortex. The left columns show the dot plots of cells in forward scatter (FSC) 
and side scatter (SSC) with a polygon indicating the gate selecting the healthy cells. The histograms in the 
right columns show the number of cells (‘events’, y-axes) with the fluorescent intensity indicated on the x-
axis. The percentage of fluorescent cells in the sort gate (gray shading, a,b) is indicated. (a’,b’) depict 
examples of clones derived from single sorted radial glial cells of the respective sort gate. Sorted cells are 
plated at clonal density on a rat feeder layer and their progeny is detected after 7 days in vitro as distinct 
cell clusters defined as clones labeled by the mouse neural-specific monoclonal antibody mix M2M6 (in 
red), the neuron-specific anti β-III-tubulin (green in a’) or the astrocyte-specific anti-GFAP (blue in b’). (c) 
depicts the composition of cells 2 hours (2h) or 5-7 days after the sort (days in vitro, div). Neurons are 
depicted in blue, precursor cells in gray. Note the enrichment in the number of pure neuronal clones 





Figure 10. Neurosphere cultures. (a) Shows a phase contrast micrograph of neurosphere cultures. (b) 
Micrographs of neurons (anti β-III-tubulin-positive), (c) astrocytes (anti-GFAP-positive) and (d) 
oligodendrocytes (anti-O4-positive) derived from neurosphere cells. Precursors in neurospheres cultured 





Figure 11. Quantitative RNA analysis of transcription factors in different subsets of telencephalic 
precursors. Gene expression levels of the transcription factors (Emx1/2, Ngn2, Pax6, Olig2, Dlx1/2, Gsh2, 
Mash1) are depicted relative to the expression levels of GAPDH (for quantification, see also Material and 
Methods). (a) Primary tissue isolates from the E14 cortex or GE. Note that all of the tested genes showed 
differential expression between the dorsal (cortex) and ventral (GE) telencephalic regions (b). Quantitative 
mRNA analysis of precursors sorted on the basis of their GFP content from the cortex of E14 hGFAPeGFP 
mice. Note that the neurogenic populations (GFP+) expressed 4.6 fold higher levels of Pax6 compared to 
the non-neurogenic population (GFP++). (c) Quantitative mRNA analysis of neurosphere cultures from 
E14 cortex, GE, or the adult SEZ. Note, that neurosphere cells exhibit little difference in their gene 





Figure 12. Summary of the expression levels of Olig2 and Pax6 in the functionally distinct precursor 
subtypes for direct comparison. Note the high expression levels of Pax6 in the neurogenic precursors and 





Figure 13. Immunohistochemical analysis of Mash1 and Olig2 in neurospheres Single optical sections 
of confocal images of single neurospheres stained for Mash1 (a,b,c) and Olig2 (d,e,f) in green, and 
propidium iodide in red. Note that almost all cells in neurospheres are Olig2-immunoreactive, independent 





Figure 14. Immunohistochemical analysis of transcription factors in cortical precursors after 
exposure to the growth factors FGF2 or EGF. Histogram in a depicts the percentage of immunopositive 
cells from E14 cortex (a) cultured for 48 hours on poly-D-lysine –coated coverslips in the absence (-) or 
presence of 20ng/ml EGF or FGF2. Note that the number of Olig2 and Mash1 immunoreactive cells 
increases, while the number of cells immunoreactive for Emx1 and Pax6 decreases in cortical cultures 
exposed to EGF or FGF2. In contrast, Dlx- or Gsh2-immunopositive cells were not affected upon addition 
of EGF or FGF2. (b–c’) depict micrographs of cortical cells cultured for 48 hours in the absence (b, CTRL) 
or presence of 20ng/ml FGF2 (c, FGF2) stained with anti-Olig2 (red, b,c) and DAPI (blue b’,c’). Arrows 





Figure 15. Immunohistochemical analysis of transcription factors in precursors of the GE after 
exposure to the growth factors FGF2 or EGF. Histogram depicts the percentage of immunopositive cells 
from E14 GE (a) cultured for 48 hours on poly-D-lysine –coated coverslips in the absence (-) or presence 





Figure 16. Quantitative RNA analysis of transcription factors in different subsets of telencephalic 
precursors. Gene expression levels of the transcription factors (Emx1/2, Ngn2, Pax6, Olig2, Dlx1/2, Gsh2, 
Mash1) are depicted relative to the expression levels of GAPDH (for quantification, see also Material and 
Methods). Quantitative mRNA analysis of neurosphere cultures from E14 cortex (a) or GE (b) exposed for 
1 and 3 days to differentiating conditions (plating on adherent substrate and growth factor withdrawal). 
Note, that the highest expression levels of Olig2 are present during expansion conditions of neurosphere 





Figure 17. Verification of the gene expression levels detected on the microarray by quantitative RNA 
analysis in different subsets of telencephalic precursors. Gene expression levels of tweety, FABP7 and 
sirtuin (sirt2, a), and Klf9 and Sox9 (b), and Sox4 and Lmo1 (c) are depicted relative to the expression 
levels of GAPDH (for quantification, see also Material and Methods). Quantitative mRNA analysis of these 
genes was performed on the precursors sorted on the basis of their GFP content from the cortex of E14 
hGFAPeGFP mice (+ and ++), on undifferentiated neurosphere cultures from E14 cortex and on 
undifferentiated neurosphere cultures from E14 cortex exposed for 1 to differentiating conditions. Note, 
that selected genes can be grouped in 3 different categories: 1) Genes expressed in multipotent stem cells 
(yellow and orange bars, a); 2) Genes expressed in neurogenic precursors (blue bars, c); 3) Genes 





Figure 18. Functional analysis of Pax6 in adult neurosphere cells. (a) Micrograph of examples of 
control infected adult neurosphere cells generated from E14 cortex (green, arrows) Note that none of the 
infected cells colocalizes with β-III-tubulin (b) Micrograph of examples of cells from neurospheres 
infected with the GFP-containing control virus (green in a) or the Pax6IRESGFP virus (green in b) fixed 7 
days after infection and culturing in differentiation conditions and immunostained for the neuron-specific 
antigen anti-β-III-tubulin (red). Note the prominent increase in β-III-tubulin-immunoreactive neurons 
amongst Pax6-transduced cells (Arrows indicate the double positive cells in (b) compared to cells infected 
with the control virus (arrowheads indicate the cells that are only GFP-positive (a). (c) Histogram of cell 
type analysis of cells from adult neurosphere cultures dissociated after the fourth passage and infected with 
control (red bars) or Pax6-containing virus (blue bars) analyzed after 7 d in differentiation conditions. Note 






Figure 19. Functional analysis of Pax6 in embryonic neurosphere cells. (a) Histogram of cell type 
analysis of cells from neurospheres derived from E14 GE or cortex upon viral infection. Note the high 
number of neurons after Pax6 transduction. (b) Histogram of cell type analysis of neurosphere cells from 
Pax6 mutant (Sey/Sey; blue bars) and wildtype (WT) littermate (red bars) cortex or GE infected with 
control virus and analyzed after 7 days in differentiating conditions. Note, that neurogenesis depends on 
functional Pax6 independent of the region of origin. (c,d) Histograms of clonal analysis in dissociated cells 
cultures from E14 cortex (c) or GE (d) infected with the control (red bars) or Pax6 containing virus (blue 
bars) after 7 days in vitro. Note that the number pure neuronal clones (containing only β-III-tubulin- or 





Figure 20. Functional analysis of Olig2 in neurosphere cells. (a) Reduction of Olig2 by means of the 
siRNA technology. Neurosphere cultures were plated after 4 passages, not transfected (black bar) or 
transfected with different siRNAs targeting the Olig2mRNA (blue bars) or the respective control construct 
(gray bar) and immunostained for Olig2 48 hours later. (a’) depicts cells from neurosphere cultures 2 days 
after transfection with Olig2 RNA#19 and its control construct stained with anti-Olig2 (green) and DAPI 
(blue). Note, that RNAi#19 was most effective in the reduction of Olig2 protein. (b) Effect of Olig2 
reduction on self-renewal of neurosphere cells. After transfection of cells from neurosphere cultures as 
described above the number of neurospheres was quantified 7 days after the fourth passage. Note that only 
about half the number of neurospheres was generated by cells transfected with Olig2 RNAi compared to 
the cultures transfected with the scrambled control. (c) Influence of Olig2 on cell fate. Neurosphere cultures 
derived from the GE (blue bar) or cortex (light blue bar) were plated after 4 passages, transfected with 
Olig2 RNAi and the control construct (gray bar) and immunostained for the neuron-specific antigen β-III-
tubulin. Note, that the number of neurons was decreased to a third of the number of neurons present in 





Figure 21. Functional analysis of Olig2 in neurosphere cells 
(a,b) Histogram of cell types generated from neurosphere cells derived from the GE (blue bars) or the 
cortex (light blue bars) infected with the control (black bars) or Olig2VP16 virus 7 d after culturing in 
differentiation conditions. Cells were stained for either the neuron-specific antigen β-III-tubulin (a) or the 
oligodendrocyte-specific O4 (b). Note that the number neurons, as well as the number of oligodendrocytes 
decreases after Olig2VP16 transduction. (c-e’). Pairs of corresponding micrographs (c,c’,d,d’,e,e’) showing 
examples of virally infected cells labeled with GFP (c’,d’,e’) cultured for 7 days in differentiating 
conditions and stained for the neuron-specific antigen anti-β-III-tubulin (red in c, DAPI in blue), the 
astrocyte-specific GFAP (blue in f, DAPI also in blue) and the oligodendrocyte-specific O4 (blue in I, 






Figure 22. Ectopic expression of Olig2 gene induces age-related neuronal degeneration and astrocyte 
development. (a) Schematic overview of an in utero injection. The virus containing solution is injected in 
the ventricles of the embryo (see Material and Methods for details). Schematic brain sections (below) show 
the distribution of the infected cells shortly after injection (left) and 21days after injection (right). (b-d) 
Brain tissue was harvested at P21 and immunostained for GFP activity after retroviral infection of embryos 
at E14. Ectopic expression of Olig2 in mouse brain resulted in a large population of astrocytes visible in 
gray matter of the cerebral cortex (b). Morphology-based identification of astrocytes (b) was validated by 
immunostaining with astrocyte marker antibodies GFAP (c) and S100β (d, arrows indicate the 
doublepositive cells). Note that Olig2 overexpressing astroglial-like cells do not express GFAP (c). (e,f) 
Representative examples of neurons infected with the Olig2 containing retroviral construct at E14 and 
harvested at P2. (e) At P2, most Olig2 -infected (green) cells show neuronal morphology. Note the axons 
projecting in the corpus callosum (f) A GFP+ cell (green) with neuronal morphology is immunostained 





Figure 23. Olig2 expression pattern in the adult cortex. (a) scheme of a sagittal section of a postnatal 
mouse brain at postnatal day 21 (P21) depicting the localization of the micrographs (b,c,d; red insets). (b-e) 
show micrographs of Olig2-immunoreactivity (green) combined with CC1 (red, b), GS (red,c) and S100β 
(red, d). Arrows indicate the doublepositive cells. Note, that many astrocytes in the postnatal and adult 
brain express Olig2, but also all the oligodendrocytes. SEZ: subependymal zone, RMS: rostral migratory 





Figure 24. Regions of ongoing neurogenesis in the adult forebrain. (a) Schematic drawing of the adult 
forebrain highlighting in color the regions with ongoing neurogenesis, the dentate gyrus of the 
hippocampus and the adult subependymal zone (SEZ) with the rostral migratory stream (RMS). Regions 
containing astrocytes (the SEZ of the basal ganglia, the RMS or the subgranular layer of the dentate gyrus) 
at the source of adult neurogenesis are indicated in red, neuron-restricted precursors (‘neuroblasts’) are 
indicated in blue (Doetsch et al., 1999; Seri et al., 2001). (b) Micrograph of a sagital section of the telen-
cephalon of an hGFAPeGFP adult mouse forebrain stained for GFP. Note the high number of GFP-positive 
cells in the SEZ. LV: lateral ventricle, SEZ: subependymal zone, RMS: rostral migratory stream, OB: 





Figure 25. Expression pattern of the transcription factors Pax6 in the SEZ and RMS. (a) scheme of a 
sagittal section of an adult mouse brain depicting the localization of the micrographs (b,c,d,e; red insets). 
(c-g) show micrographs of Pax6-immunoreactivity (green or red) combined with PSANCAM (green, g), or 
GFP-immunoreactivity (green, f) Note the higher frequency of Pax6-positive cells in the caudal, central and 
rostral RMS (c,d,e) compared to the SEZ (b). Note that Pax6-immunoreactivity is contained within PSA-
NCAM-positive neuroblasts (examples indicated by arrows, g). (f) depicts Pax6-immunoreactivity (red) in 
a subset of GFP-positive cells in the RMS of adult hGFAPeGFP mice (double-labeled cells are indicated by 
arrows). Arrows in (f,g) depict double positive cells. Scale bars (b,c,e) 60µm, (d) 150µm, (f) 60µm, (g) 
15µm, SEZ: subependymal zone, RMS: rostral migratory stream, OB: olfactory bulb, CC: Corpus 





Figure 26. Expression pattern of the transcription factors Pax6 in the OB. (a) scheme of a sagittal 
section of an adult mouse brain depicting the localization of the micrographs (d,e; red inset). b, micrograph 
of a section of the OB, indicating the different regions of the OB. c, scheme of a section of the OB. 
Precursors migrate into the OB and then leave the RMS to migrate radially in the neuronal layers (GL and 
GCL). (d,e) show micrographs of Pax6-immunoreactivity (green) combined with TH-immunostaining (red, 
e), (inset in d and e: scheme of the OB). Z axes in (i) confirm that GFP and TH are colocalized in one cell 
body. Scale bars (b) 400µm, (d) 150µm, (e) 20µm. SEZ: subependymal zone, RMS: rostral migratory 
stream, OB: olfactory bulb, CC: Corpus Callosum,  GL: glomerular layer; GCL: granule cell layer. 
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Figure 27. Expression pattern of the transcription factors Olig2 in the SEZ-OB pathway. (a) scheme 
of a sagittal section of an adult mouse brain depicting the localization of the micrographs (b,b’,c,d,e,f,g;  
red insets). (c-g) show micrographs of Olig2-immunoreactivity (red) combined with LewisX-
immunostaining (green, c), PSANCAM (green, d), GFAP (green, e), or BrdU-immunoreactivity (green, 
f,g). Note the lower frequency of Olig2-positive cells in the RMS (b’) compared to the SEZ (b). (c) depicts 
Olig2- (red) and LewisX- (green) immunoreactive cells in the SEZ. Arrows indicate the Olig2/LewisX 
double-positive cells, arrowheads indicate the cells that are only Olig2-positive, and the arrowhead with 
asterisk indicates a single LewisX-positive cell. (d) Note the lack of colocalization of Olig2 and 
PSANCAM as indicated by arrows. Note that Olig2 is not contained in GFAP-positive cells as indicated by 
arrows depicting cells that are only Olig2-positive (e). (f,g) Micrographs depicting Olig2- (red) and BrdU- 
(green) immunoreactive cells in the SEZ (f), BrdU was provided for 14 days in the drinking water, labeling 
all proliferating cells; (g), BrdU was infused twice a day for three days 14days before sacrifice, and mostly 
slowly dividing precursors should maintain the label in this paradigm). Arrows in (e,f,g) depict double 
positive cells. Arrows in (c,d) indicate single positive cells. Scale bar, b,b’ 60µm, c 20µm, d 7µm, e 45µm, 






Figure 28. Viral infections can be specifically targeted to the SEZ/RMS by stereotactic injections. 
a,c,e Schematic drawings illustrating the injection sites (RMS, SEZ) of the virus. (b,d,f) micrographs of 
stainings in sagittal sections of the adult mouse subependymal zone (SEZ), rostral migratory stream (RMS) 
and olfactory bulb (OB), 3 (b,d,) and 7 (f) days after vector injection. Insets (red) in (b) and (d) show 
infected cells in higher magnification. Scale bars in (b,d,f): 500 µm (for insets: 200µm); SEZ: 





Figure 29. Functional analysis of the transcription factors Pax6 and Olig2 in adult neurogenesis. 
(a,b,d,e) micrographs of stainings in sagittal sections of the adult mouse subependymal zone (SEZ), rostral 
migratory stream (RMS) and corpus callosum (CC), 3 (d) and 7 (a,b,e) days after vector injection. 
Histograms in (c,f) summarize the quantification of SEZ cells 7 days after injection of the viral vectors 
indicated on the x-axis. Note, that Pax6 plays a role in neurogenesis, while Olig2 promotes the generation 
of oligodendrocytes and undifferentiated precursors. Z axes in (a) and (b) confirm that GFP and DCX (a) or 
GFAP (b) are colocalized in one cell body Scale bars in (a) and (b): 8 µm; (d): 180 µm and (k):40µm. CC: 





Figure 30. In vitro analysis of the retroviral vectors. Here I used a well-established in vitro system for 
the analysis of telencephalic precursors, where the effect of Pax6 is particularly well characterized(Haubst 
et al., 2004; Heins et al., 2002). Previous work had shown that Pax6 overexpression promotes neurogenesis 
and reduces clone size, i.e. the number of descendants generated by a single precursor cell, while the loss of 
functional Pax6 in Small Eye mutant mice (Sey/Sey) results in decreased neurogenesis and an increase in 
clone size(Haubst et al., 2004; Heins et al., 2002). As expected, infection with the Pax6-engrailed 
containing virus resulted also in a decrease of neurogenesis that was almost identical to the effect in 
Sey/Sey mutant cells deficient of functional Pax6 protein compared to wildtype cells. Thus, the Pax6-
engrailed is as sufficient as the loss of functional Pax6 protein. Next, I also examined the specificity of 
both, the Pax6-engrailed and the Olig2VP16 constructs by expression in cells that do not contain Pax6 or 
Olig2 respectively. For example, cells from the embryonic cortex do not express Olig2 and should therefore 
not be affected by Olig2-VP16 transduction, as is indeed the case. Thus, Olig2-VP16 does not superactivate 
target genes in cells where Olig2 plays no endogenous role. Similarly, Pax6-engrailed transduction of 
precursors from the ventral telencephalon that do not contain endogenous Pax6 protein exerted no effect, 





Figure 31. Functional analysis of the transcription factors Pax6 and Olig2 in adult neurogenesis by 
other means. (a) To address the neurogenic role of the transcription factors Pax6 in adult neurogenesis by 
other means I used the Cre-based deletion of Pax6 in Pax6flox/flox mice (Ashery-Padan et al., 2004). 
Histogram shows the number of DCX+ cells among the GFP-positive cells after infection with the virus 
containing GFP (control) or Cre (see Materials and Methods). Virus was injected in the subepenymal zone 
(SEZ) and animals were sacrificed 7 days after infection. The infected cells were analyzed in the SEZ. 
Note, that the percentage of DCX-positive cells is significantly reduced The lentiviral vectors (LV-GFP and 
LV-Cre) used are based on a recently described vector system (Follenzi et al., 2000) and carry the enhanced 
green fluorescent protein (eGFP) reporter transgene or the Cre recombinase. Recombinant lentivirus was 
produced as previously described (Pfeifer et al., 2002). Histogram in (b) summarizes the quantification of 
SEZ cells 7 days after injection of the viral vectors indicated on the x-axis. Note, that the injection of the 
bHLH-only construct displays a similar effect as the Olig2VP16 construct, indicating that the reduction in 






Figure 32. Quantitative localization analysis of infected cells after virus injection into the SEZ or the 
RMS of the adult forebrain. a-d, Histograms showing the localization of GFP-positive cells after 
infection with the control-virus containing GFP only (a), with the Olig2-IRES-GFP-containing virus (b), 
with the Olig2VP16-IRES-GFP viral vector, (c) with the Pax6-IRES-GFP-containing virus (d), or the 
Pax6-engrailed-IRES-GFP-containing viral vector (e). Virus was injected either in the subependymal zone 
(SEZ) or the rostral migratory stream (RMS) and animals were sacrificed at different times after infection 
[7 days (yellow bars), 21 days (orange bars) for SEZ infection and 14-18 days (blue bars) for RMS 
infection]. Note that only precursor cells infected in the SEZ, but not those in the RMS were able to 
generate oligodendrocytes and that Olig2-infected cells migrate faster into the CC and differentiate into 
many more oligodendrocytes than control infected cells. On the contrary, Pax6 increases the number of 
neuroblasts in the RMS 7 days after injection compared to the control virus injection (compare a and d, 
yellow bars), while after 21 days most cells have reached the OB in both conditions. Notably, a larger 
proportion of infected cells have reached the OB 14 days after injection of both the Pax6- or Olig2-
containing viral vectors compared to the control injections (compare blue bars in a,b,d), while Pax6-
engrailed containing virus reduces the proportion of neurons in the OB. Similarly, cells infected with the 
Pax6-engrailed containing virus in the SEZ remained to a larger extent in the SEZ and few of them had 





Figure 33. Functional analysis of Pax6 and Olig2 in the specification of neuronal subtypes in adult 
neurogenesis. Panel (a) depicts the injection sites as described in Fig.25. (b) depicts a micrograph of the 
OB with the red inserts indicating the position of the micrographs (c,d). (c,d) depict representative 
micrograph examples with z-stacks of the confocal pictures taken at the position of the red and green lines 
and higher magnification (inset in d). Histograms in (e,f) depict the quantification of GFP-positive cell 
types in the OB 21 (e) or 14-16 days (f) after viral infection as indicated in the panels in (c,d,g). c, depicts a 
double-stained (NeuN-immunopositive and GFP) periglomerular neuron in the GL. (d) shows double-
stained neurons in the GCL. Note that Pax6 is involved in the specification of the periglomerular neurons 
located in the GL. SEZ: subependymal zone, RMS: rostral migratory stream, OB: olfactory bulb. GL: 





Figure 34. TH-positive periglomerular fate is strongly promoted by Pax6-overexpression. (a) depicts a 
representative micrograph examples of a GFP and TH double-immunoreactive cell with z-stacks of the 
confocal pictures taken at the position of the red and green lines and higher magnification b, Histogram of 
TH-positive periglomerular neurons (PGN, y-axis) after viral vector injection (x-axis) into the SEZ (3 
weeks survival) or RMS (2 weeks). Note that only RMS, but not SEZ precursors, generate TH-positive 
PGN and that this fate is strongly promoted by Pax6, while blocking of Olig2 function (Olig2VP16) has no 
effect. SEZ: subependymal zone, RMS: rostral migratory stream, OB: olfactory bulb. GL: glomerular layer; 





Figure 35. Separate lineages in SEZ and RMS. (a) and (b), summarize the content and function of Pax6 
and Olig2 in the two lineages of adult neural precursors depicted as in Fig.2b. SEZ: subependymal zone, 





Figure 36. Generation of young neurons in the postnatal cerebral cortex by Pax6 transduction in 
vivo. (a) Schematic drawing of a sagittal sections of the adult mouse illustrating the injection sites (cortex) 
of the viruses. (b-e) show micrographs of the postnatal cortex 14 days after viral infection as indicated in 
the panels. GFP-immunostaining (green) is combined with cell type specific markers GFAP (red, b,d), 
PSANCAM (red, c) and DCX(red, e). Histogram in (f) depicts the quantification of GFP-positive cell types 
in the cortex 14 days after viral injection indicated on the x-axis. Note that the control GFP-virus infected 
cells are exclusively GFAP-positive and do not generate neurons 2 weeks after viral transduction. In 
contrast, almost 30% of GFP-positive cells have differentiated into young neurons 2 weeks after 
transduction with Pax6. RMS: rostral migratory stream, OB: olfactory bulb. Scale bars in (b,d) 3µm, (c) 
1µm, (e) 2µm. 
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Primer name Forward sequence Reverse sequence 
Pax6 CGGAGGGAGTAAGCCAAGAG TCTGTCTCGGATTTCCCAAG 
Emx1 GAGCCTTTGAGAAGAATCAC CTAGTCATTGGAGGTGACAT 
Emx2 TCAGAACCGGAGAACGAAAT TCTCCACCGGTTAATGTGGT 
Ngn2 ACCGCATGCACAACCTAAAC AGCGCCCAGATGTAATTGTG 
Olig1 CCAAAGAGGAACAGCAGCAG GTGGCAATCTTGGAGAGCTT 
Olig2 CACAGGAGGGACTGTGTCCT GGTGCTGGAGGAAGATGACT 
Mash1 AGATGAGCAAGGTGGAGACG TGGAGTAGTTGGGGGAGATG 
Dlx1 TGGAATCCGAACTCCTCATC TCACATCAGTTGAGGCTGCT 
Dlx2 TTTGACAGTCTGGTGGCTGA CTGTTGCTGCTGCTGCTGTT 
Gsh2 CCTTTGCTCAAAAGCCAGTT GGTGATGGTGATGATGATGC 
Vax1 ATTACTGTCGCCGGATCCTA GTATTGGCAACGCTGGAACT 
Prox1 AGGAAGGGCTATCACCCAAT ACGCGCATACTTCTCCATCT 
Nkx2.2 GCTGACCAACACAAAAGACG CTCTCCTCCTCTGGCCCTTC 
islet-1 GCAACCCAACGACAAAACTA GGCTGGTAACTTTGCACCTC 
Sox4 CTGCCGCAAGAAAGTGAAG TTCGTACAACCCCAGTGGAT 
tweety CCgCAGACAGGAGAGAAAAG CAATGGAAGGGCAGCATAAC 
Klf9 CAATGGAAGGGCAGCATAAC CTTACGACCTCCAAGGACCA 
Sirt2 CCCTGACTGGGCATCTATGT GTGGCATGGATTTTGACTCC 
Sox9 ATCAAGACGGAGCAGCTGAG TCTGATGGTCAGCGTAGTCG 
FABP7 ATCCAACCGAACCACAGACT GAAGGTGGCAAAGTGGTGAT 
LMO1 TCAAAGGTGCCATTGAGATG AAGCTGATCCCAGCTTTTA 
GAPDH ATTCAACGGCACAGTCAAGG TGGATGCAGGGATGATGTTC 




















cortex      
Pax6 1.1E-01 3.0E-03 1.3E-03 1.5E-03 1.3E-03 
Emx1 8.4E-02 1.2E-02 7.5E-04 1.3E-03 1.1E-03 
Emx2 1.0E-02 1.0E-03 2.0E-03 1.3E-03 5.0E-03 
Ngn2 6.0E-02 6.0E-03 4.1E-04 2.9E-04 2.8E-04 
GE      
Olig1 3.6E-03 1.8E-02 8.9E-02 6.2E-02 3.4E-02 
Olig2 1.8E-04 6.8E-03 9.5E-03 8.2E-03 2.0E-02 
Mash1 2.7E-04 3.1E-03 6.7E-04 6.3E-04 1.1E-03 
Dlx1 2.7E-03 7.6E-02 2.0E-03 1.6E-03 1.3E-03 
Dlx2 6.5E-03 5.9E-02 1.6E-04 8.7E-05 1.3E-04 
Gsh2 5.2E-05 6.0E-04 4.6E-05 2.1E-05 6.2E-05 
Vax1 2.7E-05 6.9E-03 1.1E-05 9.6E-06 7.8E-06 
Prox1 8.6E-05 2.3E-02 5.4E-03 6.3E-03 3.8E-03 
Nkx2.2 1.7E-04 6.1E-02 4.7E-04 6.7E-04 2.0E-04 













for 1 day 
neurospheres 
of the cortex 
differentiated 
for 3 days 
neurospheres 
of the GE 
differentiated 
for 1 day 
neurospheres 
of the GE 
differentiated 
for 3 days 
cortex       
Pax6 5.7E-02 1.2E-02 1.9E-03 6.1E-03 2.2E-03 6.3E-03 
Emx1 1.8E-02 2.3E-02 1.1E-03 4.5E-03 1.8E-03 3.1E-03 
Emx2 3.3E-03 2.1E-02 3.3E-03 7.6E-03 2.9E-03 6.2E-03 
Ngn2 1.5E-03 1.9E-03 5.1E-04 1.1E-03 4.0E-04 1.1E-03 
GE       
Olig1   3.1E-02 2.7E-03 2.7E-02 2.9E-03 
Olig2 1.4E-04 6.2E-04 4.9E-03 2.4E-03 4.0E-03 2.5E-03 
Mash1 3.5E-04 2.4E-04 1.3E-03 1.9E-03 1.1E-03 1.6E-03 
Dlx1 7.3E-04 7.3E-04 2.9E-04 1.0E-04 3.6E-04 7.7E-05 
Dlx2 3.9E-03 1.8E-03 1.7E-04 2.0E-04 2.0E-04 3.8E-04 
Gsh2 8.2E-05 2.1E-05 4.2E-05 9.4E-05 5.1E-05 7.7E-05 
Vax1   5.6E-06 5.0E-06 9.4E-06 1.1E-05 
Prox1   2.1E-03 5.5E-04 2.4E-03 9.6E-04 
Nkx2.2   9.0E-04 1.7E-03 8.1E-04 1.9E-03 




Table 2. Quantitative mRNA analysis of transcription factors in precursors derived from the 
hGFAPeGFP and WT E14 cortex and the precursors sorted on the basis of their GFP content from 
the cortex of E14 hGFAPeGFP mice (+ and ++) (b); and on undifferentiated neurosphere cultures 
from E14 cortex or GE or the adult SEZ exposed for 1 or 3 days to differentiating conditions (a). 
Note, that the region specific differences in gene expression between cells from cortex and GE are severely 














tweety 7.7E-01 2.1E-01 3.0E-03 3.0E-03 
sirt2 2.2E-01 5.1E-02 5.3E-04 2.6E-03 
Sox4 2.3E-04 2.0E-04 8.5E-04 9.8E-03 
Sox9 1.3E-02 7.9E-02 7.3E-02 5.0E-03 
FABP7 3.9E-01 1.1E-01 2.9E-03 2.9E-03 
KLf9 2.2E-01 1.1E-01 2.2E-02 3.5E-03 
LMO1 2.9E-04 4.6E-04 3.4E-03 2.0E-02 
 
 
Table 3. Quantitative mRNA analysis of the selected genes of the microarray experiments on the 
precursors sorted on the basis of their GFP content from the cortex of E14 hGFAPeGFP mice (+ and 
++) and on the precursors on undifferentiated neurosphere cultures from E14 cortex and on 











PLEASE SEE ATTACHED CD 
 
Table 4. Thresholded genes of the microarray experiment performed on the precursors sorted on the 
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Table 5. Thresholded genes of the microarray experiment performed on the precursors on 
undifferentiated neurosphere cultures from E14 cortex and on undifferentiated neurosphere cultures 
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